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After a severe brain injury leading to a period of coma, a 
possible scenario is that the patient remains with an altered state of 
consciousness for a prolonged period. These disorders of 
consciousness (DOC) encompass the unresponsive wakefulness 
syndrome (UWS); a state of awakening with only reflexive 
movements and the minimally conscious state (MCS); where 
fluctuating but reproducible signs of consciousness are observed. The 
ability to functionally use objects or communicate then marks the 
transition to the emergence of the MCS (EMCS). The management of 
patient with DOC represents a medical challenge from both 
diagnostic and treatment perspectives. Given the absence of 
subjective report, the brain injury-associated cognitive and motor 
deficits and the fluctuations in vigilance that characterize them, the 
misdiagnosis rates can go up to 40%, with dramatic impact on their 
care. Furthermore, therapeutic approaches to increase their level of 
consciousness and ameliorate their functional status are lacking and 
poorly investigated. The present thesis had therefore two aims: i) 
better characterizing the path to recovery from a behavioral 
perspective (Part One) and ii) investigate the use of non-invasive 
brain stimulation, more specifically transcranial direct current 
stimulation (tDCS), and its different application parameters, as a 
treatment option (Part Two). 
In Part One, we present two retrospectives studies using data 
collected by therapists in a specialized rehabilitation setting. We used 




R), the current gold standard for behavioral assessment of DOC 
patients, to pin down the initial transition from unconscious states 
(i.e., coma or UWS) to recovery of consciousness (i.e., MCS or EMCS). 
Among the 13 CRS-R behaviors depicting consciousness, visual 
pursuit most often marked the transition while the time to recovery 
of consciousness was approximately six weeks after injury. We then 
focused on a specific and highly clinically relevant behavior that is the 
recovery of communication; anticipated by both relatives and 
therapists as it substantially ameliorates the interactions and the 
care. Within our 8-week observation period, the ability to answer 
some close-ended questions, despite of accuracy (i.e., intentional 
communication) was usually recovered within 40 days after injury 
while correctly answering six out of six close-ended questions (i.e., 
functional communication) reappeared about nine days later. 
In Part Two, we develop four studies: a pilot trial, two 
randomized controlled trials and a study protocol, aiming at 
answering the following questions regarding the use of tDCS as a 
therapeutic option: In what kind of setting can we apply it? Where 
should we stimulate? When? 
Which setting – In a feasibility and efficacy randomized 
controlled trial, we investigated the home-based application of tDCS, 
applied for a prolonged period of 20 days over the left prefrontal 
cortex of 27 chronic MCS patients following traumatic or non-
traumatic insult. There was a significant behavioral treatment effect 
at the group level, as long as at least 80% of the planned sessions 
were applied. No severe adverse events were reported. 
Where – The first pilot study investigated the effects of a 
single session of tDCS applied over the motor cortex in ten UWS and 




behavioral treatment effect was identified at the group level while at 
the individual level, two patients responded to tDCS by showing a 
new sign of consciousness for the first time after active and not sham 
stimulation. In a randomized controlled trial performed on 46 
patients in UWS, MCS or EMCS with traumatic or non-traumatic 
etiologies, we used multifocal network-based tDCS to stimulate the 
frontoparietal network, also known as the external awareness 
network. Again, there was no group level behavioral treatment effect 
while at the individual level, seven patients responded positively to 
tDCS. Seven other patients negatively responded by losing a sign of 
consciousness after active stimulation that was present before. These 
patients presented an initial significantly higher complexity of the 
EEG signal in the theta band.  
When – Finally, we developed an original study protocol 
based on brain-state dependent application of tDCS, in a closed-loop 
fashion. Based on electroencephalographic entropy patterns as 
markers of vigilance, we aim to compare the behavioral and 
electrophysiological effects of tDCS applied at high and low levels of 
vigilance and hypothesize this approach will significantly impact the 
individual response to tDCS. 
Overall, the present findings show that patients with DOC 
have a strong potential for recovery in the subacute phase of their 
injury, and that false despair should be avoided in the early stages. 
These patients could benefit from tDCS, which has a proven efficacy 
when applied over the prefrontal cortex and when repeating the 
amount of sessions. Caregivers and relatives can be safely involved to 
apply this type of treatment and there is a potential in determining 






A la suite d’une lésion cérébrale sévère ayant mené à un 
coma, il est possible de présenter une altération prolongée de la 
conscience. Ces états de conscience altérée (ECA) comprennent le 
syndrome d’éveil non-répondant (ENR) ; un état d’éveil avec la 
présence de comportements réflexes uniquement, et l’état de 
conscience minimale (ECM) ; où l’on peut observer des signes 
fluctuants, mais reproductibles de conscience. La capacité d’utiliser 
des objets ou de communiquer de manière fonctionnelle marque 
alors l’émergence de l’ECM (EECM). La prise en charge des patients 
en ECA représente un défi médical d’un point de vue à la fois du 
diagnostic et des perspectives de traitement. Étant donné 
l’impossibilité de compte-rendu personnel, les déficits cognitifs et 
moteurs associés à l’atteinte cérébrale, ainsi que les fluctuations de 
vigilance qui caractérisent ces patients, le taux d’erreur diagnostique 
peut atteindre 40%, avec des conséquences dramatiques sur leur 
prise en charge. De plus, les options thérapeutiques visant à 
augmenter leur niveau de conscience et améliorer leur statut 
fonctionnel manquent et sont peu investiguées. Cette thèse avait dès 
lors deux objectifs : i) mieux caractériser la récupération 
comportementale (première partie) et ii) explorer l’usage de la 
stimulation cérébrale non-invasive, et plus particulièrement la 
stimulation transcrânienne à courant continu (ou tDCS) et ses 





Dans la première partie, il est question de deux études 
rétrospectives qui ont été réalisées en centre de rééducation 
spécialisé. Nous avons utilisé des évaluations répétées avec l’échelle 
de récupération du coma (CRS-R) – la mesure étalon pour 
l’évaluation comportementale des patients en ECA à l’heure actuelle 
– afin de déterminer la première transition depuis des états 
inconscients (c-à-d. coma ou ENR) vers la récupération de la 
conscience (c-à-d. ECM ou EECM). Parmi les 13 signes 
comportementaux de conscience de la CRS-R, la poursuite visuelle 
annonçait le plus souvent cette transition. De plus, la durée de 
récupération de la conscience était d’environ six semaines après la 
lésion. Nous nous sommes ensuite concentrés sur un comportement 
spécifique et d’un grand intérêt clinique qu’est la récupération de la 
communication ; très attendue par les proches et les soignants, car 
elle améliore de manière substantielle les interactions et les soins. 
Sur la période des huit semaines d’observation, la capacité de 
répondre à certaines questions fermées (c-à-d. la communication 
intentionnelle) était récupérée endéans 40 jours après la lésion 
tandis que la capacité de répondre correctement à au moins six 
questions fermées (c-à-d. la communication fonctionnelle) était 
récupérée environ neuf jours plus tard.  
Dans la seconde partie, quatre études sont développées : une 
étude pilote, deux essais randomisés contrôlés et un protocole, avec 
l’objectif de répondre aux questions suivantes concernant l’utilisation 
de la tDCS comme outil thérapeutique : Dans quel environnement 
stimuler ? Où ? À quel moment ? 
Quel environnement – Dans un essai randomisé contrôlé de 
faisabilité et d’efficacité, nous avons étudié les effets de la tDCS du 




prolongée de 20 jours, chez des patients en ECM chronique à la suite 
d’une lésion traumatique ou non. Il y avait un effet comportemental 
significatif du traitement au niveau du groupe, pour autant qu’au 
moins 80% des sessions prévues étaient effectivement administrées. 
Où – La première étude pilote a permis d’étudier les effets 
d’une session de tDCS du cortex moteur chez dix patients en ENR et 
ECM à la suite de lésions traumatiques ou non-traumatiques. Nous 
n’avons pas identifié un effet comportemental du traitement au 
niveau du groupe. Au niveau individuel, en revanche, deux patients 
ont répondu à la tDCS en montrant un nouveau signe de conscience 
pour la première fois après la stimulation active et non placebo. 
Ensuite, dans un essai randomisé contrôlé incluant 46 patients en 
ENR, ECM ou EECM, à la suite d’une lésion traumatique ou non, nous 
avons utilisé la tDCS multifocale afin de stimuler le réseau 
frontopariétal, également connu comme étant le réseau de la 
conscience externe. À nouveau, aucun effet comportemental du 
traitement n’a été identifié au niveau du groupe, alors qu’au niveau 
individuel, sept patients ont répondu positivement à la tDCS. En 
revanche, sept autres patients ont répondu négativement à la 
stimulation en perdant un signe de conscience qui était présent 
auparavant. Ces patients se démarquaient électrophysiologiquement 
par une complexité du signal EEG significativement plus élevée dans 
la bande thêta. 
Quand – Finalement, nous avons développé un nouveau 
protocole utilisant un mode d’application dépendant de l’état 
cérébral, dans un modèle en boucle fermée. En se fondant sur des 
marqueurs entropiques de vigilance identifiés par 
électroencéphalographie, nous allons comparer les effets 




un niveau de vigilance élevé ou faible, en émettant l’hypothèse que 
cette approche aura un impact significatif sur la réponse individuelle 
à la tDCS. 
Globalement, ces résultats montrent que les patients en ECA 
ont un bon potentiel de récupération au stade subaigu de leur lésion 
et qu’un faux désespoir devrait être évité lors de la prise en charge 
initiale. Ces patients peuvent bénéficier de la tDCS ; elle a démontré 
son efficacité lorsqu’elle est appliquée au niveau du cortex 
préfrontal, et ce lors de sessions répétées, et il est également 
sécuritaire d’impliquer activement les soignants et les proches dans 
cette approche thérapeutique. Enfin, déterminer le moment 










AE   Adverse Event 
CMD   Cognitive Motor Dissociation 
CRS-R   Coma Recovery Scale-Revised  
DBS   Deep Brain Stimulation 
DLPFC   Dorsolateral Prefrontal Cortex 
DRS   Disability Rating Scale  
DOC   Disorders of Consciousness 
DOCS   Disorders of Consciousness Scale 
EEG   Electroencephalography 
EMCS   Emergence from the Minimally Conscious State 
ES  Effect Size 
FC   Functional communication 
FDG-PET  Fluorodesoxyglucose positron emission tomography 
fMRI   Functional Magnetic Resonance Imaging 
FOUR   Full Outline of UnResponsiveness 
GCS   Glasgow Coma Scale 
GLS   Glasgow-Liège Scale 
GPI   Globus Pallidus Interna 
IC   Intentional Communication 
IQR   Interquartile Range 
ITB   Intrathecal Baclofen 
IQBA   Individualized Quantitative Behavioral Assessment 
LTD   Long-Term Depression 
LTP   Long-Term Potentiation 




MAS   Modified Ashworth Scale 
MCS   Minimally Conscious State 
mITT   Modified Intention to Treat 
MRI   Magnetic Resonance Imaging 
MTS   Modified Tardieu Scale 
NCS-R   Nociception Coma Scale-Revised  
NMDA   N-methyl-D-aspartate  
PCI   Perturbational Complexity Index 
POC   Percentage of Change 
PP   Per Protocol 
REDCap  Research Electronic Data Capture 
REM sleep  Rapid Eye Movement sleep 
rTMS   Repeated Transcranial Magnetic Stimulation 
SCS   Spinal Cord Stimulation 
TBI   Traumatic Brain Injury 
tACS   Transcranial Alternating Current Stimulation 
tDCS   Transcranial Direct Current Stimulation 
TMS   Transcranial Magnetic Stimulation 
tRNS   Transcranial Random Noise Stimulation 
UMN   Upper Motor Neuron 
UWS   Unresponsive Wakefulness Syndrome 
VNS   Vagal Nerve Stimulation 
VS   Vegetative State 
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1.1. Consciousness and its altered states 
 
Defining consciousness has been a matter of debate for a 
very long time, both within and beyond the scope of neurosciences. 
Originally, John Locke proposed a definition related to the modern 
concept of consciousness in 1690 as “the perception of what passes 
in a man’s own mind” (Locke, 1841). Since then, definitions have 
flourished, borrowing alternately concepts from philosophical, 
psychological or religious fields. The clinical approach, widely used by 
neuroscientists, researchers and care practitioners, uses two main 
components to define different levels of consciousness: arousal and 
awareness. Arousal means wakefulness while awareness refers to the 
content of consciousness (Plum and Posner, 1972; Laureys et al., 
2002). A natural conscious experience is therefore characterized by 
maximum levels of both arousal and awareness: the person is awake 
in the sense that the eyes are spontaneously open; the person is also 
aware in the sense that he/she is mindful of his/her own 
environment. While one could think a person needs to be awake in 
order to be aware, lucid dreaming or Rapid Eye Movement sleep 
(REM sleep) are conditions that prove the contrary. This example 
shows that various combinations of high or low levels of wakefulness 
and awareness are possible and that a continuum of modified states 
of consciousness exists. Figure 1 is a commonly used two-
dimensional representation of this continuum using the two axes 
(i.e., arousal and awareness) to integrate these modified states of 
consciousness. Besides different stages of sleep or the medical 
intervention of general anesthesia, this diagram includes a clinical 
population of interest: patients with disorders of consciousness 
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(DOC). DOC include the unresponsive wakefulness syndrome (UWS; 
previously coined as ‘vegetative state’ – VS – (Laureys et al., 2010)) 
and the minimally conscious state (MCS); later subcategorized 
between MCS plus and minus (Bruno et al., 2011).  
 
 
Figure 1 – Simplified diagram of the two main components of 
consciousness: the level of consciousness (i.e., arousal or wakefulness) and 
the content of consciousness (i.e., awareness of the experience). From 
Laureys S (2009) Coma. Encyclopedia of Neuroscience 2: 1133-1142. With 
the authors’ permission. 
 
DOC usually occur after a severe brain injury leading to coma. 
The etiologies vary from hypoxic/ischemic incidents, traumatic brain 
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injury, or infection; but are commonly subdivided into non-traumatic 
and traumatic brain injuries (TBI).  
In the comatose state, the patient is completely 
unresponsive to the environment, as assessed at the bedside by the 
sustained absence of eye-opening, even in response to painful 
stimulation (Plum and Posner, 1972). This is due to the alteration of 
the arousal systems (reticular activation system) located in the 
brainstem, the basal ganglia and projecting up to cortical areas. As 
opposed to other states of transient unconsciousness (e.g., 
concussion, syncope), coma means the period of unconsciousness 
lasts for at least one hour. Similarly, in contrast to popular beliefs, 
the coma period does not extend over four weeks. Indeed, it then 
evolves either to brain death, to UWS or to MCS. In brain death, vital 
functions such as respiration, homeostatic regulation or cardiac 
function are irreversibly down (Bernat, 1998). The diagnosis is made 
within six to 24 hours post-injury (Barclay, 1981). For the UWS, the 
first formal definition brings us back to 1972, when Jennett and Plum 
introduced the “Persistent Vegetative State” (PVS) to define patients 
who awoke from coma (i.e., opened their eyes) but were unable to 
show responses other than reflexive (e.g., withdrawal to painful 
stimulation) (Jennett and Plum, 1972). They proposed the term 
vegetative with reference to the preservation of autonomic nervous 
functions (e.g., sleep-wake cycles, digestion, respiration) and are 
insured by the vagus nerve. The authors also remind the term 
vegetative suggested relates to the Oxford English Dictionary 
definition of “to vegetate”; “to live a merely physical life, devoid of 
intellectual activity or social intercourse” (1740) and of “vegetative”; 
“an organic body capable of growth and development but devoid of 
sensation and thought” (1764). The term “persistent” was introduced 
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in opposition to the existing terms around that period that had an 
irrecoverable connotation such as “permanent” or “irreversible”. 
Later on, in 1994, the US Multi-Society Task Force on PVS extended 
the medical description of these patients by describing seven 
diagnostic criteria: (1) no evidence of self or environmental 
awareness; (2) no evidence of voluntary responses to external 
stimuli; (3) no evidence of language abilities; (4) intermittent 
wakefulness; (5) preservation of autonomic functions; (6) 
incontinence and; (7) variable preservation of cranial-nerve and 
spinal reflexes (The Multi-Society Task Force on PVS, 1994a). They 
also described, for the first time, a time frame for consciousness 
recovery based on prospective data collected on more than 750 post-
comatose patients. According to their statement, recovery of 
consciousness after a non-traumatic brain injury (non-TBI) is unlikely 
after three months while after a TBI, this period extends to a year 
(The Multi-Society Task Force on PVS, 1994b). 
While the term vegetative was initially chosen to describe 
preservation of vegetative functions, it appeared later on that an 
increasing number of care practitioners felt uncomfortable using that 
terminology, partly given the pejorative connotation perceived by 
most of the lay public and the media. Indeed, the ongoing confusion 
with the concept of vegetable felt unacceptable for many medical 
and scientific authors as well as social, political and religious groups. 
The fact that patients could be incorrectly referred to as vegetable-
like was perceived as a violation of their right to be considered as 
human beings. To respond to the need for a new name, the European 
Task Force on Disorders of Consciousness presented the 
Unresponsive Wakefulness Syndrome (UWS): a neutral descriptive 
term depicting patients showing numerous clinical symptoms (hence 
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the use of syndrome) of wakefulness without responsiveness (i.e., 
the inability to show purposeful behaviors or command following 
while being awake as shown by spontaneous or induced eye opening) 
(Laureys et al., 2010). 
The Minimally Conscious State (MCS) was in turn introduced 
in 1997 as a replacement for the term Minimally Responsive State 
(Giacino et al., 1997) to better discriminate patients lacking any sign 
of consciousness (i.e., coma and UWS) from those presenting with 
some preservation of conscious awareness. However, further 
diagnostic criteria were needed: they were released in 2002 and 
based on an expert panel consensus (the Aspen Neurobehavioral 
Conference Workgroup) (Giacino et al., 2002). The following 
behavioral features were described to diagnose MCS: following 
simple commands, ability to gesture or verbalize yes/no responses 
(regardless of accuracy), intelligible verbalization, and showing 
purposeful behaviors occurring following relevant stimuli that are 
distinguishable from reflexive responses (e.g., appropriate smiling or 
crying, reaching for objects and/or using them, eye pursuit or fixation 
to moving stimuli). 
Once the criteria were well established and applied, it 
appeared that the MCS clinical entity was quite heterogeneous in 
terms of range of behaviors observed. Therefore, it was later 
subdivided into two clinical entities: the MCS plus (MCS+) and the 
MCS minus (MCS-). Initially, Bruno and colleagues defined MCS+ 
based on the presence of either command following, intelligible 
verbalization or intentional communication while MCS- included the 
rest of the MCS features, such as automatic movement, object 
manipulation or visual pursuit (Bruno et al., 2011). This initial 
dichotomous classification was based on the level of complexity of 
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the observed behaviors. Later neuroimaging studies assessed the 
difference between MCS+ and MCS-, using however a different 
classification. Indeed, another inaugural study led by Bruno et al used 
[18F]-fluorodeoxyglucose positron emission tomography (FDG-PET) 
and functional magnetic resonance imaging (fMRI) to assess cerebral 
glucose metabolism and functional connectivity in patients in MCS, 
but they characterized MCS+ by the presence of command following 
only. This study showed a significantly greater preservation of 
metabolic and functional activity (at rest) in the language network 
(i.e., Broca’s and Wernicke’s regions, left premotor, left caudate and 
post- and precentral cortices) of patients behaviorally diagnosed as 
MCS+, as compared to the MCS- ones (Bruno et al., 2012). Later 
neuroimaging studies however relied on the first criteria proposed by 
Bruno et al (i.e., command following, intelligible verbalization and/or 
intentional communication) and showed similar results (Zheng et al., 
2017; Aubinet et al., 2018). There seems to be a lack of consensus 
about the exact diagnostic criteria for MCS+, as confirmed by authors 
using either their own criteria (e.g., object recognition, command-
following and intelligible verbalization (Schnakers et al., 2015)) or 
simply generally referring to “preserved language functions” or 
“high-level behavioral interactions” (Estraneo et al., 2016; 
Guldenmund et al., 2016). As it was the case for the definition of MCS 
before 2002, standardized consensus-based criteria still need to be 
set up. 
Like the vegetative state, the term minimally conscious is 
currently subject to some debate as it represents a too large and 
heterogeneous set of states. The term “minimally” raises confusion, 
notably for caregivers and relatives and can also be seen as 
pejorative. On the contrary, the “conscious state” is usually perceived 
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as positive, assuming the patient is conscious and thereby able to 
self-report which is contradictory with the typical clinical picture. For 
these and other reasons, Naccache suggested to reframe this 
definition and proposed the term ‘cortically mediated state’. This 
terminology is mainly based on the CRS-R, in which signs of MCS 
actually depict cortically mediated behaviors (Naccache, 2018). While 
a consensus still needs to be reached on this interesting 
reconceptualization, the present work will continue to use the term 
MCS, as it is also encouraged by recently updated guidelines from 
both American and European Academies of Neurology (Giacino et al., 
2018b; Kondziella et al., 2020).  
When the patient regains the ability to show some even 
more complex behaviors such as functional communication (i.e., the 
ability to answer correctly six out of six situational questions) or 
functional use of objects (i.e., the ability to appropriately use two 
different objects), he is considered to have emerged from the MCS 
(Giacino et al., 2002). Emergence from the MCS (EMCS) lies therefore 
between the MCS and the fully conscious state but the precise 
boundary is ill-defined. Recent research emphasizes, however, the 
important disability and the cognitive alterations (in orientation, 
memory and attention) associated with the EMCS state, that are 
similar with the acute confusional state (Bodien et al., 2019). To sum 
up, after a severe brain injury leading to a coma, a patient can evolve 
either to brain death or to VS or MCS. From there, the path to full 
recovery passes by the EMCS and severe disabilities, as shown in 
Figure 2.  
 




Figure 2 – Path to recovery from coma with gradually increasing levels of 
behavioral and cognitive output. From (Chatelle and Laureys, 2011), with 
the authors’ permission. 
 
However, a full recovery is never guaranteed. This 
progression path is not fixed in the sense that a patient can evolve 
from UWS to MCS and then decline back to UWS. Not only the 
evolution after brain injury is a highly dynamical situation, but also 
these patients are known to present fluctuation of their state over 
time, in different time scales (from one hour to another as well as 
from one day to another or a week). This makes diagnosing them a 
challenging task for clinicians. 
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From an epidemiological perspective, patients with DOC 
present a low prevalence and fall within the definition of a rare 
disease. Overall, UWS prevalence estimation varies from 0.2 to 6.1 
patients per 100 000 individuals as reported by a systematic review 
including data from Europe, Asia and the USA (van Erp et al., 2014). 
Most of the studies retrieved in this review however predated the 
clinical definition of MCS (Giacino et al., 2002) and thereby most 
probably merge UWS and MCS cases. Another review focusing on the 
USA reports prevalence estimates ranging between 1.78 and 15 per 
100 000 individuals for UWS and 40 and 99 per 100 000 individuals 
for MCS (Giacino et al., 2018a). Given the local economic and health 
insurance factors, these figures are presumably underestimated as 
many patients are not tracked in the healthcare system. In Belgium, 
initial censuses from the Health Federal Public Service report 359 
UWS and MCS patients in 2004 and an average of 250 new cases 
yearly. It is difficult to obtain the exact prevalence because of the 
heterogeneity of the diagnostic criteria applied, especially regarding 
the MCS. 
As DOC classically occur following a severe brain injury, it is 
relevant to know the incidence of DOC in patients who sustained 
such injury. Again data is lacking but a Norwegian study focused on 
prospectively computing the rate of DOC in adults after a TBI using 
the CRS-R. They found that 2% of patient admitted with TBI remain in 
UWS or MCS three months after injury and that this rate was reduced 
by half after one year (Løvstad et al., 2014). All these studies 
acknowledge that epidemiological data for DOC is difficult to 
accurately collect, mainly because of methodological flaws in existing 
publications and the challenge of accurately diagnosing these 
patients.   
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1.2. Diagnosing disorders of consciousness 
 
Obtaining an accurate diagnosis has tremendous implications 
regarding several aspects. First of all, from an ethical perspective, 
diagnosing a coma from an UWS or a MCS will have consequences 
regarding end-of-life decisions, since the prognosis differs for each 
state. Furthermore, clinicians’ opinion toward treatment withdrawal 
is not the same for UWS and MCS: they tend indeed to remove 
treatment less frequently in MCS (Demertzi et al., 2011). Second, the 
pain management may vary as patients in UWS and MCS do not 
process painful stimuli in similar ways. Neuroimaging studies showed 
a cortical activation in MCS patients following a painful stimulus that 
is similar to healthy controls, while UWS patients showed way less 
activation (Laureys et al., 2002; Boly et al., 2005). To obtain a 
diagnosis regarding the level of consciousness of these patients 
several tools are available. We can distinguish the diagnosis 
performed at the bedside, where a clinician will obtain behavioral 
information; and the complimentary diagnostic information provided 
by neuroimaging, where the clinician will obtain some additional 
data, but often delayed due to the demanding processing the 
collected signals require. 
 
1.2.1. At the bedside 
 
Naccache accurately described the “bipedal approach” of the 
neurologist when evaluating a patient presenting neurological 
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symptoms (Naccache, 2018). The first component of this approach is 
the so-called “behaviorist foot”, which consists in the observation of 
spontaneous and elicited behaviors (e.g., reflex testing). The second 
one, the “psychologist foot”, concerns the collection of patient’s 
subjective reports (e.g., symptoms description). By combining both 
approaches, the neurologist maximizes his chances to establish the 
correct diagnosis. However, as mentioned is his work, when working 
with patients who have trouble understanding and communicating 
(e.g., dementia, newborn babies), we cannot rely on the patient’s 
subjective report and have to focus on the objective assessment 
approach alone. This includes of course DOC patients, for whom the 
neurologist or clinician aims to assess the level of consciousness they 
have (UWS, MCS or EMCS), but without subjective report. This makes 
the situation paradoxical since consciousness itself is defined as the 
ability to formulate internal thoughts and to report them (e.g., 
feelings, perception, actions) (Dehaene and Naccache, 2001). To help 
the “one-legged” neurologist making the most of his behaviorist foot, 
standardized behavioral scales were developed to evaluate the level 
of consciousness in DOC patients. Initially, the Glasgow Coma Scale 
(GCS) was developed to “assess the depth and duration of impaired 
consciousness and coma” (Teasdale and Jennett, 1974). It consists of 
three subscales assessing motor responsiveness, verbal output and 
eye opening and can be performed in a couple of minutes. The total 
score ranges from 3 (deep coma) to 15 (normal consciousness). Later 
in the 1990s, a new generation of scales designed specifically for DOC 
patients were developed, with varying levels of structure and 
standardization. This proliferation of new DOC scales led Seel and 
colleagues to perform a systematic review in 2010 and to evaluate 
the diagnostic utility (i.e., differentiating UWS, MCS and EMCS), the 
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interrater reliability, the validity and the prognostic value of these 
instruments (Seel et al., 2010). They identified 13 different 
assessment scales for DOC and rated seven aspects based on expert 
consensus between paired reviewers: (1) standardized 
administration and scoring guidelines; (2) content validity; (3) 
reliability (i.e., internal consistency, interrater reliability, test-retest 
reliability); (4) criterion validity; (5) construct validity; (6) diagnostic 
validity and; (7) prognostic validity. The experts’ ratings ranged from 
unacceptable to excellent. The scale that best survived the ranking is 
the Coma Recovery Scale-Revised (CRS-R) (Giacino et al., 2004), 
given its excellent content validity, acceptable standardized 
administration and scoring procedures, as well as good to excellent 
reliability. Its criterion validity is however unproven. It was also the 
only scale recommended for use to assess patients with DOC with 
minor reservations. Other scales such as the Sensory Modality 
Assessment and Rehabilitation Technique (SMART) (Gill-Thwaites and 
Munday, 1999), the Wessex Head Injury Matrix (WHIM) (Shiel et al., 
2000) or the Disorders of Consciousness Scale (DOCS) (Pape et al., 
2005) were recommended with moderate reservations, while some 
were simply not recommended (e.g., Full Outline of 
UnResponsiveness; FOUR (Wijdicks et al., 2005), Glasgow-Liège Scale; 
GLS (Born, 1988)).  
The CRS-R presented by Giacino and colleagues in 2004 is 
therefore currently the gold standard for behavioral assessment of 
patients with DOC. It consists in 23 items, hierarchically organized 
within six different subscales. Every subscale is designed to 
interrogate a function: auditory, visual, motor, oromotor/verbal, 
communication and arousal. The list of the items and their 
administrating procedures can be found in Appendix 1. Within each 
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subscale, the items range from high-level cortically mediated 
behaviors (e.g., response to command) to lower-level reflexive 
movements (e.g., auditory startle). The use of the CRS-R requires 
some training, but is an essential tool for clinicians and researchers 
working with patients with DOC. Since its development, there has 
been ongoing research on how to best use the administration 
guidelines. For instance, the CRS-R recommends to use a “a brightly 
colored or illuminated object” to assess visual fixation, but Di and 
colleagues showed that using a mirror is the most efficient, as 
compared to a ball or a light (Di et al., 2014). Likewise, using the 
patient’s own name to evaluate localization to sound, is more 
efficient than using a meaningless sound such as a ringing bell, given 
the high saliency of the personal stimulus (Cheng et al., 2013). In the 
same vein, using patient’s preferred objects to evaluate functional 
object use (e.g., cigarette or paper instead of the comb or cup 
recommended by the CRS-R) elicits more responses in patients in 
EMCS (Sun et al., 2018). Finally, a key study regarding CRS-R 
evaluation in DOC patients concerns the repetition of the 
assessments to tackle the behavioral fluctuation, that is a well-known 
feature of this population (Sherer et al., 2005; Candelieri et al., 2011; 
Piarulli et al., 2016). Wannez and colleagues indeed showed that the 
number of consecutive assessments had a significant impact on the 
clinical diagnosis: up to the fourth evaluation, the risk of misdiagnosis 
is still 17%, while the risk is reduced to 10% at the fifth assessment 
and onwards (with no significant difference anymore between 
misdiagnosis rates). The authors therefore recommend performing at 
least five CRS-R assessments in DOC patients to obtain an accurate 
diagnosis (Wannez et al., 2017b). 
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1.2.2. Using neuroimaging 
 
Neuroimaging methods allow for structural, metabolic and 
electrophysiological investigation of the brain and may complement 
the behavioral diagnosis. This is of particular interest in specific cases 
where executive functions are impaired and/or the deficit in motor 
abilities prevent the patient to show any behavioral response while 
having, at least partly, preserved signs of consciousness. This 
situation, coined cognitive motor dissociation (CMD) or covert 
consciousness (Laureys and Schiff, 2012; Fernández-Espejo et al., 
2015), can raise the rate of misdiagnosis up to 32% (Stender et al., 
2014). Therefore, the role of neuroimaging to detect responses 
invisible at the bedside is of paramount importance. Magnetic 
resonance imaging (MRI) uses strong magnetic fields to form 
tridimensional representations of the brain’s structure. It is therefore 
widely used in clinical settings to objectify swelling, bleeding and 
other injury processes concerning white and grey matter in patients 
with brain injury (Kampfl et al., 1998; Giacino et al., 2014). For white 
matter specifically, diffusion tensor imaging (DTI) uses the diffusion 
of water molecules to reveal the structural integrity of axon tracts in 
the brain and thereby map white matter tracts. The decrease in 
water diffusion would reflect a diminished myelination of white 
matter and is negatively correlated with functional outcome 
(Newcombe et al., 2011). 
Functional MRI (fMRI) uses the blood oxygen level 
to monitor neuronal activity and therefore enables measurement of 
cerebral processes with a high temporal resolution. At rest, 
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spontaneous blood oxygen level fluctuations allow to assess 
functional connectivity between regions of interest. Within the 
default mode network, for instance, the connectivity decreases with 
the level of consciousness and can discriminate between conscious, 
MCS, UWS and comatose patients (Demertzi et al., 2015; Di Perri et 
al., 2016). In so-called active paradigms, cortical activation can be 
measured with fMRI following application of visual, auditory and/or 
somatosensory stimuli and is known to encompass associative 
cortices in patients in MCS, similar to what is observed in healthy 
controls (Di et al., 2008). While patients in UWS show, in contrast, 
activation only in primary sensory areas following these stimuli (Di et 
al., 2007). fMRI is particularly interesting in the detection of CMD and 
could even, in some cases, be used to establish communication using 
« yes-no » active paradigms (Monti et al., 2010). 
 From a metabolic standpoint, FDG-PET studies the glucose 
consumption of cerebral areas and can therefore quantify the global 
and regional brain metabolism, based on 18FDG uptake. In patients in 
UWS, the decrease in global brain metabolism can go up to 40% as 
compared to healthy controls (Laureys, 2005). As opposed to 
previous beliefs, however, global brain metabolism does not 
accurately discriminate between conscious and unconscious states. 
Some areas are indeed more crucial than others in consciousness 
recovery processes (i.e., frontoparietal network, posterior parietal 
cortex and anterior cingulate cortices (Nakayama et al., 2006; Silva et 
al., 2010)). Diagnostic-wise, FDG-PET seems to present better 
sensitivity and agreement with behavioral diagnosis as compared to 
fMRI (Stender et al., 2014). 
 Recently, emphasis has been placed on more affordable, 
user-friendly bedside neuroimaging tools such as 
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electroencephalography (EEG). High-density resting-state EEG (256 
channels) derived metrics, for instance, are able to accurately 
discriminate between UWS, MCS and EMCS (Chennu et al., 2017) and 
event present prognostic value. Indeed, patients with high 
connectivity (i.e., strong connections between different cortical 
areas) in the delta frequency band (slow wave activity) tend to have a 
negative outcome at one year, meaning dead or chronic UWS. In 
contrast, patients with positive outcomes (i.e., severe disability up to 
good recovery) had lower delta connectivity (Chennu et al., 2017). 
Low-density clinical EEG (19 channels) also confirm poor CRS-R 
outcome when important delta activity is observed and better 
outcome when alpha rhythms are present (Bagnato et al., 2015). 
Beyond resting-state, recording the EEG brain response when 
exposed to external perturbation (e.g., transcranial magnetic 
stimulation – TMS) can also contribute to characterize patients’ levels 
of consciousness. Again, patients in UWS and in MCS present 
different type of responses to the magnetic trigger: a stereotypical 
slow wave that mostly remains local and short lasting for the first; a 
widespread, differentiated and long lasting wave for the second 
(Rosanova et al., 2012). The perturbational complexity index (PCI) 
allows to quantify these patterns, by calculating the spatial and 
temporal brain responses to the TMS perturbation. PCI successfully 
differentiates between conscious and unconscious states, with a 
clear-cut difference at the individual level (Casali et al., 2013; 
Casarotto et al., 2016). The calculation of the PCI uses a specific 
lossless data compression algorithm based on providing an upper 
bound to the data compression ratio: the Lempel-Ziv compression 
(Ziv and Lempel, 1978). The range of sensitive techniques 
complementing the bedside behavioral diagnosis is thus wide (Figure 
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3). But we should keep in view the limits inherent to their use, 
including poor affordability, high expertise required for both 




Figure 3 – Illustrative summary of some of the neuroimaging techniques 
available for DOC patients across different diagnoses. Brain activity typically 
decreases with the level of consciousness. From (Gosseries et al., 2014), 
with the authors’ permission.  
1.3   Clinical management of disorders of consciousness 
38 
 
1.3. Clinical management of disorders of 
consciousness 
 
1.3.1. Active treatment 
 The field of treatment options for patients with DOC suffers 
from a scarcity of evidence due to the small amount of studies 
and/or the low class of evidence they provide. To date, both 
pharmacological and non-pharmacological options haven been 
investigated in either randomized controlled trials, open-label and/or 
case report studies. The aim of these studies is to improve patients’ 
level of consciousness and functional recovery, while understanding 
the cerebral mechanisms of the interventions. 
1.3.1.1. Pharmacological treatments 
Only one pharmacological agent has been investigated in a 
large randomized controlled trial providing class II evidence: 
amantadine hydrochloride. Initially used as an antiviral agent and in 
order to treat Parkinson, it acts as a dopamine agonist and N-methyl-
D-aspartate (NMDA) antagonist (Peeters et al., 2002). Its efficacy for 
DOC patients has been shown in subacute (4 – 16 weeks after injury) 
patients with TBI; as compared to the placebo arm, the amantadine 
arm had a significantly faster recovery over 4-week treatment and 2-
week follow-up, as measured by the Disability Rating Scale (DRS) and 
the CRS-R (Giacino et al., 2012). 
Zolpidem is a GABA-agonist hypnotic agent that occasionally 
induces paradoxical responses in patient with DOC. Dramatic, yet 
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transient, improvements have been described (e.g., recovery of 
functional communication, reading abilities) but the rate of 
responders is extremely low. A double-blind crossover randomized 
controlled trial performed with 84 patients with DOC reported 5% 
(n=4) of responders only (Whyte et al., 2014). A higher proportion 
(20%) was described in a placebo-controlled trial that included 60 
patients with DOC; improvements included recovery of response to 
command or objet localization (Thonnard et al., 2014). Further 
studies are needed to determine why some patients respond so well 
and others do not. 
An increasing interest has been growing around 
apomorphine as a new treatment option. This non-selective 
dopamine agonist has a relatively short half-life (30 – 90 minutes 
(Kolls and Stacy, 2006)) and it is therefore recommended to 
administer it continuously through a subcutaneous pump 
(Katzenschlager et al., 2005). For DOC patients, one case report and 
one prospective open-label trial (including 8 patients) performed by 
the same team reported fast and nearly complete cognitive and 
functional recovery, with enduring effects after the end of the 3-
month treatment period (Fridman et al., 2009, 2010). Given the 
promising results, proper randomized controlled trials are on their 
way (Sanz et al., 2018). Other drugs such as levodopa or midazolam 
have been investigated but in case reports only (Carboncini et al., 
2014; Herrold et al., 2014), larger randomized controlled trials are 
needed to confirm their effects.  
To sum up, some drugs appear somewhat efficient for 
treating patients with DOC. However, as for many pharmacological 
agents, some undesired side effects can be observed (e.g., 
drowsiness, emesis), the rate of response is inconsistent, and the 
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habituation effect hinders the clinical efficacy. Therefore, non-
pharmacological interventions have been investigated as well. 
 
1.3.1.2.  Invasive brain stimulation 
Deep brain stimulation (DBS) is probably one of the most 
famous interventions in this category following the renowned case 
report of Schiff and colleagues in 2007 (Schiff et al., 2007). This team 
surgically implanted electrodes targeting the intralaminar nuclei of 
the thalamus in a patient who was in MCS for six years after a TBI and 
evaluated the effects using the CRS-R, in a double-blind alternating 
crossover fashion (stimulator turned on and off every 30 days for 6 
months). When the stimulator was on, important clinical 
improvements were observed, such as consistent response to 
command, functional communication and oral feeding. The clinical 
state of the patient decreased when the stimulator was off and 
statistical logistic regression modelling showed a significant link 
between the improvements and the stimulation. Two other 
prospective open-label studies were conducted in a total of 19 
patients with DOC and reported moderate clinical improvements 
(CRS-R score increase of 1-3 points) (Magrassi et al., 2016) and 29% 
of responders (i.e., emergence from MCS, response to command 
recovery), respectively (Chudy et al., 2018). This appears encouraging 
but several challenges are reported too, such as poor enrollment due 
to strict inclusion criteria, scalp infection and legal issues. Besides, no 
sham-controlled trial is available yet. 
Spinal cord stimulation (SCS) is classically used to treat 
refractory neuropathic pain by masking pain signals before they 
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reach the brain. It modulates the spinal neurons’ excitability and 
firing rate toward excitation or inhibition depending on the 
frequencies used (Yampolsky et al., 2012). Aiming at reaching cortical 
neural networks, SCS has been investigated for patients with DOC 
too. To date however, only two sham-controlled studies using SCS in 
DOC were performed by the same team, and neither of them 
measured behavioral changes after stimulation; they focused on EEG 
only. The first one was performed on 11 MCS patients and found 
altered band power and synchronization in delta and gamma bands 
after active and not sham SCS session. The authors suggest SCS does 
modulate brain function, particularly the frontal region, in MCS 
patients through thalamo-cortical connections including the reticular 
formation (Bai et al., 2017b). In the second one, using a similar design 
with 16 MCS patients, they focused on frontal connectivity in the 
gamma band (high frequency; 30 – 45 Hz) and showed decreased 
connectivity in the frontal regions after active stimulation (Bai et al., 
2017c). These findings thus pertain to the mechanisms of SCS (i.e., 
alteration of thalamo-cortical connections via the frontal cortex) 
more than its potential therapeutic use. 
Vagal nerve stimulation (VNS) is another neuromodulation 
technique that can be applied invasively (surgical implantation) or 
not. To date, however, only one case report of invasive VNS 
performed with a chronic (15 years) UWS patient is available and 
showed diagnostic improvement to MCS (Corazzol et al., 2017). 
Stimulating the vagal nerve would induce compensatory responses 
from the central thalamus and hypothalamus to distal fronto-parietal 
and striatal networks through basal forebrain or brainstem 
projections. VNS can also be administered in a non-invasive way 
through afferent branches located in the ear concha. Again, a single 
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case report is the only mention of using this technique in another 
chronic (3 months) UWS patient who showed new motor and 
oromotor signs of consciousness and thereby evolved to MCS within 
the next few weeks (Yu et al., 2017). 
 
1.3.1.3. Non-invasive brain stimulation 
 The most widely studied method with DOC patients certainly 
is transcranial direct current stimulation (tDCS). tDCS is a non-
invasive neuromodulation technique using weak electrical currents 
(1-2 mA) applied on the scalp to modify the excitability of targeted 
cortical areas, with stimulation durations classically varying between 
five to 40 minutes. The direct current circulating between the anode 
and the cathode can modulate brain activity and thereby improve the 
functions underpinned by the stimulated brain area (Stagg and 
Nitsche, 2011). The direction of the current is responsible for the 
excitability changes of the neural membrane. Sending current 
through the anode will indeed induce a slight depolarization which 
lowers the threshold for membrane depolarization and action 
potential generation (Purpura and McMurtry, 1965). On the contrary, 
cathodal stimulation will induce a hyperpolarization of the neural 
membrane and thus increase the threshold for depolarization and 
action potential generation. These electrical changes are responsible 
for the immediate effects of tDCS and are related to ion channels 
activity. Latest findings in human studies confirm the major 
contribution of membrane potential alterations over synaptic 
changes for the direct effects of tDCS. When inactivating voltage-
gated ion channels involved in neural membrane depolarization, the 
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motor effects of tDCS disappear while blocking glutamate receptors 
and GABA receptor has no effect (Nitsche et al., 2003a; Stagg et al., 
2018). The so-called long term effects (lasting a few hours after a 
single session) involve long-term potentiation (LTP)- and long-term 
depression (LTD)-like synaptic pathways through glutamatergic 
synapses and especially NMDA receptors (Nitsche and Paulus, 2001). 
Blocking NDMA receptors using an antagonist such as 
dextromethorphan indeed abolish motor tDCS effects as assessed by 
motor evoked potentials with single-pulse TMS (Liebetanz et al., 
2002). On the contrary, using a NMDA agonist such as D-cycloserine 
prolongs these tDCS effects (Nitsche et al., 2004). These longer-
lasting after effects can be enhanced by stronger and longer 
stimulation (Stagg et al., 2018). One should however keep in view 
that most of the animal and human studies focused on the motor 
cortex and that the results should not be directly translated to other 
areas. 
Many other factors further affect the functioning of tDCS: 
intensity and duration of the applied current, surface of the sponges, 
underlying neural activity and orientation of the neurons themselves 
(Stagg and Nitsche, 2011). The physiological effects are indeed 
optimal when the current flows in the same direction of the neuron, 
along its axis; as opposed to when the current flows perpendicularly 
to the neuron orientation and the effects are decreased as 
demonstrated by in vivo and in vitro animal studies (Bindman et al., 
1964; Bikson et al., 2004). Another important modulator of tDCS 
effects is the intracellular calcium (Ca2+). Intracellular Ca2+ levels 
control LTP and LTD mechanisms in animal models (Lisman, 2001) 
and in humans, blocking calcium Ca2+ channels inhibits plasticity 
induced by tDCS (Nitsche et al., 2003a). On top of that, Ca2+ signalling 
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in astrocytes, the most represented glial cell type surrounding 
neurons, also supports synaptic plasticity and can be modulated by 
tDCS as shown by recent in vivo animal studies (Monai et al., 2016; 
Monai and Hirase, 2018). 
Traditional montages use one anode and one distant cathode 
(typically sponge electrodes between 25 and 35 cm²) and it has been 
reported that only 10 to 50% of the current sent reach the cortex 
with this kind of setting and thereby only cortical areas could be 
stimulated (Miranda et al., 2006; Coben and Evans, 2011). However, 
recent advancements in both montage optimization and modelling 
challenge this premise. Indeed, with multi-electrode montages 
amplifying current sources and optimizing configuration directed 
toward specific targets, deep subcortical structures such as basal 
ganglia can be reached (Gomez-Tames et al., 2020). This applies 
especially to areas located close to the ventricles and their cerebro-
spinal fluid which has important conductive properties (Huang and 
Parra, 2019). As a matter of fact, it is important to keep a comfort-
efficacy balance and even though multifocal montages allow applying 
higher amounts of total current (above 4 mA), the intensity should be 
limited at 1 mA per electrode. This limit allows decreasing the risk of 
discomfort or burning since these electrodes are usually smaller (3-4 
cm²). 
Given its numerous advantages (inexpensive, painless, safe, 
easily applicable), this tool has been investigated as a therapeutic 
option for various neurological diseases (Lefaucheur, 2016). It has 
been shown to improve cognitive functions (i.e., working memory, 
attention) in Alzheimer’s disease (Khedr et al., 2014), Parkinson’s 
disease (Boggio et al., 2006) and stroke (Schlaug et al., 2008), when 
applied over the left dorsolateral prefrontal cortex (DLPFC). It also 
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has strong indications for depression (Ferrucci et al., 2009) and 
chronic pain (Valle et al., 2009) and could thereby even prevent and 
treat opioid-dependence (Gallucci et al., 2019). For studies aiming at 
improving cognitive functions, the left DLPFC is the preferential 
target because most of the functions underpinned by this brain area 
mainly relate to executive functions including attention and working 
memory. A majority of tDCS studies performed both in healthy 
volunteers and pathological populations therefore used stimulation 
over the left DLPFC. This area integrates a high amount of inputs 
from associative cortices and is a key component of motor control, 
planning and behavior (Devinsky and D’Esposito, 2004; Heekeren et 
al., 2006). The right DLPFC has also an important role to play in 
arousal and attention (Sturm and Willmes, 2001) but is far less 
involved in higher level cognitive functions.  
For severely brain-injured patients with DOC, tDCS also 
emerged as a potential candidate in their unsatisfyingly small 
therapeutic arsenal for severely brain-injured patients with DOC. It 
could indeed be used to improve the level of consciousness in these 
patients. To investigate this, Thibaut and colleagues conducted a first 
of its kind double-blind randomized controlled trial, evaluating the 
effects of tDCS applied for 20 minutes at 2 mA on the left DLPFC on 
both acute and chronic patients with disorders of consciousness 
(UWS or MCS) following severe acquired brain injury (Thibaut et al., 
2014). Fifty-five patients were included (with both traumatic and 
non-traumatic etiologies) and, while at the whole group level the 
treatment effect (based on the CRS-R total score) was not significant, 
it was in the MCS subgroup of 30 patients (p=0.003, Cohen’s effect 
size; ES =0.38). This was the first study showing that MCS patients 
appear to respond better to tDCS as compared to UWS patients, with 
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also a higher proportion (43% against 8%) of tDCS responders (i.e., a 
patient showing a new sign of consciousness after active stimulation 
that was never observed before or before/after sham stimulation). 
This does not mean that UWS patients are not a suitable population 
to target, since individual responders are identified within this 
population as well. In a case report, for instance, a chronic UWS 
patient was able to follow commands only following the application 
of a tDCS session over the DLPFC (Thibaut et al., 2018a). It simply 
implies that one would expect a lesser proportion of responders in 
the UWS population as compared to the MCS population. These 
inaugural results still paved the way for further trials to favor 
inclusion of MCS patients and to enhance the duration of tDCS 
related effects (which are usually transient and vanish within an 
hour). Several teams therefore opted for increasing the tDCS dose by 
repeating the amount of sessions received. In another randomized 
controlled trial, Thibaut and colleagues applied prefrontal tDCS for 
five consecutive days, stimulating 16 MCS patients (acute and 
chronic, traumatic and non-traumatic etiologies) daily (Thibaut et al., 
2017b). This time, not only significantly greater clinical improvements 
were observed in favor of the active stimulation after five days 
(p=0.013, Cohen’s ES=0.43), but these effects remained up to one 
week after the end of the stimulation sessions. This study showed 
that for five of the nine patients who responded to tDCS, the new 
sign of consciousness appeared after two, three, four days of 
stimulation, meaning individual response to tDCS cannot be 
predicted from the application of a single session; at least several 
sessions are needed. Another team also tested the effects of five 
days of tDCS in 10 UWS or MCS subacute and chronic patients in a 
non-randomized controlled fashion. The target area was either the 
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DLPFC or the primary sensorimotor cortex and the MCS patients 
behaviorally improved for both montages while the UWS patients did 
not (Angelakis et al., 2014). The five consecutive tDCS sessions were 
further tested by another group on 13 patients (7 UWS and 6 MCS) in 
a double-blind randomized controlled design and enabled clinically 
relevant behavioral improvements in five patients that were 
paralleled with enhancement of EEG background (Estraneo et al., 
2017). Other studies investigated different areas than the DLPFC but 
showed less important behavioral effects. For instance, stimulating 
the posterior parietal cortex for five days targeting the precuneus, 
that is a critical area for consciousness recovery, in 33 MCS patients 
showed a significant behavioral improvement at the group level, but 
with a lesser Cohen’s ES (0.31 against 0.43 previously reported) than 
for the DLPFC as well as fewer responders identified (18% against 
56%) (Huang et al., 2017). The orbitofrontal cortex was targeted in 
another prospective open-label study and did not elicit any clinically 
relevant behavioral change in 22 patients with DOC (Naro et al., 
2015). Finally, Wu et al checked the behavioral and 
electrophysiological differences between stimulating the left and 
right DLPFC (controlled with sham conditions), given the role of the 
right DLPFC in arousal mentioned above, that could be particularly 
relevant for DOC (Wu et al., 2019). They included 15 patients with 
DOC (5 in each stimulation group) and showed that left DLPFC 
stimulation significantly increased EEG functional connectivity 
between the stimulation site and central and parietal cortices while 
for right DLPFC stimulation, no such changes were observed and 
connectivity even tended to decrease. Two patients behaviorally 
improved by increasing their CRS-R score (2 and 7 points gained, 
respectively) in the left stimulation group while in the right 
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stimulation as well as in the sham groups, no behavioral changes 
were observed.  
 Based on a recent scoping review (Thibaut et al., 2019b) and 
an ongoing systematic review (Martens et al., 2019a), a summary of 
all tDCS randomized controlled trials performed with DOC patients 
and reporting behavioral outcome (i.e., CRS-R) is presented in Table 
1. It clearly appears that tDCS represents a valuable therapeutic 
option for patients with DOC (ES ranging from 0.31 to 2.22). 
However, montages targeting other areas than the DLPFC could still 
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Effect sizes were taken from the articles when available or calculated (Cohen’s effect size – small: d=0.2; medium: d=0.5; large: 
d=0.8) based on data provided between active and controlled condition when a statistical difference was found (*). “/” refers to 
no statistical difference between groups. tDCS= transcranial Direct Current Stimulation, DLPFC= DorsoLateral PreFrontal Cortex; 
TBI= Traumatic Brain Injury, MCS= Minimally Conscious State; UWS= Unresponsive Wakefulness Syndrome; EEG= 
Electroencephalography; PPC= Posterior Parietal Cortex. Adapted from (Thibaut et al., 2019b), with the author’s permission.  
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 Another increasingly investigated non-invasive brain 
stimulation method is repeated TMS (rTMS); that uses an 
electromagnetic pulse to focally depolarize the neurons and induce 
firing. As with other brain stimulation methods, it allows for 
inhibition (low frequency – about 1 Hz) or activation (higher 
frequencies: 5-20 Hz) of neuronal populations (Thibaut et al., 2019b). 
The clinical effects seem however less remarkable than for DBS or 
tDCS, as reported by three different randomized controlled trials 
totaling 31 patients (21 UWS and 10 MCS) and reporting no 
behavioral improvement at all (Cincotta et al., 2015; Pisani et al., 
2015a; Liu et al., 2016a). Other outcomes however seemed to be 
influenced by rTMS such as cerebral blood flow velocity (Liu et al., 
2016b), EEG slow wave activity and power (Pisani et al., 2015b); that 
were increased only in MCS patients and not in UWS. On top of that, 
rTMS is expensive, requires a lot of training and is far from portable. 
Therefore, its therapeutic interest is limited, as opposed to its 
diagnostic use. 
 As a matter of fact, other non-invasive options are available 
such as VNS mentioned above, transcranial alternating current 
stimulation (tACS) or transcranial random noise stimulation (tRNS); 
but there is scarce evidence to date of their efficacy for DOC patients. 
An illustrative summary of available techniques is presented in Figure 
4. 
 




Figure 4 – Therapeutic options and their neuroimaging findings for patients 
with disorders of consciousness. From (Thibaut et al., 2019b), with the 
authors’ permission. 
 
A common framework for the mechanisms underlying 
treatment efficacy relies on the mesocircuit hypothesis. Initially 
proposed by Schiff (Schiff, 2010), it describes a model for neural 
mechanisms of impaired consciousness. It is based on the 
interactions between the thalamus, the frontal cortex, and the basal 
ganglia; forming a thalamo-cortical loop that can be affected by 
cerebral lesions and external therapeutic interventions. As shown in 
Figure 5, in a healthy brain, the frontal cortical areas activate the 
thalamus in a direct bidirectional fashion, as well as in an indirect 
manner through the basal ganglia. The striatum is indeed activated 
by the frontal cortex and, in turn, inhibits the globus pallidus interna 
(GPI) that inhibits the thalamus. This double inhibition leads to an 
excitation of the thalamus and sustains further bidirectional 
activation between the thalamus and associative fronto-parietal 
cortices. This cortico-thalamo-cortical loop that drives internal and 
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external awareness can be impacted in case of a brain injury. The 
striatal neurons have an important metabolic demand and are 
thereby particularly sensitive to oxygen deprivation (Grillner et al., 
2005; Schiff, 2010). In case of focal traumatic/hemorrhagic or anoxic 
brain injury, these striatal neurons will be primarily affected and, 
since they project on the GPI, the GPI will be “free” to inhibit the 
central thalamus, in turn weakening its activation of the fronto-
parietal cortical areas. 
This model sheds light on mechanistic effects of several 
therapeutic interventions mentioned above. Neuromodulation using 
tDCS or non-invasive brain stimulation using rTMS allow, for 
instance, to directly target the frontal cortex and thereby increase 
the activation over the thalamus, but also over the striatum, with 
which the frontal cortex has many connections. Indirectly stimulating 
the striatum might decrease the inhibition over the thalamus and 
restore the damaged cortico-striato-thalamic loop (Fridman et al., 
2014). Zolpidem, as a GABAergic agent, preferentially acts on the 
GPI, which expresses many GABA subunits. Its selective inhibitive 
action could substitute the normal inhibition from the striatum and 
unleash the thalamus (Schiff, 2010). Amantadine, in turn, would rely 
on dopaminergic modulation of the associative fronto-temporo-
parietal areas, as suggested by a PET case report with a chronic MCS 
patient. This patient was given amantadine for two times six weeks 
separated by a 6-week washout period. There was a behavioral 
improvement when amantadine was on, marked by recovery of 
response to command and automatic motor responses. PET 
investigations at baseline, during amantadine and washout showed 
increased regional metabolism in the temporo-parietal, mesiofrontal 
and right sensorimotor areas during amatandine as compared to 
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baseline and sham (Schnakers et al., 2008). Other treatment 
interventions directly target the central part of the loop, the 
thalamus, such as DBS or low intensity focused ultrasound pulse; a 
novel technique showing promising effects (recovery of 
communication and spatio-temporal orientation) in a case report 
with an acute TBI patient (Monti et al., 2016). The thalamus can also 
be indirectly stimulated through the brainstem using VNS.  
This mesocircuit model therefore provides a natural common 
ground for all treatment interventions aiming at improving the level 
of consciousness in patients with DOC. It can also pave the way for 
future research in treatments development. 
 
Figure 5 – The mesocircuit model proving neuroanatomical and connectivity 
rationale for the effects of various therapeutic interventions. tDCS= 
transcranial direct current stimulation; rTMS= repeated transcranial 
magnetic stimulation; DBS= deep brain stimulation; LIFUP= low-intensity 
focused ultrasound pulsation; VNS= vagal nerve stimulation. Adapted from 
(Thibaut et al., 2019b), with author’s permission. 
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To sum up, several therapeutic interventions are available for 
patients suffering from disturbances in consciousness following 
severe brain injury. Invasively, DBS or VNS could be considered, with 
the associated surgical risks. Non-invasively, both pharmacological 
and brain stimulation options are available with relative efficacy. This 
field still suffers from a scarcity of evidence, especially for 
pharmacological studies. There clearly is a growing interest in the 
field of neuromodulation, as shown by the increasing amount of 
randomized controlled trials. tDCS, in particular, represents a 
promising treatment option, especially for patients in MCS. As a 
matter of fact, there is still plenty of work to be achieved, such as 
better characterizing treatment responders and optimizing 
stimulation interventions, both from a spatial (i.e., montage) and 
temporal (i.e., timing) perspective. 
 
1.3.2. Palliative treatment 
 
After a severe brain injury leading to a DOC, several primary 
and secondary complications may arise depending on the extent and 
the localization of the cerebral lesions. These lesions may affect 
upper motor neurons (UMN) including the pyramidal tract which is 
the neural pathway responsible for voluntary movements. The axonal 
fibers of this tract originate from the primary, the secondary and the 
supplementary motor cortices, cross the internal capsule to the 
brainstem where about 80% of the fibers cross the median line and 
continue to contralateral section of the spinal cord arriving at the 
dorsal horn. At the spinal level, the fibers project on the secondary 
motor neuron, which leaves the spinal cord through the ventral horn 
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on to the neuromuscular junction. Other UMN fibers run closely to 
fibers of the pyramidal ones and are therefore called parapyramidal 
fibers. They are responsible for tone and movement modulation 
(Gladson, 2010). Involuntary motor commands such as anti-gravity 
reflexes and postural balance are managed by the extrapyramidal 
system, that modulates motor activity but without directly projecting 
on the secondary motor neuron. The extrapyramidal tracts mainly 
originate from the brainstem, with higher influence from basal 
ganglia and sensory cortical areas. When any part of the UMN is 
damaged, there is a risk for spasticity to arise because of the 
disturbed balance between supraspinal excitatory and inhibitory 
inputs (Martens et al., 2018a). However, parapyramidal fibers (and 
especially the dorsal reticulospinal tract) are thought to be 
responsible for most of the spastic features (Balakrishnan and Ward, 
2013). Indeed, an isolated lesion of the pyramidal tract does not 
cause spasticity however because of their anatomical proximity a 
single lesion often affects both pyramidal and parapyramidal tracts 
and the clinical picture thereby reflects the combined lesion (Sheean, 
2002). Spasticity is a motor disorder arising from anarchic 
reorganization of the central nervous system and is clinically 
characterized by increased velocity-dependent stretch reflexes 
(Gracies, 2005).  Another definition depicts spasticity as “a 
disordered sensory-motor control, resulting from an UMN lesion, 
presenting as intermittent or sustained involuntary activation of 
muscles” (Pandyan et al., 2005). The latter one better represents the 
clinical picture of patients suffering from spasticity, shown in Figure 
6.  
 




Figure 6 – Spastic joints after brain injury. Imbalance between activation of 
the flexing muscles and of the stretching muscles creates a classical pattern 
of equinovarus feet (left) and internal rotation of the shoulder with flexion 
of the wrist and fingers (right). From (Thibaut et al., 2013), with the author’s 
permission. 
 
Since this motor trouble arises after a central lesion affecting 
the UMN responsible for inhibitory and excitatory supraspinal drive, 
it is classically observed in patients with stroke, spinal cord injury, 
multiple sclerosis or TBI. However, while its occurrence and 
pathophysiology are well described in these populations, little is 
known about the cases involving more complex lesions leading to 
DOC. In most of cases, DOC patients are bedridden and suffer prom 
paresis or paralysis, which favors the apparition of spasticity (by 
disuse and immobilization) and can provoke loss in range of motion, 
pain and bed sores (Martens et al., 2018a).  
A retrospective study performed by Nakase-Richardson et al 
collected all medical complications arising during rehabilitation in a 
sample of 122 veterans and active duty military individuals with DOC 
following severe brain injury. Spasticity was, by far, the most 
common complication, affecting 70% of the study participants. Next 
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in line were autonomic nervous system dysregulation (e.g. autonomic 
storming, fever, tachycardia) for 34% of the sample, epileptic seizure 
(30% – more frequent for blast-related etiologies), hydrocephalus 
(25%) and intracranial infection (22%) (Nakase-Richardson et al., 
2013). Two other prospective studies documented the prevalence of 
spasticity in patients with DOC and found rates of 57% spastic 
patients (in a sample of 68 patients (Ganesh et al., 2013)) and 89% 
(sample of 65 patients (Thibaut et al., 2015a)). Even though the 
prevalence is known to be that high, few studies investigating 
treatment options for DOC patients are available. A systematic 
review performed in 2017 retrieved only four interventional studies 
primarily targeting spasticity in patients with DOC (Martens et al., 
2017): two clinical trials investigating soft splints (Thibaut et al., 
2015b) and acupuncture (Matsumoto-Miyazaki et al., 2016) as well as 
two case reports about intrathecal baclofen (ITB) (Francois et al., 
2001; Shrestha et al., 2011). All these techniques led to a clinically 
significant decrease in spasticity and thereby in the level of disability. 
They should therefore be considered in the palliative/comfort care 
arsenal for patients with DOC. Soft splints are polyurethane materials 
designed in the form of a roller splint that fits in the palm of the hand 
and promotes its (passive) opening. The softness of the splint allows 
for muscle contraction and grasping reflex, as opposed to 
conventional rigid splints that are less tolerated and can even induce 
skin injuries or pain. However, for now, they are only applicable to 
the hand. Acupuncture, a medical practice far more used in Asia than 
in Western Europe or North America, relies on ancient traditions only 
and is not truly backed up by modern scientific works. The 
mechanisms for spasticity reduction would involve modulation of 
motor cortex excitability, potentially associated with a reduced spinal 
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motor neuron activity (Matsumoto-Miyazaki et al., 2016). Baclofen, 
on the contrary, is part of the conventional treatment package for 
spastic disorders and can be administered either per os or by an 
intrathecal pump. This GABAergic compound enhances presynaptic 
inhibition at the spinal level and thereby reduces spastic overactivity 
(Richard and Menei, 2007).  
 Interestingly, when spasticity was considered as a secondary 
outcome, further treatment options could be identified such as tilt 
table therapy (Krewer et al., 2015) or invasive thalamic stimulation 
(Magrassi et al., 2016). These approaches initially focused on 
improving the level of consciousness but proved their efficacy in 
reducing spasticity as well. It is also interesting to note that, for ITB 
therapy, the primary indication is to decrease spasticity but it further 
enables to increase the level of consciousness, with case series 
reporting recovery of conscious cortically mediated behaviors such 
visual pursuit, object recognition and verbalization (Margetis et al., 
2014; Pistoia et al., 2015). 
Unfortunately, none of these studies formally evaluated the 
effect of a multidisciplinary program that would combine 
pharmacological, orthopedic and rehabilitation approaches; while 
this is the approach used on the field. This still has to be investigated 
in future studies. In the meantime, pharmacological and non-
pharmacological treatments usually used for post-stroke spasticity 
are administered for patients with DOC too. A summary of these 
interventions and where they act is presented in Figure 7. However, 
patients with DOC differ from stroke patients in several aspects, the 
main one being the extent of the brain lesions. In DOC patients, 
numerous cortical and subcortical areas are damaged most of the 
time, leading to an atypical clinical presentation of spastic features. 
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Indeed, in stroke patients, the clinical spastic component assessed by 
bedside standardized scales evaluating resistance to passive 
movement such as the Modified Ashworth Scale (MAS) is often 
reflected by the electrophysiological component assessed by the so-
called Hmax/Mmax ratio. This ratio represents the percentage of 
excited afferent fibers through spinal reflexes (H response) over the 
direct activation of efferent fibers (M response), following electrical 
stimulation of the motor nerve (Katz et al., 1992). In DOC patients 
however, we did not find such correlation between clinical and 
electrophysiological measures of spasticity in a sample of 21 patients 
(Martens et al., 2019c). This discrepancy could be due to the 
localization of the lesions; the ratio was more increased when they 
were both cortical and subcortical lesions (objectified by MRI), while 
it was in a normal range when the lesions were subcortical only. This 
suggests that cortical lesions may be partly obscured by subcortical 
ones and therefore less electrophysiologically expressed. 
Furthermore, oral antispastic medication such as baclofen did not 
significantly influence the clinical or the electrophysiological 
component of spasticity in this study. This is concerning since it 
means the pharmacological management of spasticity in DOC is still 
inappropriate. Future trials need to focus on treating spastic DOC 
patients only and on consistently reporting follow-up data. 
 




Figure 7 – Available treatments for spasticity in DOC patients. CATS= cortical 
activation by thalamic stimulation; ITB= Intrathecal baclofen; PMS= passive 
muscle stretch. Conventional pharmacological treatments are shown in 
italics. From (Martens et al., 2017). 
 
Finally, spasticity does not only impact the motor status of 
the patient; it also induces pain. Indeed, in a sample of 65 chronic 
DOC patients, Thibaut et al showed that 58 of them presented with 
spasticity and there was a significant correlation with the Nociception 
Coma Scale-Revised (NCS-R) scores, a clinical scale specifically 
designed and validated to evaluate pain in patients with DOC 
(Chatelle et al., 2012). This further highlights the need for 
appropriate spasticity and pain management for DOC specifically. The 
lack of available well-designed studies, however, forces clinicians to 
rely on empirical approaches. 
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1.4. Objectives of this work 
 
The work presented in this dissertation aims to improve the 
multidisciplinary management of patients with DOC. This population 
is indeed often neglected by care practitioners and researchers, due 
to assumed poor prognosis and low prevalence. These patients 
present with an intricate clinical picture and a challenging 
therapeutic strategy. The primary objectives of this doctoral thesis 
are thus two-fold: first, to contribute to the behavioral diagnosis at 
the bedside and second, to investigate alternative administration 
methods for therapy using tDCS.  
The first part focuses on early detection of consciousness 
recovery at the bedside to improve the initial diagnosis and to 
provide quantitative behavioral data regarding the months that 
follow the initial brain lesion, in a rehabilitation program setting. 
Emphasis is placed on a particular milestone highly valued by both 
medical personnel and relatives: recovery of meaningful 
communication. Providing clinicians and families with objective and 
realistic expectations hopefully contributes to a better care for these 
patients. 
In the second part, the optimal use of tDCS is investigated. 
Indeed, it is known as a potentially efficient treatment option for 
patients with DOC, but its application is still subject to a lot of 
variations (i.e., environment, montage, timing). We first focus on the 
environmental setting for tDCS therapy and investigate the 
feasibility, the safety and the efficiency of a long-term tDCS protocol 
delivered at home or in rehabilitation centers. We then focus on 
stimulating other areas than the prefrontal cortex based on 
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neuroanatomical and functional hypotheses. The motor cortex plays 
a key role in expressing signs of consciousness and is therefore our 
first target. Second, based on pre-identified crucial networks for 
consciousness recovery, we investigate the effects of network-based 
stimulation and particularly the frontoparietal network involved in 
external awareness. Eventually, interested as well in the timing of 
delivering tDCS, we hypothetically explore the use of brain-state 





2. Part One: Toward enhanced diagnosis 
at the bedside, a field approach 
 
“The spirit of a man can endure his sickness, But as for a broken spirit 
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A critical challenge in the appropriate care of patients with 
DOC pertains to the diagnosis and, specifically, the misdiagnosis. 
Diagnostic error between UWS and MCS is unfortunately common 
and it has been shown that about 40% of patients clinically diagnosed 
as UWS were actually MCS when evaluated with standardized 
behavioral features (Childs et al., 1993; Andrews et al., 1996; 
Schnakers et al., 2009) or with an active fMRI paradigm (Monti et al., 
2010). As mentioned above, misdiagnosing conscious and 
unconscious patients can have major consequences regarding 
admission to rehabilitation, pain management and end of life 
decisions (Giacino et al., 2014). Patients with DOC are also prone to 
exhibit confounding factors that make the diagnosis even more 
challenging. Indeed, sensory deficits, neuromuscular dysfunction, 
subclinical seizure activity or fluctuations in vigilance will make it easy 
to miss signs of consciousness at the bedside (Giacino et al., 2009).  
It is therefore important to detect the transition from 
unconscious (i.e., coma, UWS) to conscious (i.e., MCS, EMCS) states 
as early as possible. Some previous studies detailed below focused on 
quantifying the prevalence of MCS signs at various stages post-injury. 
Little is known, however, about the initial manifestation of MCS 
signs: which one(s) tend to reappear first and thereby signal the 
transition from an unconscious state to a conscious state? Which 
one(s) appear later on and might suggest they are more difficult to 
recover or to assess?  
Among these signs, an item that appears more valuable than 
the other ones in the eyes of the close relatives is the ability to 
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communicate again. Consistent recovery of communication is not 
only a critical milestone during the rehabilitation period, it is also the 
most anticipated one. Indeed, both relatives and caregivers want to 
know which needs, thoughts or emotions the patient is experiencing. 
Objective data extracted from similar situations may guide both 
clinicians and relatives through their expectations. 
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2.2.  ‘Which behaviors should I track?’ – a 
clinicians’ perspective 
 
Monitoring recovery of consciousness in the subacute setting 
is of paramount importance for any clinician: for the physician in 
charge of the patient’s treatment and management, for the 
rehabilitation interventions (physical therapy, occupational therapy, 
speech therapy) and for the nursing team. While major decisions 
concerning end of life or discharge disposition are often addressed in 
the intensive care units in the days or weeks following the incident, 
some patients remain unconscious (i.e., comatose or UWS) for longer 
than that. It is therefore not rare that these patients get discharged 
to rehabilitation facilities still being unconscious. These patients 
obviously represent a challenge for rehabilitation interventions and 
there are a lot of unknowns as to whether they are going to regain 
consciousness during their stay or not. Physicians in charge of these 
patients have no quantitative data to rely on while they are 
responsible for the accuracy of the diagnosis, appropriate treatment 
planning and family counseling. From the clinician’s perspective, 
recovery of consciousness is marked by the transition from 
unconscious states (i.e., coma and UWS) to conscious states (i.e., 
MCS and EMCS); but which signs can they first expect to see at the 
bedside? It is known that visual behaviors such as pursuit or fixation 
are most often observed, as suggested by previous studies, including 
the inaugural one from Noé and colleagues, who prospectively 
followed 32 patients with severe acquired brain injury (20 MCS and 
12 in UWS). It appeared that, on admission, patients in MCS were 
diagnosed as such based solely on visual abilities (relying on the CRS-
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R visual subscale) (Noé et al., 2012). The high prevalence of visual 
conscious behaviors to diagnose MCS was later confirmed by a larger 
multicenter cross-sectional study conducted by Estraneo and 
colleagues and identifying 52 patients in MCS using the CRS-R, both 
in the intensive, rehabilitation and long-term care settings. In most 
patients (43/52), the diagnosis of MCS was, again, captured by the 
CRS-R visual subscale (Estraneo et al., 2015). Finally, a recent 
retrospective study led by Wannez and colleagues and focusing on 
documenting the prevalence of MCS signs on a large sample of 
patients diagnosed as MCS at various times post-injury revealed that, 
among the 282 chronic MCS patients assessed with the CRS-R, visual 
fixation and visual pursuit were the two most frequently observed 
conscious behaviors (57%, and 52% of cases, respectively), preceding 
reproducible movement to command (51%) (Wannez et al., 2017a). 
This is however still not informative enough regarding the time and 
the nature of the initial emergence of conscious behaviors. Bagnato 
and colleagues attempted to characterize the clinical signs denoting 
the first occurrence of conscious behavior in 31 patients in UWS 
(both TBI and non-TBI) admitted to rehabilitation about two months 
(mean of 54 ± 35 days) after their injury and followed them with the 
CRS-R at month 1, 2, 3, 6 and 12 post-admission (Bagnato et al., 
2016). Interestingly, they found that 21 patients regained 
consciousness during the study period and that in 42.9% of the cases, 
this was objectified with only the visual CRS-R subscale, while the 
motor subscale alone accounted for 9.5% of cases. Timewise, they 
observed that 90.5% of the patients who regained consciousness did 
so within the first three months post-admission. Another interesting 
finding pertains to the influence of etiology: patients with TBI 
showed significantly more signs of consciousness as compared to the 
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non-TBI group. The authors concluded that visual pursuit and fixation 
are the commonest early behaviors denoting MCS. However, since 
CRS-R evaluations were performed on a monthly basis, early signs of 
consciousness might have been missed between consecutive 
evaluations and more frequent evaluations could capture this 
transition more precisely. 
To address these questions, we conducted a retrospective 
observational study focusing on capturing the transition from 
unconsciousness to consciousness, from a behavioral perspective, 
using the gold standard CRS-R. We aimed at answering the following 
questions: 1) How long does it take for patients admitted as 
unconscious to a rehab program to regain consciousness? 2) Which 
behavior(s) mark the transition to consciousness? 3) Is there any 
significant influence of etiology on consciousness recovery (TBI 
versus non-TBI)?  
We extracted data from a REDCap (Harris et al., 2009) 
database housing demographic and clinical metrics collected by 
trained rehabilitation therapists on all patients admitted to the 
specialized DOC program at Spaulding Rehabilitation Hospital in 
Boston, MA. This program includes bi-weekly assessments of patients 
with DOC using the CRS-R until the patient emerges from the MCS. 
We extracted our data from this database using the following 
criteria: (1) at least 17 years old, (2) documented acquired brain 
injury with medical diagnosis of coma or CRS-R-based diagnosis of 
UWS/VS on admission to the DOC program and (3) evidence of 
transition to consciousness during the inpatient rehabilitation stay, 
defined as two consecutive CRS-R assessments obtained within seven 
days indicating a new MCS or eMCS diagnosis. As presented in Figure 
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8 below, 79 out of 323 patients screened met these criteria and were 
included in the study.  
 
 
Figure 8 – Participant flow diagram. MCS= Minimally Conscious State; 
EMCS= emergence from the MCS; CRS-R= Coma Recovery Scale-Revised 
According to the CRS-R, 11 items denote MCS (i.e., consistent 
movement to command, reproducible movement to command, 
object recognition, object localization, visual pursuit, visual fixation, 
automatic motor response, object manipulation, localization to 
noxious stimulation, intelligible verbalization, intentional 
communication) while two other ones denote EMCS (i.e., functional 
object use, functional communication). We used these 13 behavioral 
markers to characterize consciousness recovery. These 13 items and 
their operational definitions can be found in Appendix 2. 
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 Regarding the analyses, we used descriptive statistics to 
summarize the study sample characteristics. We then computed 
incidence rates along with 95% confidence intervals for the first 
behavioral signs of consciousness to reemerge. To compare the time 
to recovery of consciousness, the CRS-R total score and the number 
of conscious behaviors observed at transition between TBI and non-
TBI patients, we used the Wilcoxon Rank Sum Test. Results were 
considered significant at p < 0.05. To further evaluate the influence 
of etiology on the nature of conscious behaviors recovered, we 
clustered them into three categories: 1) language abilities (i.e., 
consistent and reproducible command following, intelligible 
verbalization, intentional and functional communication); 2) motor 
abilities (i.e., functional object use, automatic movement, object 
manipulation, localization to pain) and; 3) visuoperceptual abilities 
(object recognition, object localization, visual pursuit, visual fixation). 
Differences between the TBI and non-TBI subgroups were tested 
using Fisher’s exact test, with a Bonferroni correction for multiple 
comparisons (3 comparisons; p < 0.016). 
The demographic data and clinical characteristics of the 
study sample are presented in Table 2. It can be noted that the TBI 
group was significantly younger than the non-TBI one, which is not 
surprising as it has been reported in similar studies (Bagnato et al., 
2016; Bodien et al., 2019). Otherwise, these two subgroups 
presented no other difference. Patients were admitted within the 
month following their injury and six patients were still in a comatose 
state while the rest of the sample was in UWS. 
 
2.2   ‘Which behaviors should I track?’ – a clinicians’ perspective 
74 
 
Table 2: Demographic and clinical characteristics of the study sample on 
admission.  
 
Total TBI Non-TBI p value 
N (male) 79 (51) 34 (25) 45 (26) 0.147 a 
Age, median [IQR] 
48  
[26 – 61] 
33  
[23 – 53] 
57  
[33 – 64] 
0.002 * b 
Days from injury 
to admission 
26  
[20 – 36] 
29  
[20 – 36] 
25  
[20 – 36] 
0.454 b 
Initial CRS-R total 
score 
4 [3 – 6] 4 [3 – 6] 4 [3 – 6] 0.869 b 
TBI= Traumatic Brain Injury; IQR= Interquartile Range; CRS-R= Coma 
Recovery Scale-Revised; a = Fisher’s exact test TBI vs. non-TBI; b = Wilcoxon 
Rank Sum test TBI vs. non-TBI; *= significant statistical difference (p<0.05). 
 
Regarding the CRS-R monitoring, patients were assessed 
twice a week and were followed for a median [IQR] time of 61 [42 – 
98] days before either the discontinuation criteria for the CRS-R were 
met (i.e., the patient emerged from MCS) or the patient was 
discharged. The initial CRS-R exam, on which the initial diagnosis was 
based, took place upon admission (median time of one day post-
admission). The median time between consecutive CRS-R 
assessments was 4 days [3– 5]. 
 
Time to consciousness recovery 
Patients admitted as unconscious recovered their first signs 
of consciousness in a median [IQR] time of 44 [33 – 59] days (about 6 
weeks) after the injury and 14 [6 – 26] days after admission. This is 
consistent with previous findings reporting consciousness recovery 
within 12 weeks after injury but provides more granular data. Indeed, 
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given the present study is the first of its kind using bi-weekly follow-
up, behavior-specific estimates of time to recovery of consciousness 
are provided and suggest the transition to conscious states can 
actually be expected within a shorter time window in this type of 
patients. We should however bear in mind that it concerns about 
85% of the patients followed. Indeed, for the purpose of this study, 
we excluded 15 patients who did not transition during their 
rehabilitation and remained unconscious.  
 
Nature of signs of consciousness recovered 
When plotting the most common behavioral signs of 
consciousness (MCS or EMCS) observed on the very first assessment 
denoting consciousness recovery, visual pursuit clearly ranks first 
(see Figure 9). It was observed in 41% (95% CI 30.2 – 51.8) of our 
sample while the next most commonly-observed behaviors 
concerned 25% of cases or less. The second was reproducible 
movement to command (25%; 95% CI [15.5 – 34.6]) and the third was 
automatic movement (24%; 95% CI [14.6 – 33.4]). The remaining 10 
behavioral markers of consciousness emerged first in less than 16% 
of the sample. 




Figure 9 – Proportion of patients (n=79) presenting with each behavior as 
the first sign of consciousness. Bars indicate the percentage of the sample 
that recovered each behavior. 
 
It is unsurprising that visual pursuit was the most prevalent 
initial sign of consciousness recovery, as it has already been well 
documented as an early indicator of consciousness (Dolce et al., 
2008; Candelieri et al., 2011; Noé et al., 2012). Visual fixation, 
however, was less observed as compared to previous studies. Two 
hypotheses might explain this. First, from a methodological 
perspective, CRS-R guidelines state that when an item is successfully 
passed within a subscale, the examiner moves on to the next 
subscale and does not asses the lower-level behaviors underneath 
the successful item. However, in the study from Wannez et al 
reporting a higher prevalence of visual fixation in MCS (52%), each 
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pursuit and fixation. Second, from a neuroanatomical perspective, 
the reoccurrence of visual pursuit likely reflects some preservation of 
connectivity between the brainstem and the cortex, supporting not 
only basic arousal functions but also complex eye movements 
(complex enough to present visual pursuit as an output, and not only 
fixation). Since the inputs from the vestibular nuclei to the pons are 
reactivated, they mediate arousal but further activate downstream 
frontal and parietal cortices responsible for eye movement control, 
reflected by visual pursuit. 
Reproducible command-following (i.e., the ability to follow a 
simple one-step command at least three out of four trials) was the 
second most observed behavior denoting consciousness recovery, 
which is reassuring since it is widely used during routine bedside 
examination as a definitive sign of conscious awareness (Teasdale 
and Jennett, 1974). The incidence we found (25%) falls within the 
range previously reported from 14 to 51% (Estraneo et al., 2015; 
Bagnato et al., 2016; Wannez et al., 2017a) but there seems to be a 
wide variability for which it is unclear what the contributing factors 
are. It could, again, be due to the administration of this item during 
the CRS-R assessment. Indeed, even though the CRS-R guidelines are 
unequivocal, there is no standard expliciting the type of commands 
administered and the amount of trials for different commands. What 
is consistent across studies is the lower occurrence of consistent 
command following (i.e. the ability to clearly answer at least two 
different commands on four out of four trials each), ranging within 0 
to 6% and probably reflecting a way more cognitively demanding 
task, especially regarding working memory and attention capacities. 
Automatic motor movement ranks closely after reproducible 
command following. These over-learned, often repetitive, behaviors 
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(e.g., nose-scratching, bedrail gripping) are triggered either by 
interoceptive or exteroceptive stimuli and are supposed to reflect at 
least partial preservation of self and environmental awareness. They 
can also be a prognostic sign of better outcome, as suggested by 
Rémi and colleagues who prospectively followed a cohort of 120 
patients after severe acute stroke and found that the ones presenting 
with automatic movement (n=34), specifically leg-crossing, had a 
better functional outcome one year after the injury than a matched 
control group (n=34) who did not (Rémi et al., 2011). 
The remaining ten signs of MCS or EMCS emerged first in 
15% of cases or less. This lower prevalence can be explained either 
because these behaviors depend upon well-preserved network 
connectivity (often absent at this stage of recovery) or because they 
require an important participation of motor abilities, often 
significantly impaired in patients with DOC. 
An interesting observation is that in 72% (95% CI [62.1 – 
81.9], n=57) of the sample, recovery of consciousness was signaled 
by the emergence of a behavior in only one of the CRS-R subscales. 
This implies that the procedures used to detect behavioral signs of 
consciousness should be designed to reliably detect them, with a 
specific attention to visual pursuit, command-following and 
automatic movements. For visual pursuit, it is strongly recommended 
to use a mirror, as the high saliency of this stimulus (probably due to 
its auto-referential aspect) has been emphasized by previous works 
(Vanhaudenhuyse et al., 2008; Wannez et al., 2017c). Command-
following should be evaluated using standardized procedures such as 
those described in the CRS-R (Giacino et al., 2004), the WHIM (Shiel 
et al., 2000) or the SMART (Gill-Thwaites and Munday, 1999). In a 
more selective fashion, individualized quantitative behavioral 
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assessment (IQBA) methods use statistical comparisons between 
volitional (target command), noise (other command) and rest 
(absence of command) conditions to reliably discriminate command-
following from random behavior on a single-subject level (Whyte et 
al., 1999). Regarding automatic movement, they are by their nature 
difficult to elicit at the bedside but assessment methods using 
passive observation or active alternating commands using familiar 
gestures (as offered by the CRS-R) to capture spontaneous or induced 
automatic motor responses can be used (Giacino et al., 2004). 
An important aspect of capturing these early behavioral signs 
of consciousness pertains to the fluctuations in arousal and vigilance 
specific of this population. Serial assessment is therefore essential to 
reduce the diagnosis error rate and to avoid missing critical behaviors 
(Wannez et al., 2017b; Giacino et al., 2018b). Finally, it is interesting 
to note than in very few cases, the transition of recovery did not 
follow the typical course of recovery (i.e., coma to UWS to MCS to 
EMCS). Two patients indeed transitioned from UWS directly to EMCS 
within several days. This could either be a very fast recovery or a 
misdiagnosis on the first baseline assessment. 
Influence of the etiology 
When comparing the TBI (n=34) and the non-TBI (n=45) 
subgroups, it appeared that there were no significant difference in 
terms of time to recovery of consciousness, CRS-R total score at 
transition and number of conscious behaviors recovered at 
transition, as presented in Table 3. 
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Table 3 – Clinical characteristics of the study sample (n=79) at the time of 














[33 – 59] 
41  
[29 – 50] 
46  
[35 – 63] 
0.517  
CRS-R total score 
9  
[8 – 11] 
9  
[7 – 11] 
9  





[1 – 2] 
1  
[1 – 2] 
1  
[1 – 1] 
0.250  
TBI= Traumatic Brain Injury; IQR= Interquartile Range; CRS-R= Coma 
Recovery Scale-Revised; a = Wilcoxon Rank Sum test TBI vs. non-TBI 
 
This is in agreement with Bagnato’s findings, with the 
exception of the number of behaviors recovered, that was reported 
to be significantly higher in TBI patients as compared to the non-TBI 
in their study (Bagnato et al., 2016). The sample in the present study 
is more than three times larger than Bagnato’s one meaning this 
difference did not survive in a larger population. This divergence 
could also be explained by the difference in patients’ time post-
admission between the two studies, the patients presented here 
being in a more acute stage. Concerning the type of behaviors 
recovered, there was a significant influence of etiology only for the 
motor behaviors, and not for the language-related or visual ones, as 
depicted in Figure 10. Patients with TBI showed motor function 
compatible with consciousness recovery significantly more often 
than non-TBI patients at time of transition to consciousness (Fischer’s 
p=0.011) while there was no difference in the frequency of recovery 
of language (p=0.99) or visual (p=0.066) signs of MCS. This might be 
due to the pathophysiological differences between TBI and non-TBI 
2.2   ‘Which behaviors should I track?’ – a clinicians’ perspective 
81 
 
insults. It is indeed known that non-traumatic lesions arising from 
severe hypoxic-ischemic events preferentially damage brain areas 
with high oxygen consumption demands (Cervós-Navarro and 
Diemer, 1991; Busl and Greer, 2010). The basal ganglia, for instance, 
which have a high metabolic activity and oxygen demand, play a key 
role in motor control and execution. This may participate in the lower 
frequency of automatic movements observed in the non-TBI patients. 
For the visual cluster, a trend can be noted toward non-TBI patients 
showing initial visual conscious behaviors more frequently than the 
TBI ones, both from a graphical and statistical perspective (p value 
close to significance). A larger sample of patients might confirm this 
trend and thereby suggest patients with anoxic and vascular injuries 
present a better preservation of visual pathways.  
Figure 10 – Comparison of behavioral recovery by domain in patients with 
TBI and non-TBI. *= Statistically significant difference between TBI and non-
TBI (p<0.05). 
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Some limitations hindering the generalizability of the results 
should be mentioned. First, the setting of the rehabilitation facility 
may represent a selection bias in the sense that only patients 
discharged to that facility were included, between three to five 
weeks from injury. This means patients transitioning to MCS or EMCS 
earlier, in the intensive care for instance, have not been captured 
and may present with a different pattern for behavioral recovery. 
Therefore, prospective studies performed in the acute setting should 
be conducted to fill in this knowledge gap. Second, since this was a 
single-site study, the sample size is limited and the characteristics of 
the sample (demographics and behavioral) might be slightly different 
from one site to another. Multi-center or replication studies would 
address this issue. Last but not least, a more general issue pertains to 
the aim of the study. We indeed used the behavioral output 
observed at the bedside, however, as stated above, we cannot infer 
the presence or absence of consciousness based solely on behavior. 
It has been raised previously that behavioral testing without 
subjective report from the patient does not provide the full picture of 
conscious awareness (Bernat, 2002; Giacino et al., 2009; Naccache, 
2018). There is, however, no existing way yet to fully address this 
issue, as it is related to the conception of consciousness itself. 
To sum up, this study shows that patients who have been 
behaviorally unconscious for weeks due to a severe acquired brain 
injury and recovered consciousness during their rehabilitation stay, 
did so within approximately six weeks post-injury. The first 
behavioral signs of consciousness typically recovered were visual 
pursuit, command-following and automatic movement, with a single 
subscale depicting transition in most of the cases (72%). The etiology 
(traumatic or non-traumatic) did not influence the time to recovery 
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or the amount of behaviors initially recovered but it did influence the 
type of behaviors recovered. Motor behaviors were indeed more 
frequently observed in TBI patients, as compared to the non-TBI. The 
take-home message for clinicians working with these cases would be 
to use neurobehavioral methods sensitive enough to detect these 
three behaviors and to perform repeated exams, as the diagnosis of 
the patient might change in a few days’ span. It would be interesting 
to investigate further whether the early emergence of these specific 
behaviors is associated with long-term functional outcome. 
  




2.3. ‘When will we be able to 
communicate?’ – a relatives’ 
perspective 
 
The clinicians working with patients with DOC are 
undoubtedly facing many challenges on a daily basis, as depicted by 
the high amount of burnout in caregivers (Gosseries et al., 2012). But 
one should keep in view the biggest burden is on the family and 
relatives, dealing with a lot of anxiety and unanswered (or 
unanswerable) questions: “Can he/she hear me?”, “Is he/she in 
pain?”, “Will he/she recover? When?”. And while the clinician is 
sometimes focusing on the tiniest improvements (e.g., recovering 
visual fixation or localization to pain), one critical step prioritized by 
the relatives is “When will I be able to communicate again with 
him/her?”. Recovery of communication is, as a matter of fact, a 
highly anticipated milestone for the patient and for all the parties 
directly or indirectly involved. It means indeed the patient can 
reliably express his/her own needs, participate actively in the care 
with autonomous decision-making and have meaningful social 
interaction. It is known to be part of the most important anticipated 
behavior to be recovered in related conditions such as locked-in 
syndrome and stroke (Wallace and Bradshaw, 2011; Krishnan et al., 
2017; Lugo et al., 2017; Bucki et al., 2019). However, the time course 
to recovery of this crucial behavior has not been properly 
investigated yet, to the best of our knowledge, while it would be 
useful to assist with early decision-making regarding treatment 
planning but also with legal questions such as guardianship.  




Previous early studies report recovery of communication in 
patients with chronic DOC between four months and several years 
post-injury (Najenson et al., 1978; Andrews, 1993). Qualifying this 
range as wide would be an understatement. Furthermore, these 
studies are limited by low sample size and non-standardized nor 
validated communication assessment methods. Indeed, according to 
the gold standard CRS-R (Seel et al., 2010; Giacino et al., 2018b), 
communication should be assessed using six consecutive situational 
orientation questions requiring “yes/no” verbal or gestural responses 
(e.g., “Am I clapping my hands right now?”) (Giacino et al., 2004). The 
scoring criteria describe three items hierarchically organized by 
cognitive complexity. The lower level is the absence of 
communication, determined by the absence of discernable responses 
to the questions, or the presence of only one tentative answer. The 
next item, intentional communication (IC), is scored when there are 
clearly discernible yes/no responses to at least two out of the six 
questions, regardless of accuracy. Finally, functional communication 
(FC) means the patient is able to respond accurately to the six 
consecutive questions. The latter has a high level of cognitive 
complexity and is therefore considered as a sign of EMCS. A 
prospective study used the CRS-R on a monthly basis to follow 32 
patients with DOC admitted to rehabilitation about five months post-
injury and showed that eight patients (25%) were EMCS within one 
year after admission (Noé et al., 2012). Unfortunately, no distinction 
was made between emergence based on functional object use or 
functional communication so no data can be extracted regarding 
time-course to communication recovery. A larger multicenter study 
followed 52 patients with DOC both in intensive care and 
rehabilitation settings for six weeks and showed that 30% of the 




patients recover FC (based on the CRS-R administered at enrolment 
and at week 6) within approximately three months post-injury 
(Giacino et al., 2019). Replicating these results on a larger sample 
with closer CRS-R assessments would provide more granular 
quantitative data for clinicians and caregivers to rely on. 
We therefore conducted another retrospective observational 
study using the same REDCap database described above with the 
following inclusion criteria: 1) acquired brain injury; 2) at least 16 
years old at admission; 3) admitted to rehabilitation with no evidence 
of communication on initial CRS-R administration 4) at least three 
valid CRS-R assessments within two-weeks of rehabilitation 
admission; 5) at least an eight-week rehabilitation length of stay, or 
recovery of functional communication prior to the eighth week. We 
chose the eight-week cut-off as it is the standard length of the 
specialized DOC program on site. However, in a secondary analysis, 
we looked at the patients who stayed longer than eight weeks as 
well. 
Of the 323 patients screened, 175 patients met the inclusion 
criteria (see Flowchart – Figure 11), their demographic characteristics 
are presented in Table 4. We identified four different patterns of 
communication recovery when sampling time to recovery of IC or FC 
over the eight weeks post-admission: 1) patients who did not recover 
IC nor FC (Group 1: -IC-FC); 2) patients who recovered IC, but not FC 
(Group 2: +IC-FC); 3) patients who recovered IC then FC (Group 3: 
+IC+FC) and; 4) patients who recovered FC, without prior recovery of 
IC (Group 4: -IC+FC). 





Figure 11 – Flow diagram and days to recovery of communication for each 
group. IC= Intentional Communication; FC= Functional Communication; CRS-
R= Coma Recovery Scale-Revised. Results are presented as median [IQR]. 
 
We described the time to recovery to IC and FC (i.e., days 
between injury and the first CRS-R indicating IC or FC) using medians 
and IQRs in each of these groups as well as in the whole study 
sample. We checked any significant difference between the four 
groups regarding gender, age, days post-injury on admission, etiology 
and length of rehabilitation stay using non-parametric analyses. We 
used Pearson’s Chi-squared test for dichotomous variables and 




Kruskal-Wallis Rank Sum Test for continuous variables. When a 
significant result was obtained (p < 0.05), we conducted post-hoc 
pairwise comparisons using Fisher’s test for dichotomous variables 
and Wilcoxon Rank-sum test for continuous variables. We applied a 
Bonferroni correction to adjust for multiple comparisons (n=6; 






















p value c 
Gender (% male) 60% 31 12 53 9 p=0.008 
Age (years) 
48 
[27 – 61] 
34 
[25 – 52] 
55 
[37 – 64] 
52.5 
[27 – 66] 
53 
[40 – 59] 
p=0.023 
Days between injury and 
admission 
28 
[21 – 38] 
33.5 
[27 – 51] 
29 
[20 – 34] 
26 
[20 – 33] 
23 
[21 – 29] 
p=0.0004 
Etiology (% TBI) 57% 32 11 48 9 p=0.034 
Days of rehabilitation 
admission 
94 
[67 – 152 
131 
[87 – 198] 
100 
[78 – 157] 
75 
[57 – 113] 
98 
[58 – 121] 
p=0.00003 
Days from injury to recovery 
of IC  
40 
[34 – 54] a 
NA 
52 
[38 – 67] 
37 
[32 – 47] 
NA p=0.0004 
Days from injury to recovery 
of FC  
49 
[41 – 61] b 
NA NA 
50 
[42 – 61] 
43 
[32 – 63] 
p=0.106 
 Post-hoc pairwise comparisons d 
Groups  1 vs. 2 1 vs. 3 1 vs. 4 2 vs. 3 2 vs. 4 3 vs. 4 
Gender  p=0.136 p=0.99 p=0.629 p=0.018 p=0.650 p=0.99 




Days between injury and 
admission 
p=0.016 p=0.00009 p=0.0029 p=0.515 p=0.366 p=0.513 
Etiology p=0.466 p=0.775 p=0.370 p=0.450 p=0.141 p=0.370 
Days of rehabilitation 
admission 
p=0.157 p=0.000004 p=0.041 p=0.005 p=0.388 p=0.353 
Data are median [IQR] unless indicated. Group Definitions- Group 1: patients who did not recover communication within 8 weeks or 
prior to discharge from rehabilitation, Group 2: patients who recovered IC but not FC within 8 weeks, Group 3: patients who 
recovered IC and then FC within 8 weeks, Group 4: patients who recovered FC (without prior evidence of IC) within 8 weeks. 
a
 
includes 102 patients in Group 2 + Group 3 who recovered IC; 
b
 includes 91 patients in Group 3 + Group 4 who recovered FC; 
c
 
Pearson’s Chi-squared test for dichotomous variables and Kruskal-Wallis Rank Sum Test for continuous variables; 
d
 Fisher’s test for 
dichotomous variables and Wilcoxon Rank-sum test for continuous variables. Bonferonni’s corrected threshold for multiple 
comparisons= 0.05/6 (p<0.0083). p values in bold depict significant differences at p<0.0083 




At the group level, the 102 patients (58% of the sample) who 
recovered IC did so in a median time of 40 days following injury. The 
91 patients (52%) who went on to recover FC, did so at 49 days post-
injury. Within each of the four above-identified subgroups, the 
demographic and clinical characteristics have different patterns, as 
underlined by the significant differences between the groups for all 
our variables of interest but the time to recovery of FC. Post-hoc 
comparisons revealed, most notably, that patients in Group 1 (-IC-FC) 
were younger than Group 2 (+IC-FC), had longer acute length of stay 
than Groups 3 (+IC+FC) and 4 (-IC+FC) and longer rehab length of stay 
than Group 3 (+IC+FC). Moreover, patients who recovered IC but not 
FC within eight weeks (Group 2: +IC-FC) had longer rehab lengths of 
stay than patients who recovered IC and then FC within eight weeks 
(Group 3: +IC+FC). The time from injury to recovery of IC and FC for 
each group is illustrated in Figure 12. 
 
 
Figure 12 – Timeline of the recovery of communication after injury. Days are 
reported using medians. Group 1 (-IC-FC): Patients who did not recover 
communication within the eight-week primary observation period (31% of 




the study sample); Group 2 (+IC-FC): Patients who recovered IC but not FC 
within eight weeks (17% of the sample); Group 3 (+IC+FC): Patients who 
recovered IC and then FC within eight weeks (41% of the sample); Group 4 (-
IC+FC): Patients who recovered FC (without prior evidence of IC) within 
eight weeks (11% of the sample). 
 
Secondary analyses were performed on 49 patients who did 
not recover IC or FC by week 8 after admission and 26 who recovered 
IC but not FC. Among these 75 patients, 16 (21%) recovered FC within 
15 [13 – 19] weeks; nine (12%) recovered only IC within 16 [13 – 18] 
weeks and 50 (67%) recovered neither IC nor FC by discharge. This 
means that, overall, 52% (n=91) of the whole sample recovered FC 
within the 8-week rehabilitation program (in a median time of seven 
weeks post-injury). When taking into account these patients as well 
as those presenting later recoveries of FC (i.e., past 8 weeks), 61% 
(n=107) of the patients recovered FC with a median time of 15 weeks 
after injury. These findings have several implications. 
First of all, it was somewhat surprising to identify four 
different patterns of communication recovery. Indeed, without any 
a priori hypothesis, we would expect to see patients either 
recovering IC and then FC during their rehabilitation, or not. This 
binary perspective was challenged here by the emergence of groups 
recovering IC but not FC or recovering FC without any prior evidence 
of IC. The transition to communication therefore does not appear to 
be a long calm (and predictable) river. In patients following the 
‘classic’ transition path (i.e., Group 3; +IC+FC), FC emerged about 
nine days following IC, suggesting IC might be a harbinger of FC.  
Second, our findings suggest that patients with shorter acute and 
post-acute rehab length of stay are more likely to recover FC by 




discharge. This confirms previous results showing shorter acute 
length of stay in patients who recovered communication as 
compared to those who did not (Noé et al., 2012). This might be due 
to the severity of the initial lesions. Shorter acute and post-acute 
lengths of stay may indeed reflect a less severe initial injury that can 
reasonably be associated with an increased likelihood of recovering 
cognitive abilities (such as communication) early on. Third, another 
surprising finding was the significantly younger age in the group of 
patients who did not recover any evidence of communication during 
these eight weeks, which contradicts previous works associating 
younger age with better prognosis (The Multi-Society Task Force on 
PVS, 1994b). This suggests that in spite of being a prognostic factor, 
age does not specifically influence recovery of communication. An 
important fact to consider at this stage is the setting of the study and 
the local healthcare policies applied. In the USA where this study 
took place, healthcare is privatized and thereby not every patient has 
access to the intensive care and rehabilitation facilities. Admission 
and care in these structures highly depend on the patient’s socio-
economic status. In practical terms, this means that there is an 
important selection bias on the front end. Likewise, as hospitals 
depend on their survival and outcome statistics to obtain funding and 
maintain a certain level of reputation, they preferentially admit 
patients with better prognosis in order to report good outcomes for 
the admitted populations. This further reinforces the selection bias 
and leads to admitting younger patients in intensive settings. This 
could partly explain our findings about younger patients not 
recovering communication: there are probably far more young 
people admitted to start with, as compared to studies conducted in a 
setting with public healthcare and inclusive admissions (e.g., 




European countries). Nonetheless, despite this selection process, 
nearly two thirds overall went on to recover FC, which is encouraging 
for clinicians and relatives in the early stages of the injury and 
contributes to refining outcomes for patients admitted to 
rehabilitation. 
Regarding our primary aim, the time range from injury to 
communication recovery reported here (seven weeks) falls within the 
broad range reported by previous studies. Interestingly, some 
patients presented a late recovery of communication (about four 
months after injury), which has also already been observed 
previously and has important clinical implications. Indeed, decisions 
regarding palliative care or referral to rehabilitation are taken at the 
acute stage, when the clinical picture and prognosis seem hopeless. It 
turns out however that even patients who are unable to 
communicate in this post-acute setting on admission to 
rehabilitation, later improve to communication recovery in more 
than half of the cases. Referral to rehabilitation should therefore be 
supported early on. We were unable to include acute patients in an 
intensive care setting in the present study and overcoming this 
limitation would provide a comprehensive picture of the prevalence 
and the time course to communication recovery in severely brain-
injured patients. Other limitations include a monocentric 
retrospective design and strict criteria for presence of 
communication based on the CRS-R. The scale recommends indeed 
assessment of communication with situational orientation questions 
while other administration criteria (e.g., using autobiographical 
questions) could elicit more responses (Nakase-Richardson et al., 
2009). 




 Nevertheless, this study shows that patients with severe 
brain damage suggestive of a poor prognosis may achieve this highly 
relevant recovery milestone during rehabilitation, which should be 
initiated and encouraged as much as possible. The data presented 
here provides inpatient rehabilitation clinicians with quantitative 
parameters and caregivers with realistic expectations for 
communication recovery. Contributing to a better initial behavioral 
diagnosis will further guide treatment interventions, as they may 






3. Part Two: Transcranial direct current 
stimulation as a therapeutic option 
 
“Do not fear failure but rather fear not trying.” 
Roy T. Bennett 
 
 
The present section is based on the following articles: 
Martens, G., Ibanez-Soria, D., Soria-Frisch, A., Barra, A., Piarulli, A., 
Gosseries, O., Salvador, R., Rojas, A., Nitsche, M., Laureys, S., 
Ruffini, G., & Thibaut, A. A novel closed-loop EEG-tDCS approach 
to promote responsiveness of patients in minimally conscious 
state: a study protocol. Submitted 
Martens, G., Kroupi, E., Bodien, Y., Cassol, H., Barra, A., Martial, C., 
Annen, J., Soria-Frisch, A., Gosseries, O., Ruffini, G., Laureys, S., 
& Thibaut, A. Behavioral and electrophysiological effects of 
network-based frontoparietal tDCS in patients with severe brain 
injury: a randomized controlled trial. Submitted 
Martens, G., Fregni, F., Carrière, M., Barra, A., Laureys, S., & Thibaut, 
A. (2019). Single tDCS session of motor cortex in patients with 
disorders of consciousness: a pilot study. Brain Injury, 1-5.  
Martens, G., Lejeune, N., O'Brien, A. T., Fregni, F., Martial, C., 
Wannez, S., Laureys, S. & Thibaut, A. (2018). Randomized 
controlled trial of home-based 4-week tDCS in chronic minimally 
conscious state. Brain stimulation, 11(5), 982-990. 




3.1. Context  
 
While patients with DOC face a critical lack of treatment 
options, tDCS appears as a valuable adjuvant to their therapeutic 
management. As opposed to pharmacological options, it does not 
present a risk of inducing adverse effects such as sleepiness, emesis 
or agitation. Amantadine, for instance, is the drug presenting the 
highest level of evidence for post-acute TBI patients with DOC but 
can reduce the epileptogenic threshold, thereby increasing the risk of 
seizure. Drugs can also be contraindicated in some cases, partly 
because of their metabolic interactions. This is not a concern with 
tDCS, as its action mainly affects cortical areas. Since tDCS is also 
affordable and easy to administer, it is an optimal candidate for 
therapeutic applications in patients with DOC. 
Prefrontal tDCS has been shown to be efficient to transiently 
improve the level of consciousness for some patients, especially 
those in MCS, while repeating the amount of sessions could prolong 
the duration of its effects (Bourdillon et al., 2019). This latter aspect 
is not easy to comply with in classic clinical or research settings and 
alternative applications in other environments have not been 
investigated in patients with DOC. 
When reviewing the literature, it appears that a majority of 
the interventional studies using tDCS focused on stimulating the left 
DLPFC, partly because of its involvement in many different functions 
such as attention, working memory and its integrative role in motor 
control and behavior (D’Esposito et al., 1995, 1998; Heekeren et al., 
2006). However, other regions are crucial in consciousness recovery 
processes. The precuneus, for instance, located in the posterior 




parietal cortex and part of internal awareness network is known as a 
critical hub for consciousness recovery (Laureys et al., 2004). 
Therefore, Huang et al targeted this area by stimulating the posterior 
parietal cortex in 33 patients in prolonged MCS using repeated 2 mA 
tDCS (applied for 20 minutes over five consecutive days). This led to 
significant clinical improvements as measured by the CRS-R but to a 
lesser extent than the studies stimulating the DLPFC (Huang et al., 
2017). Since other brain regions are also important for consciousness 
recovery or motor output, we want to investigate montages targeting 
other critical zones. 
Likewise, most tDCS studies with DOC patients use 
conventional unifocal montages with two electrodes: an anode and a 
cathode, allowing to stimulate a single cortical area. Recent 
technologic advancements however allow to target larger areas using 
multifocal stimulation. This type of administration enables to target 
specific cortical areas with a high-definition or to stimulate entire 
brain networks. This method has however not been applied to 
patients with DOC, yet. 
 




3.2. Translation into clinical and home use  
 
As for any type of device or drug investigated in clinical 
research, the endpoint is “Is this efficient, safe and usable in the 
patient’s daily life?”. Indeed, tDCS, as many other techniques has 
been widely investigated in research and clinical settings, but less is 
known about the applicability of the method in patients’ day-to-day 
routine. The fact that tDCS has to be applied by trained researchers 
or care practitioners limits its use outside of a hospital or a research 
facility. This means that since most of the chronic patients with DOC 
are discharged from hospital or rehabilitation centers to nursing 
homes or at home, they are unable to benefit from the potential 
long-lasting effects that characterize repeated stimulations sessions 
(Boggio et al., 2007; Ulam et al., 2014). In patients with DOC, the 
repetition of tDCS sessions leads indeed to higher rates of responders 
and greater amplitude of clinical improvement (Thibaut et al., 2017b; 
Zhang et al., 2017).  
A way to overcome both of these issues of routine 
applicability and repetition of the sessions is remotely supervised 
tDCS. A controlled remote application could indeed reduce the 
burden of travelling to a specialized facility, allowing for time gain 
and larger sample sizes (leading in turn to enough powered studies 
and diminished dropout rates). However, major aspects have to be 
addressed on the front end such as safety, compliance and feasibility. 
To that end Charvet and colleagues provided the scientific 
community with clearly established guidelines for using remotely-
supervised tDCS (Charvet et al., 2015). These are as such: 1) 
Appropriate training of the persons in charge of applying the 




stimulations; 2) Continuous evaluation of the subject’s compliance 
with study inclusion and exclusion criteria; 3) Support with training 
procedures and manuals of operating procedures; 4) User-friendly 
electrode preparation and montage; 5) Fixed stimulation parameters; 
6) Ongoing assessment of the subject’s compliance with the 
treatment intervention; 7) Continuous monitoring of potential 
adverse events; 8) Strict procedures for discontinuation of a session 
or for the study, adapted to each population of patients. These 
guidelines apply for all types of patients (e.g., attention deficit 
hyperactivity disorder, depression, multiple sclerosis) but endorse a 
particular importance for our population of patients with DOC, as 
these patients are non-communicative in a majority of cases and are 
therefore unable to provide any feedback on how the stimulation 
sessions are tolerated. They are also unable to apply the stimulations 
themselves for obvious reasons; the major cognitive and motor 
disabilities they face hinder their ability to participate actively in 
conventional therapies. We still decided to address all these 
challenges and to conduct a first of its kind home-based tDCS study, 
with the aim of bringing the tDCS technique that is known to be 
efficient for a proportion of patients with DOC, directly at their 
bedside. We used a randomized double-blind sham-controlled 
crossover design to include patients according to the following 
criteria: established diagnosis of MCS following an acquired severe 
brain injury; at least 16 years old; chronic state (i.e., more than three 
months post-injury); stable vital condition (i.e., no infection, 
intubation, recent hospitalization). Exclusion criteria were: presence 
of intracerebral metallic material, pacemaker, uncontrolled epilepsy, 
central-acting medication and introduction any new kind of 
treatment during the study period. Patients were screened during a 




one-week hospitalization to assess their level of consciousness and 
their prognosis using advanced neuroimaging and 
electrophysiological techniques. The study protocol was presented to 
their relatives and if they were interested and could identify a person 
responsible for applying the stimulations (e.g., a member of the 
family, a therapist, a nurse), the patient was included in the trial. The 
first phase consisted in training this dedicated person (i.e., the 
stimulation referent) to apply the stimulations independently. The 
training was composed of 1) watching a video with theoretical 
introduction and placement instructions; 2) receiving a user guide for 
placement instructions (available in Appendix 4); 3) observe and 
video-tape the investigator applying the device and; 4) applying the 
whole set-up themselves. We used a customized device provided by 
Cefaly Technology (Belgium) designed for an ease of use (see Figure 
13). It consists in a constant battery-driven stimulator, with 
preprogrammed stimulation settings (i.e., 2 mA, 20 minutes) and an 
internal clock monitoring the usage (i.e., amount of sessions applied 
and total time of each session). A set of two devices, one active and 
one sham was assigned to every new patient included. Only one 
device was provided at a time to the stimulation referent, in a 
randomized order. Since the firm was responsible for treatment 
allocation, patients, stimulation referents and investigators were 
blinded to the active/sham order.  





Figure 13 – Device designed for applying tDCS in a home environment 
(image provided by Cefaly Technology®)  
 
The protocol consisted in applying the stimulation daily for 
four consecutive weeks, five times a week for a total of 20 
stimulation sessions per period. The two periods, active and sham, 
were spaced by eight weeks of washout, as presented in Figure 14. 
The active tDCS sessions used 2 mA direct current for 20 minutes 
(with 5 seconds ramp-up and ramp-down periods) while the sham 
ones used 2 mA current for 5 seconds only, with the same ramping 
scheme. As shown in Appendix 4, the anode had to be placed over F3 
corresponding to the left DLPFC according to the 10-20 international 
EEG placement system (Herwig et al., 2003) while the cathode was 
placed over the supraorbital contralateral area. During the 4-week 
stimulation periods, the stimulation referent and the relatives and 
caregivers had to fill in a detailed questionnaire regarding potential 
adverse events (AE) as well as anything else they would consider 
abnormal. An example of this questionnaire, extracted from the Case 
Report Form, is available in Appendix 5. The investigators performed 




CRS-R assessments at baseline (week 0), after the end of the first 
stimulation period (week 4), after eight weeks of washout (week 12), 
after the end of the second stimulation period (week 16) and after 
the last eight weeks of washout (week 24). 
 
 
Figure 14 – Study protocol with timeline of assessments. tDCS= transcranial 
direct current stimulation; CRS-R= Coma Recovery Scale-Revised. From 
(Martens et al., 2018b)  
 
 Our primary outcomes included the change in CRS-R total 
score after four weeks of stimulation (active versus sham). It also 
included the safety estimation of this type of home-based study 
assessed by our AE questionnaire (i.e., amount of AEs reported) and 
the patients’ adherence to the treatment, recorded by the device 
(i.e., ratio between effective stimulations and planned stimulations). 
Our secondary outcome was the change in CRS-R total score at 8-
week follow-up. 
 For the statistical analyses, we first compared the baseline 
characteristics of the two groups (active-sham and sham-active) in 




terms of age, time since injury, and baseline CRS-R score; using 
Wilcoxon Rank-sum tests. For the tDCS treatment effect, we checked 
a potential carryover effect between active and sham conditions 
using a Wilcoxon match-paired test to compare the CRS-R total 
scores before active and before sham stimulations. In the absence of 
a significant difference, the treatment effect was calculated by 
comparing the CRS-R score difference following four weeks of active 
tDCS (ΔCRS-R active) and the difference following four weeks of sham 
(ΔCRS-R sham). The same procedure was applied for the secondary 
outcome, after the eight weeks of washout using the score difference 
at week 12 minus baseline (active versus sham). All the statistical 
analyses were performed on Stata 13 (StataCorp LP) and results were 
considered significant at p < 0.05. When looking at our other primary 
outcome, the adherence, we noted that some of the patients did not 
receive all of the planned stimulations and this accounts for our 
decision to conduct modified intention to treat (mITT) and per 
protocol (PP) analyses separately for the tDCS treatment effect. For 
the mITT, we used all available data meaning the CRS-R scores of the 
subjects who underwent all the CRS-R assessments (Raine et al., 
2005). For the PP, we considered only the scores of the patients who 
received at least 80% of the planned sessions (Leuchter et al., 2015; 
Thibaut et al., 2017a). For the two types of analyses, the Cohen’s d 
effect size was calculated as the difference in means and standard 
deviations between baseline and post-treatment comparing active 
with sham tDCS. Regarding the other primary outcomes, every AE 
extracted from the CRF was expressed as a percentage of the total 
amount of sessions delivered. For the adherence, the effectively 
applied sessions were expressed as a percentage of the total 
duration of planned stimulations (i.e., 6 hours and 40 minutes). 




 After screening 86 patients, 37 were deemed eligible and 
included in the study after legal representatives agreed and signed 
informed consent. The study flowchart is presented in Figure 15. 
During the study, ten patients were excluded due to one of the 
above-mentioned exclusion criteria. These patients did not 
significantly differ from the final study sample in terms of age, time 
since injury and baseline CRS-R (all p’s > 0.05). Upon study 
completion, when consulting the adherence data, five patients were 
excluded from the PP analysis because they received less than 80% of 
the planned sessions. The final study sample therefore consisted of 
27 patients for the mITT analysis and 22 patients for the PP analysis. 
No significant differences between the active-sham and sham-active 
groups were observed (all p’s > 0.05). 
 





Figure 15 – Study participants flow diagram. mITT= modified intention to 
treat; PP= per protocol. From (Martens et al., 2018b). 
 
Overall, the stimulations were applied at home by the family 
for 17 patients and in rehabilitation or nursing homes by the nursing 
team for 10 patients. All the patients tolerated the tDCS sessions well 
and no severe AE (i.e., threatening the patient’s life) was reported. A 
total of 13 mild AE were reported: skin redness for 10 patients and 
sleepiness for three patients; this represents 1% of the total amount 
of sessions performed (n=946). Regarding adherence, the mean ± SD 




of stimulation duration was 94 ± 14% (range: 48 – 130%), as 
presented in Figure 16. Five patients received less than 80% (16 
sessions) of active treatment sessions; three of them were in 
rehabilitation centers and two were at home. On the other hand, five 
patients at home received more than the 20 treatment sessions 
planned.  
 
Figure 16 – Percentage of adherence for each patient, for active and sham 
conditions. Percentage of use expressed over the total time of stimulation 
planned (i.e., 6 hours and 40 minutes – 20 sessions). The cut-off line 
represents 80% of the planned stimulation time. MD= missing data. From 
(Martens et al., 2018b).  
 
Regarding the evolution of the CRS-R total score, no 
carryover effect was identified between baseline active and sham 
conditions for both mITT (n=27; Z=1.506; p=0.132) and PP (n=22; 
Z=0.893; p=0.372) analyses. There was no significant treatment effect 
at four weeks in the mITT analysis (Z=1.934; p=0.053) while there was 
one for the PP analysis (Z=2.029; p=0.043). In terms of effect sizes in 
favor of the active treatment, it was small for the mITT (ES=0.47) and 
medium for the PP (ES=0.53). For our secondary outcome at 12 




weeks (long term effects), there was no significant treatment effect 
for both mITT (Z=1.263; p=0.207; ES=0.38) and PP analyses (Z=1.884; 
p=0.060; ES=0.67). The score variation for both types of analyses and 
both conditions is presented in Figure 17. 





Figure 17 – Boxplots of the CRS-R total score variation for active (in white) 
and sham (in grey) tDCS, after four weeks of treatment and after 8 weeks of 
washout. Delta represents post minus pre conditions CRS-R total score. 
Black lines represent the medians of the delta CRS-R, boxes represent the 




interquartile range and dashed lines represent minimum and maximum 
values. mITT= modified intention to treat analysis; PP= per protocol analysis; 
CRS-R= Coma Recovery Scale-Revised. From (Martens et al., 2018b). 
 





Table 5 – Demographic data, Coma Recovery Scale-Revised scores and adherence data.  
ID 
Age  
(gender) Etiology Time since injury Session 
 





     
Time 1 Time 2 Time 3 
 1 36 (F) TBI 12 years, 5 mo.  active 10 (3-3-2-1-0-1) 15 (3-4-4-1-1-2) 10 (1-3-2-2-1-1) 100 
  
 
    sham 10 (1-3-2-2-1-1) 6 (1-1-2-1-0-1) 8 (3-1-2-1-0-1) 95 
2  75 (M) ISCHEMIC STROKE 11 years active 9 (1-3-1-2-0-2) 11 (2-3-2-2-0-2) 8 (3-0-2-2-0-1) 48 
  
 
    sham 8 (3-0-2-2-0-1) 8 (1-2-2-1-0-2) 5 (0-1-0-2-0-2) 100 
3 35 (M) TBI 14 years  sham 10 (1-4-4-0-0-1) 11 (3-1-5-1-0-1) 10 (1-1-5-1-0-2) 96 
  
 
    active 10 (1-1-5-1-0-2) 14 (3-4-5-1-0-1) 15 (3-4-5-1-0-2) 95 
4 35 (F) TBI 5 years, 3 mo.  sham 13 (3-5-1-1-1-2) 15 (3-3-5-1-1-2) 13 (3-3-4-1-0-2) 95 
  
 
    active 13 (3-3-4-1-0-2) 15 (3-3-5-1-1-2) 16 (3-5-4-1-1-2) 95 
5 37 (M) CARDIAC ARREST 13 years, 11 mo.  active 9 (1-3-2-1-0-2) 5 (1-0-1-1-0-2) 9 (1-3-1-2-0-2) 105 
  
 
    sham 9 (1-3-1-2-0-2) 6 (1-0-1-2-0-2) 9 (1-3-1-2-0-2) 95 
6 32 (M) TBI 15 years, 4 mo. active 18 (4-5-5-2-1-1) 19 (4-5-6-2-1-1) 16 (3-5-4-2-1-1) 85 
  
 
    sham 16 (3-5-4-2-1-1) 19 (4-5-6-2-1-1) 18 (4-5-5-2-1-1) 100 
7 33 (F) TBI 15 years sham 14 (3-3-5-1-0-2) 14 (3-3-5-1-0-2) 12 (3-3-3-1-0-2) 100 
  
 
    active 12 (3-3-3-1-0-2) 12 (3-3-3-1-0-2) 13 (3-4-3-1-0-2) 93 
8 45 (M) TBI 33 years, 5 mo. sham 7 (0-3-2-1-0-1) 8 (1-3-2-1-0-1) 6 (1-1-2-1-0-1) 100 
  
 




9 31 (M) TBI 5 years, 2 mo.  sham 5 (1-0-1-2-0-1) 4 (0-0-1-2-0-1) 5 (0-0-1-2-0-2) 95 
  
 
    active 5 (0-0-1-2-0-2) 8 (3-0-1-2-0-2) 8 (3-0-1-2-0-2) 100 
10 63 (F) ANEURYSM 14 years active 14 (3-1-5-3-0-2) 14 (3-1-5-3-1-1) 15 (3-1-5-3-1-2) 100 
  
 
    sham 15 (3-1-5-3-1-2) 11 (3-0-5-2-0-1) 12 (3-0-5-3-0-1) 98 
11 45 (M) CARDIAC ARREST 3 years, 10 mo. sham 10 (2-2-2-2-0-2) 6 (1-1-2-0-0-2) 9 (2-1-2-2-0-2) 100 
  
 
    active 9 (2-1-2-2-0-2) 10 (2-2-2-2-0-2) 8 (1-1-2-2-0-2) 107 
12 55 (M) ANEURYSM 2 years, 11 mo. active 11 (1-3-5-1-0-1) 13 (2-3-5-1-0-2) 12 (2-3-5-1-0-1) 97 
  
 
    sham 12 (2-3-5-1-0-1) 13 (2-3-5-1-0-2) 14 (2-3-5-2-0-2) 91 
13 40 (M) CARDIAC ARREST 10 years sham 6 (1-1-1-1-0-2) 8 (1-3-1-1-0-2) 6 (1-1-1-1-0-2) 105 
  
 
    active 6 (1-1-1-1-0-2) 6 (1-1-1-1-0-2) 5 (1-1-1-0-0-2) 90 
14 60 (M) ANEUVRYSM 4 years, 1 mo.  active 2 (1-0-0-0-0-1) 5 (1-1-1-0-0-2) 3 (1-0-1-0-0-1) 95 
  
 
    sham 3 (1-0-1-0-0-1) 3 (1-0-1-0-0-1) 5 (1-0-1-2-0-1) 89 
15 57 (M) CARDIAC ARREST 8 years, 8 mo.  active 4 (0-0-2-1-0-1) 9 (1-1-5-1-0-1) 9 (1-1-5-1-0-1) 94 
  
 
    sham 9 (1-1-5-1-0-1) 12 (1-3-5-1-0-2) 9 (1-1-5-1-0-1) 90 
16  46 (F) CARDIAC ARREST 1 year, 5 mo.  active 3 (1-1-0-0-0-1) 4 (1-1-0-1-0-1) 5 (1-1-0-2-0-1) 54 
  
 
    sham 5 (1-1-0-2-0-1) 4 (1-1-0-1-0-1) 8 (2-2-1-2-0-1) 63 
17 33 (M) TBI 8 years, 7 mo.  sham 8 (2-3-1-0-0-2) 9 (2-3-2-0-0-2) 9 (2-3-1-1-0-2) 130 
  
 
    active 9 (2-3-1-1-0-2) 12 (2-4-2-2-0-2) 10 (2-3-2-1-0-2) 101 
18 55 (M) CARDIAC ARREST 8 years, 2 mo.  active 9 (1-3-1-2-0-2) 13 (1-3-5-2-0-2) 11 (3-3-1-2-0-2) 95 
  
 




19  48 (F) ISCHEMIC STROKE 10 mo. active 10 (0-3-5-1-0-1) 9 (1-2-5-0-0-1) 7 (0-1-5-0-0-1) 69 
  
 
    sham 7 (0-1-5-0-0-1) 8 (0-1-5-1-0-1) 10 (1-2-5-1-0-1) 73 
20 30 (M) CARDIAC ARREST 3 years, 4 mo.  active 9 (1-4-0-2-0-2) 7 (2-1-0-2-0-2) 9 (2-4-0-1-0-2) 80 
  
 
    sham 9 (2-4-0-1-0-2) 9 (2-4-0-1-0-2) 10 (3-4-0-1-0-2) 100 
21 38 (M) CARDIAC ARREST 1 year, 2 mo. active 5 (1-0-1-2-0-1) 7 (1-1-1-2-0-2) 5 (1-0-1-2-0-1) 101 
  
 
    sham 5 (1-0-1-2-0-1) 5 (1-0-1-1-0-2) 8 (1-1-2-2-0-2) 100 
22 23 (M) TBI 2 years, 2 mo.  sham 10 (1-3-2-2-0-2) 9 (1-3-1-2-0-2) 5 (0-0-1-2-0-2) 100 
  
 
    active 5 (0-0-1-2-0-2) 7 (1-0-2-2-0-2) 8 (1-1-2-2-0-2) 95 
23 70 (F) ANOXIA 4 years, 7 mo.  active 15 (3-3-5-2-0-2) 14 (3-3-4-2-0-2) 15 (3-4-4-2-0-2) 125 
  
 
    sham 15 (3-4-4-2-0-2) 14 (3-3-5-2-0-1) 16 (3-4-6-2-0-1) 95 
24  27 (M) TBI 7 years, 11 mo. sham 8 (1-3-2-1-0-1) 9 (1-3-2-1-0-2) 12 (3-3-2-2-0-2) 95 
  
 
    active 12 (3-3-2-2-0-2) 9 (1-3-2-1-0-2) 10 (1-3-2-2-0-2) 65 
25 26 (M) TBI 7 years, 4 mo.  sham 7 (0-3-2-1-0-1) 12 (2-3-5-1-0-1) 11 (1-3-5-1-0-1) 100 
  
 
    active 11 (1-3-5-1-0-1) 14 (3-3-5-1-0-2) 12 (3-4-2-1-0-2) 100 
26  17 (M) TBI 1 year, 9 mo. active 13 (3-3-2-2-1-2) 13 (3-3-2-2-1-2) 15 (3-5-2-2-1-2) MD 
  
 
    sham 15 (3-5-2-2-1-2) 11 (2-3-2-2-0-2) 13 (3-3-2-2-1-2) MD 
27 42 (F) CARDIAC ARREST 1 year, 9 mo.  active 7 (1-1-1-2-0-2) 9 (1-3-1-2-0-2) 8 (2-1-1-2-0-2) 81 
  
 
    sham 8 (2-1-1-2-0-2) 13 (3-5-1-2-0-2) 6 (2-0-1-1-0-2) 100 
Adherence (%) expressed as part of the expected total time of stimulation). Time 1= at baseline, Time 2= at 4 weeks (end of the 
treatment): Time 3= at 12 weeks (8 weeks after the end of the treatment). CRS-R= Coma Recovery Scale-Revised; mo.= months
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 This study is the first of its kind using a home-based design to 
deliver repeated tDCS during four weeks to patients in MCS in their 
daily environment and to investigate the long-term effects. It showed 




The low occurrence of AE reported here (1%) confirms the 
findings from previous works (Boggio et al., 2008; Sacco et al., 2016). 
If used in proper controlled conditions, according to established 
safety criteria, tDCS is a safe technique to use, even in patients with 
major cognitive deficits such as for DOC. These criteria mainly refer 
to the dose of tDCS received and conventional approaches establish a 
limit of 40 minutes a day at maximum 4 mA (Nitsche et al., 2003b; 
Bikson et al., 2016). Our results show that the safety in a home-based 
setting is similar, if not better, to research environments, were about 
12% of AE are reported (itching in a majority of cases) (Russo et al., 
2017). Regarding severe AE (i.e., threatening the patient’s life), none 
have been reported here which is, again, in line with the tDCS 
literature. Bikson et al reviewed indeed the use of conventional tDCS 
in human trials and found no report of any type of severe AE in a 
total of 33200 sessions and 1000 subjects with repeated sessions, 
including vulnerable population such as children, elderly or home 




Delivering tDCS to patients with impaired consciousness 
already represents a challenge for a researcher, because they cannot 
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collaborate nor communicate. Involving non-professionals to apply 
the stimulations by themselves constituted an additional stake. An 
appropriate training of the stimulation referent was therefore 
essential. The data relative to the adherence showed us that the 
average compliance is excellent (94%) indicating that the sessions 
were correctly performed; but it also appeared that compliance was 
fairly low in some cases (48%). We therefore followed guidelines 
aiming at better tackling the issue of missed tDCS sessions during 
clinical trials for our analyses by conducting both mITT and PP 
analyses based on a 80% threshold (Thibaut et al., 2017a). The five 
patients for which the adherence was below this threshold were 
mostly in rehabilitation centers where the stimulation referents were 
part of the nursing team. Even though the setup and removal 
montage time is very short (~5 minutes), it might have been too 
burdensome to incorporate in the daily care routine. It might be 
more efficient, in future trials, to apply tDCS during rehabilitation 
interventions such as physical therapy. Indeed, as most of these 
sessions have to last at least 30 minutes, the therapist could easily 
apply the device at the beginning of the sessions and remove it at the 
end. Furthermore, applying tDCS during this kind of therapy can 
increase its benefits. Indeed, the addition of motor tDCS to 
conventional motor training programs in chronic stroke patients 
leads to a significant improvement in upper limb function; as well as 
increased grey matter volume in motor and premotor cortices as 
measured by structural MRI (Allman et al., 2016). Likewise, adding 
occupational therapy to controlesional cathodal tDCS over M1 leads 
to a significant motor improvement and functional recovery (Nair et 
al., 2011). Combining tDCS application with rehabilitation 
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interventions represents thus an efficient therapeutic approach and 
could reduce the number of missed sessions. 
Unexpectedly, some relatives applied too many stimulations 
(up to 130% of the planned time). When investigating the devices 
logs, it appeared they tended to stimulate every day, without 
interruption, instead of five days a week. This could be due either to 
misinterpretation of the instructions or to deliberate protocol 
violation to increase the chances of recovery of their loved one. Even 
if comprehensible, the latter scenario raises concerns regarding 
compliance with established safety criteria. Indeed, the rationale for 
stimulating five times a week (besides feasibility in rehabilitation and 
nursing centers) relied on limiting the total dose of tDCS received, 
since a total of 20 tDCS sessions had never been investigated in 
patients with DOC at that time. The device we used had built-in 
safety features limiting the application of tDCS to 20 minutes a day; it 
did not limit its use over the course of a week. It is of course complex 
to perform ongoing monitoring of the protocol compliance but future 
trials should make additional efforts in that direction, by sending 
alerts to the investigators when there is an overuse of a tDCS device 




Regarding the therapeutic benefits of our home-based 
repeated protocol, they appeared to be significantly greater for 
active tDCS than for sham, upon the condition to meet at least 80% 
adherence. The treatment effect was indeed significant for the 22 
patients in the PP analyses, whereas only a trend could be noted for 
the 27 patients in the mITT group. This implies that continuous 
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neuromodulation through the DLPFC has moderate clinical effect in 
this subpopulation. tDCS mechanisms of action suggest long-term 
neuroplastic changes through modification of NMDA receptors 
(Nitsche et al., 2003a, 2004) and unmasking of cortical connections 
(Fregni and Pascual-Leone, 2006; Simis et al., 2014). 
Noteworthy, the patients included in the study were 
extremely chronic; the median time since injury was eight years and 
maxed out at 33 years. It is still possible to observe improvements at 
that stage, as cases of late recovery, up to years post-injury, have 
already been described in the literature (Sara et al., 2007; Estraneo et 
al., 2010; Schiff, 2010). These cases rely on a common hypothesis of 
possible axonal regrowth leading to white matter plasticity and 
recovery of long range connectivity within white matter fiber tracts 
(Voss et al., 2006). This seems to be particularly true for patients in 
MCS, who also tend to have a better potential for late recovery 
overall, as compared to UWS patients (Luaute et al., 2010). 
Regarding potential long-term effects of 20 sessions of tDCS 
(i.e., 8-week follow-up; secondary outcome), our results showed the 
treatment effect was not significant anymore. This is counterintuitive 
with regard to previous findings reporting tDCS-related enduring 
effects one week after tDCS in DOC patients (Thibaut et al., 2017b) 
and after one month in depression (Boggio et al., 2008) or pain 
(Fregni et al., 2006). However, MCS patients typically suffer from 
more extensive brain damage which might explain the need for 
continuous neuromodulation to maintain the neuroplastic changes. 
Taken together, these results suggest that, in this population of 
chronic MCS patients, tDCS should be maintained for the benefits to 
remain. 
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Inevitably, there are some limitations in this study that need 
to be considered before generalizing the results. Regarding the 
design of the protocol, we had to choose key time points for CRS-R 
assessments from a feasibility perspective. Therefore, the timeline of 
these assessments (i.e., at baseline, after four weeks of stimulations 
and eight weeks after the end of the stimulations) did not allow to 
evaluate the evolution of behavioral improvements during the four 
weeks of tDCS, neither how these faded out during the 8-week rest 
period. In the same vein, the duration of the complete protocol (i.e., 
six months) led to an important rate of dropout (27%) and a reduced 
sample size. Treatment amendments and general infections were the 
most common reasons for exclusion, yet these medical instabilities 
are likely to happen over such a long period given the frailty of these 
patients. Regarding home-based monitoring, strictly complying with 
each single one of the guidelines for remotely-supervised tDCS 
(Charvet et al., 2015) was tricky, from a feasibility and human 
resource perspective. There was therefore no daily monitoring of 
tDCS application and AE collection. This concern was mitigated by the 
previously established safety of both single and repeated sessions of 
tDCS (Bikson et al., 2016). Importantly, our aim was to investigate 
applicability of tDCS in ecological conditions; in the patient’s daily 
routine where, most of the time, relatives have to apply a wide range 
of treatments themselves (e.g., medication, aerosol therapy, 
stretching). We thus tried to be as close as possible to clinical reality 
but balancing this requirement with a safety assessment is a delicate 
challenge. 
Nevertheless, this inaugural home-based trial investigating 
20 consecutive sessions of 20 minutes 2 mA tDCS applied over the 
left DLPFC by trained relatives or caregivers demonstrated that it is 
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safe, feasible and significantly improves the level of consciousness of 
patients who adhere to the protocol. These findings pave the way 
toward involving patients’ relatives in the therapeutic management 
of their loved ones, beyond palliative care only. 
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3.3. Alternative targets and montages 
 
3.3.1. The motor cortex: stimulate or 
inhibit? 
The primary motor cortex, commonly referred to as “M1” is 
not only responsible for movement execution but also represents a 
cortical gateway to deeper structures such as the posterior cingulate 
cortex, part of the internal awareness network (Vanhaudenhuyse et 
al., 2011). A tDCS-fMRI study showed indeed increased connectivity 
in this area as well as in the right DLPFC and the left somatomotor 
cortex after 10 minutes of tDCS applied over the left M1 (Polanía et 
al., 2011). This suggests that stimulating M1 might indirectly increase 
the excitability of distant functionally related areas important for 
consciousness recovery. Moreover, the direct activation of M1 is of 
interest as well, given the important motor contribution in the 
clinical expression of signs of consciousness. There are some specific 
cases indeed where the patients are unable to show any sign of 
consciousness at the bedside, not necessarily because they don’t 
have the cognitive capacities to do so but because they may lack the 
motor abilities to show such signs. This situation of CMD or covert 
consciousness may lead to a misdiagnosis with the now well-known 
consequences. An additional confounding issue is the strong reliance 
of the gold-standard CRS-R on motor abilities, as most of the items 
require a preserved motor output (Giacino et al., 2004). Therefore, 
stimulating M1 could be a critical option to increase the level of 
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consciousness and the patient’s abilities to show signs of 
consciousness at the bedside. 
To assess feasibility and to evaluate the short-term effect of 
M1 tDCS, we conducted a pilot randomized crossover sham-
controlled trial. The inclusion criteria were as follows: 1) presenting a 
DOC following a severe brain injury as established by the 
international guidelines; 2) stable vital condition (i.e., no recent event 
requiring hospitalization, change in medication or intubation); 3) 
absence of documented neurological condition prior to the accident; 
4) no medication comprising sedative agents, Na+ or Ca2+ channel 
blockers or NMDA receptor antagonists; 5) absence of metallic 
cerebral material; 6) absence of craniectomy and; 7) absence of 
uncontrolled epilepsy. 
 For each patient, the most affected hemisphere was 
identified based on medical records and imaging review. The DC 
Stimulator Plus (Neurocare, Germany), that offers a built-in double-
blind mode using code numbers, was used to deliver one active and 
one sham session of tDCS in a randomized 1:1 order with saline-
soaked sponge electrodes (35 cm²). The anode was placed over 
either C3 or C4 (the most affected side) based on the 10-20 
international placement system (Herwig et al., 2003) while the 
cathode was placed over the contralateral supraorbital area. The 
active condition consisted in a ramp-up period of 30 seconds to 2 
mA, applied for 20 minutes before ramping down. For the sham 
condition, the current was ramped up, applied for 5 seconds and 
then ramped down, to mimic the somatosensory effects of active 
tDCS (Palm et al., 2013). The two sessions were separated by at least 
24 hours of washout. Behavioral effects were assessed at the group 
level using the CRS-R total score before and after stimulation (i.e., 
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primary outcome: treatment effect). Individual response was 
investigated as well (i.e., responder patients defined as patients 
showing a new CRS-R sign of consciousness after active stimulation 
that was not present before, neither before or after sham). 
Secondary analyses included the assessment of any side effect, the 
treatment effect in each CRS-R subscale (n=6), computation of effect 
sizes and the influence of time since injury on the difference in CRS-R 
total score (i.e., ∆CRS-R) following active stimulation. For the 
calculation of the treatment effect, we first checked the absence of 
any carryover effect between active and sham sessions, by 
comparing the CRS-R total score before active and before sham tDCS 
(baseline conditions) using a Wilcoxon matched-pairs signed rank 
test. The treatment effect was then calculated using the same test 
but comparing ∆CRS-R active (i.e., CRS-R total score after active tDCS 
minus CRS-R total score before active tDCS) and ∆CRS-R sham (i.e., 
CRS-R total score after sham tDCS minus CRS-R total score before 
sham tDCS). The Wilcoxon’s statistic Z was then used to calculate the 





This procedure was applied for the CRS-R total score as well 
as for the score in every subscale (i.e., auditory /4, visual /5, motor 
/6, verbal /3, communication /2 and arousal /3). As exploratory 
analyses, the treatment effect was computed in patients in MCS only 
(n=6), and the correlation between time since injury and ∆CRS-R 
active was investigated using Spearman’s Correlation test. All 
statistical analyses were performed using R 3.5.1 (R Core Team, 2008) 
and results were considered significant at p< 0.05. 
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 We included 10 patients, 8 men, 6 MCS and 4 UWS, 49 ± 22 
years old, 5 TBI, 7 ± 13 months post-injury. Individual demographic, 
CRS-R and MRI data are presented in Table 6. At the group level, no 
carryover was identified. No treatment effect was identified either 
(p= 0.55; r= 0.1). At the individual level, two responders were 
identified (P8 and P9) by newly showing visual pursuit and object 
localization, respectively, after active tDCS. P8 was a 19-year old man 
who had a TBI seven months earlier that caused damage in the 
frontal lobes and the hippocampi. As he was initially diagnosed as 
UWS, his diagnosis changed to MCS with the presence of visual 
pursuit following tDCS. P9 was a 64-year old man who suffered from 
a stroke 28 days before his inclusion in the study affecting the lest 
insula and the left basal ganglia. Some behavioral improvements 
were identified after sham stimulation too (e.g., object recognition, 
response to command), but no patient changed diagnosis. Regarding 
our secondary analyses, there was no significant treatment effect in 
any CRS-R subscale (all ps > 0.05), nor in the MCS patients only 
(p=0.89; r= 0.06). There was no further influence of time since injury 
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This study aimed at investigating the behavioral effects of M1 
tDCS in patients with DOC. We included both patients in UWS and in 
MCS as they could hypothetically both benefit from this montage. 
While patients in MCS tend to betted respond to prefrontal tDCS as 
stated above, the effects of motor tDCS are still unknown in these 
subpopulations. Additionally, patients diagnosed as UWS at the 
bedside might present with CMD and therefore particularly benefit of 
motor neuromodulation with tDCS. 
In our setting, this montage failed to show any significant 
treatment effect at the group level. This absence of effect can be 
explained by several hypotheses. First, the low dose of tDCS might be 
a limiting factor. Indeed, it is known that the effects of tDCS can be 
cumulative and that the number of applied sessions is an important 
factor for responsiveness in patients with brain injury (stroke, TBI and 
DOC) (Boggio et al., 2007; Ulam et al., 2014; Thibaut et al., 2017b). 
Applying more sessions could therefore have positively influenced 
the behavioral responsiveness of our sample. However, we have 
been constrained, for safety reasons, to start with investigating one 
session at a time before increasing the dose since this is a new type 
of montage and these patients are often unable to provide subjective 
report and express painful feelings. Given the absence of adverse 
events in our study, M1 tDCS sessions could be progressively 
increased in the future. Second, the outcome measure we used (the 
CRS-R), despite being the gold standard for behavioral assessment, 
might not be sensitive enough for motor related changes. 
Electromyography, motor evoked potentials or EEG might better 
reflect some neural changes following tDCS. The third and most 
important reason simply is the possible absence of M1 tDCS effect in 
DOC patients. Even though the dependency on motor behaviors is a 
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key issue in their management, targeting the motor cortex alone 
could fail to be an optimum choice. Given the extent of the brain 
damage that characterizes this population (Guldenmund et al., 2016), 
efficiently recruiting the motor cortex and distant functionally related 
areas might be impossible with such a montage.  
We could also discuss the rationale of choosing the most 
affected area for stimulation. This choice was based on tDCS study 
models for patients with stroke. Indeed, a widely used approach 
consists in stimulating the affected hemisphere with the anode while 
decreasing the excitability of the unaffected hemisphere with the 
cathode to balance the inter-hemispheric competition (Murase et 
al., 2004; Schlaug et al., 2008). However, Thibaut and colleagues 
recently showed that, at least partial structural and metabolic 
preservation of the stimulated area would be needed to observe a 
greater behavioral response in patients with DOC, by comparing 
neuroimaging data of responders and non-responders (Thibaut et al., 
2015c). This suggests that the stroke model cannot be used for our 
population, and that patients with DOC need optimized montages 
targeting cortical areas that are preserved in order to stimulate the 
local synaptic plasticity. When taking a look at the MRI data in our 
study, it appears a majority of our patients (70%) had lesions 
potentially involving the motor cortex, located in the frontal lobes, 
which might explain the low clinical effect overall. Although 
surprisingly, one of our responders (P8) suffered from structural 
damage in the frontal lobes, thereby being an exception that proves 
the rule. 
We found another pilot study investigating the behavioral 
and electrophysiological effects of bilateral M1 tDCS (Straudi et al., 
2019). This team applied 10 sessions of 40 minutes 2 mA tDCS with 
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two anodes over bilateral M1 (and the cathode over the nasion) over 
two weeks with 10 chronic patients in MCS following a TBI. 
Behavioral effects as measured by the CRS-R showed significant 
clinical improvements: median improvement of two points on the 
CRS-R at the group level and identification of eight tDCS-responders 
(80%) at the individual level. Electrophysiological effects as measured 
by low-density EEG showed significantly greater activity in the alpha 
band following stimulation. This study reports greater behavioral 
improvements than our trial and is in line with our first hypothesis 
regarding the lack of dosage. It is however limited by the design: it 
was an open label with no control condition, which significantly 
lowers the level of evidence. Moreover, the fact that they included 
only MCS patients with TBI makes the comparison with our study 
tricky as the clinical response to tDCS and the prognosis are, 
respectively, better in these subgroups. The better response to tDCS 
in this study might also be explained by the higher dose of tDCS 
applied; 40 minutes of 2 mA tDCS instead of the conventional 20 
minutes. Since, again, no severe adverse events have been reported, 
increasing the dose of received tDCS appears as an interesting path 
to follow in future trials. Taken together these results suggest that 
M1 tDCS is a suitable option for DOC and especially MCS patients. 
While the clinical improvements might appear less significant than 
for prefrontal stimulation, this type of montages targeting the motor 
cortex also have been significantly less investigated in our 
population. A proper randomized controlled trial based on an a priori 
sample size estimation would allow an efficacy comparison. 
 With regards to our patient population, a crucial component 
neglected here but that should be considered is the presence of 
spasticity. As mentioned earlier, this motor trouble results from 
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lesions and anarchic reorganization of the motor neural pathways 
and is clinically expressed by a pathologically increased muscle 
activity. Therefore, stimulating the motor cortex might not be 
suitable for these specific cases and rather inhibiting it could 
represent a benefit. This hypothesis was tested in another 
randomized controlled trial using cathodal stimulation over the 
bilateral M1 to decrease its excitability and thereby potentially 
reduce spasticity, as measured by the MAS (Thibaut et al., 2019a). 
Fourteen patients received, both cathodal and sham tDCS with 
cathodes placed over the bilateral M1 and anodes over the bilateral 
prefrontal cortex. Spasticity-wise, reduced hypertonia was observed 
in the finger flexors at the group level, and four responders 
presented decreased hypertonicity in at least two joints after active 
and not sham stimulation at the individual level. From the level of 
consciousness perspective, no significant changes in the CRS-R total 
score were observed. This means that despite somewhat decreasing 
the spastic features, decreasing the excitability of M1 using cathodal 
tDCS did not lead to better expression of signs of consciousness in 
the end. Spasticity is therefore not the only component affecting 
motor responsiveness in patients with DOC, and this issue is clearly 
multifactorial. 
Either stimulating or inhibiting the motor cortex to increase 
motor function or reduce spasticity, the above-presented studies 
showed that the level of consciousness was not significantly affected 
by these interventions, possibly because recruiting a cortical region 
and its functionally related areas requires a more complex setting 
than the ones used here. Targeting a single cortical area might 
indeed be too restrictive while recent technological advancements 
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made multi-site and network-based stimulation possible (Ruffini et 
al., 2014). 
 
3.3.2. Multifocal stimulation: network-
based approach targeting external 
awareness 
 
A common specificity to all the previous studies using tDCS 
with DOC patients is that they targeted specific cortical regions with 
unifocal stimulation while recent technological advancements have 
made simultaneous multifocal stimulation available, paving the way 
for network-based stimulation (Ruffini et al., 2014). Targeting brain 
networks could be particularly relevant for DOC patients, not only 
because brain injury is a largely heterogeneous condition that 
involves a distribution of cortical and subcortical regions, but also 
because recovery of consciousness appears to be reliant on specific 
networks rather than individual regions (Laureys et al., 2000). Two 
distinct networks have been identified as potential mediators of 
conscious awareness, which during normal consciousness activate in 
an alternating fashion (Bodien et al., 2017) and in DOC patients 
gradually increase with the level of consciousness, in terms of 
functional connectivity (Threlkeld et al., 2018). The default mode 
network, encompassing bilaterally the precuneus, the temporo-
parietal junction and the medial prefrontal cortex, is functionally 
related to internal awareness (i.e., stimulus-independent thought or 
self-related thoughts) (Vanhaudenhuyse et al., 2010). Conversely, the 
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executive control or external awareness network, located in the 
lateral frontoparietal regions, relates to external awareness 
processing (i.e., sensory perception of the environment and cognitive 
tasks) (Fox et al., 2005; Golland et al., 2007; Vanhaudenhuyse et al., 
2011). Given the apparent role of network preservation and recovery 
in patients with DOC, simultaneous stimulation of multiple regions 
could result in a more drastic improvement in recovery of awareness 
than stimulating an isolated single node. To date, network-based 
stimulation has not been investigated in patients with DOC, and the 
external awareness network appears as an accessible and optimal 
target given its role in recovery of consciousness.  
In addition to behavioral outcomes, tDCS-related EEG 
changes in patients with DOC have been investigated, but they 
focused on coherence (Bai et al., 2018; Guo et al., 2019) or P300 
amplitude (Zhang et al., 2017). Although it has been proposed as a 
deterministic way to quantify consciousness based on algorithmic 
information theory (Ruffini, 2017), no study has investigated the 
complexity of the EEG signal following tDCS in DOC patients. The 
Lempel-Ziv-Welch (LZW) algorithm provides an estimate of brain 
algorithmic complexity and has been studied in aging (Anokhin et al., 
1996; Fernández et al., 2012), as well as in neurological and 
psychiatric conditions (Li et al., 2008; Fernández et al., 2011; Méndez 
et al., 2012). It depicts the ‘randomness’ of the neural signal and 
thereby the integrity of inter-neural connectivity (Tononi and 
Edelman, 1998). For instance, LZW increases under ketamine, 
underlying its psychoactive properties (Li and Mashour, 2019) 
whereas it decreases under propofol general anesthesia (Schartner et 
al., 2015) or sleep (Schartner et al., 2017), suggesting a lower level of 
consciousness induces fewer simultaneous brain oscillations. In 
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patients with DOC, an EEG-TMS based index (the Perturbational 
Complexity Index (Casali et al., 2013)) calculated using the LZW 
algorithm is diminished as compared to healthy controls and can 
discriminate between UWS and MCS/EMCS (Casarotto et al., 2016). 
Since the LZW algorithm seems to quantify the level of 
consciousness, it could further be used to evaluate the effect of an 
external intervention on brain signal complexity and to better 
characterize patients responding to tDCS or to predict clinical 
response to tDCS in patients with DOC. 
In light of this, we conducted a new study where we 
simultaneously stimulated four key regions of the external awareness 
network (i.e. left and right dorsolateral prefrontal and posterior 
temporo-parietal cortices) of patients with DOC (UWS and MCS) and 
EMCS following severe acquired brain injury. We evaluated the 
behavioral and electrophysiological effects using the behavioral gold 
standard CRS-R as well as EEG band power and LZW complexity in 
active and sham conditions. 
For this randomized double-blind sham-controlled crossover 
study, our inclusion criteria were: 1) UWS, MCS or EMCS according to 
at least three CRS-R assessments conducted within a week; 2) 
acquired brain injury for more than 28 days before inclusion 3) 
medical stability (absence of infection, untreated epilepsy, 
ventilation); 4) free of sedative drugs, Na+ or Ca2+ blockers and NMDA 
receptor antagonists. Exclusion criteria were: 1) premorbid 
neurological or psychiatric diseases; 2) metallic cerebral implant (e.g., 
aneurysmal clip, ventricular shunt) and; 3) craniectomy or 
cranioplasty. As presented in Figure 18, subjects participated in two 
sessions, one active (a-tDCS) and one sham (s-tDCS), spaced by 48 
hours, in a randomized order. CRS-R assessments and EEG recordings 
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were performed before and after each session, following the order: 
CRS-R (~30 min) → EEG (10 min) → a-tDCS/s-tDCS [depending on 
randomization] (20 min) → EEG (10 min) → CRS-R (~30 min).  
 
 
Figure 18 – Study protocol. CRS-R *= assessments taken into account for the 
baseline diagnosis. CRS-R✝= assessments taken into account for the 
individual tDCS response. a-tDCS= active stimulation; s-tDCS= sham 
stimulation; CRS-R=Coma Recovery Scale-Revised; tDCS= transcranial direct 
current stimulation; EEG=electroencephalography 
 
Direct current was applied with the Starstim 8 tDCS system 
(Neuroelectrics, Spain), a tDCS stimulator capable of measuring EEG 
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activity (Giovannella et al., 2018). The tDCS montage comprised eight 
gelled electrodes (3.14 cm² Ag/AgCl): four anodes and four cathodes. 
Stimulation was delivered over the bilateral frontoparietal areas 
through the anodes placed on F3-F4 and CP5-CP6 according to the 
international 10-20 EEG system (Herwig et al., 2003) while the 
cathodes were placed over the prefrontal and occipital areas on Fp2-
Fpz and O1-Oz, as shown in Figure 19. This montage was based on an 
electrical field simulator and optimizer (Ruffini et al., 2014), targeting 
the highest field over the bilateral frontoparietal network. Intensity 
was set to 1 mA per anode, for a total of 4 mA of current delivered 
per session. For a-tDCS, current was applied for 20 min, preceded by 
a 30-second ramp-up period and followed by a 30-second ramp-
down period for a total session time of 21 minutes. For s-tDCS, 1mA 
was applied through each anode for 30 seconds, preceded by a 30-
second ramp-up and followed by a 30-second ramp-down and 19 min 
and 30 seconds of no stimulation. Impedances were monitored by 
the device and kept <10 kΩ and voltage <30 V. 




Figure 19 – E-field modelling with anodes in red and cathodes in black (A) 
and tDCS montage used (B). 
The ten minutes resting state EEG was recorded with eyes 
open (patients were verbally or tactilely stimulated when drowsy) 
using the Startsim 8 with the same gelled electrodes as the ones used 
for the stimulation montage (i.e., Fp1, Fpz, F3, F4, CP5, CP6, O1, Oz). 
The sampling frequency was 500Hz. Two additional sticky electrodes 
were placed on both mastoids as reference. A random number 
generator was used for each new patient included to assign 
conditions in a 1:1 manner. Randomization was performed by a 
researcher who was not involved in any assessments; thus, the 
investigators and patients were blinded to the allocation. Behavioral 
assessments and EEG recordings were carried out by two blinded 
researchers and when the tDCS device was in “double-blind mode”, 
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the screen on the device did not display information regarding 
whether the device is set to a-tDCS or s-tDCS. 
Our primary outcome measures concerned the behavioral 
effects of this new montage using the CRS-R total score at the group 
level, as well as the individual identification of new conscious 
behaviors (see Appendix 2) occurring for the first time after (a-tDCS), 
when taking into account the four CRS-R assessments conducted 
during the study period (see Figure 18). As described previously, after 
checking a potential carryover effect by comparing the median CRS-R 
total scores of the two baseline conditions (before a-tDCS and before 
s-tDCS) with a Wilcoxon matched-pairs test, we calculated the 
treatment effect using the same test but comparing the differences 
in CRS-R total score (i.e., ΔCRS-R; post tDCS minus pre tDCS) for both 
active and sham conditions. We used the same procedure to evaluate 
the treatment effect in subgroups stratified by diagnosis (i.e., UWS, 
MCS or EMCS) and by etiology (TBI or non-TBI), as part of our 
secondary outcomes. For the individual response to tDCS (primary 
outcome), we divided our sample into three categories, based on 
their individual responses: 1) “tDCS+”: patients who showed a new 
sign of consciousness for the first time following a-tDCS; 2) “tDCS=”: 
patients who neither gained nor lost a sign of consciousness 
following a-tDCS and; 3) “tDCS-”: patients who lost a sign of 
consciousness for the first time following a-tDCS. The four CRS-R 
assessments conducted during the study period were considered for 
this classification: before a-tDCS, after a-tDCS, before s-tDCS and 
after s-tDCS. Our secondary outcome measures also included tDCS 
electrophysiological effect on EEG relative power and LZW 
complexity, for which the processing is described below. We focused 
on changes in power and LZW complexity in several frequency bands 
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(i.e., delta, theta, alpha, beta1 and beta2) after a-tDCS vs s-tDCS in 
the whole sample, as well as in subgroups stratified by presence (i.e., 
MCS and EMCS) or absence (i.e., UWS) of consciousness. In order to 
estimate the difference between the active and the sham condition, 
the relative power and LZW complexity were estimated for both 
cases, as the POC with respect to the baseline condition, such as:  
𝑃𝑜𝑠𝑡 − 𝑃𝑟𝑒
𝑃𝑟𝑒
× 100  
where the Pre refers to the baseline (i.e., pre-stimulation/sham) and 
Post refers to after stimulation/sham. 
For both relative band power and LZW complexity, we 
compared the median POCs for a-tDCS vs. s-tDCS using Wilcoxon 
matched-pairs test at the group level and for conscious (MCS and 
EMCS) and unconscious patients (UWS) separately. As exploratory 
analysis, we evaluated the potential relationships between our 
behavioral and electrophysiological outcomes. We first checked for a 
correlation between the ΔCRS-R and the POCs, in band power and 
complexity for each band using a Spearman’s correlation test, at the 
group level and for conscious (MCS and EMCS) and unconscious 
patients (UWS) separately. We then checked for a significant 
difference between the three responders’ groups (i.e., tDCS+, tDCS= 
and tDCS-) for the POC in power and complexity EEG metrics using a 
Kruskal-Wallis rank sum test with post-hoc pairwise comparisons 
using Wilcoxon rank sum test with Bonferroni correction (p<0.016), 
for both active and sham conditions. Finally, we investigated the 
potential relationship between the baseline EEG metrics (power and 
complexity before stimulation) and our behavioral outcomes by 
applying the exact same procedure as for the POC (i.e., check a 
significant difference between the three responders’ groups using a 
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Kruskal-Wallis test and checked for a correlation between ΔCRS-R 
and baseline relative power/complexity, using Spearman’s correlation 
at the group level and for conscious and unconscious patients 
separately). All the statistical analyses were performed on R 3.5.1 (R 
Core Team, 2008). 
The EEG analyses were conducted on Matlab 2016b and 
Python 2.7. The acquired EEG signals were pre-processed in the 
following way: the signals were initially band-pass filtered into delta 
(1-4 Hz), theta (4-8 Hz), alpha (8-13 Hz), low beta (beta1: 13-23 Hz) 
and high beta (beta2: 23-35 Hz) bands using an Infinite Impulse 
Response Butterworth filter. The data were segmented into 5-sec 
epochs with 50% overlap, as a compromise for a sufficient number of 
cycles for all bands and a sufficient number of clean epochs, while 
dealing with the non-stationary nature of the EEG data. Epochs with 
amplitude larger than 75uV in each frequency band were considered 
artifacts (muscular) and automatically excluded from the analysis. 
Additional channel rejection was performed for each frequency band, 
based on the median absolute deviation (MAD). Specifically, channels 
larger than 2.5 MAD values were considered noisy and automatically 
excluded from the analysis. Moreover, all channels with amplitudes 
less than 2uV were also considered artifacts and automatically 
excluded from the analysis. The final clean signals were demeaned 
and detrended as well as re-referenced to the common average of 
the clean remaining channels per epoch. After pre-processing the 
data, the relative band power (with respect to 1-35 Hz) was extracted 
by computing the power on the filtered signals and integrating over 
the discrete temporal domain. The LZW was estimated for each 
frequency band separately as each EEG rhythm is associated with 
different underlying cognitive functions (Buzsáki, 2006). It was 
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extracted as an approximate to describe the incomputable 
algorithmic complexity of the EEG signals under investigation. As 
described in (Lempel and Ziv, 1976), in LZW we consider a string of 
characters and alphabet with symbols (typically binary) of length n. 
The algorithm works by initializing the dictionary to contain all strings 
of length one and then it scans through the input string sequentially 
until it finds a string that does not belong to the dictionary and adds 
it to the dictionary. This process is repeated until all input string has 
been scanned through. Following this process, we end up with a set 
of words c(n) that make up the dictionary. The length of the 
compressed string is 𝐿𝐿𝑍𝑊 ≤ 𝑛 (an upper bound to Kolmogorov or 
algorithmic complexity). The description length of the sequence 
encoded by LZW would have length equal to the number of phrases 
times the number of bits needed to identify a seen phrase plus the 
bits to specify a new symbol (to form a new phrase), hence  
𝐿𝐿𝑍𝑊  =  𝑐(𝑛)𝑙𝑜𝑔2[𝑐(𝑛) + 𝑙𝑜𝑔2𝐴] ≃ 𝑐(𝑛)𝑙𝑜𝑔2[𝑐(𝑛)] (1) 
The 𝐿𝐿𝑍𝑊 is normalized by the original string length leading to the 
final LZW. The input string is binary and is derived by taking the 
median of the input time series as the threshold as it is a robust 
metric against outliers, assigning zeros to all values below the 
threshold and ones to all values above the threshold. It was extracted 
for all channels of each epoch and frequency band concatenated, 
targeting to capture the spatially global brain complexity per 
frequency band, epoch, and patient. The LZW was then averaged 
across all epochs for each subject to get one complexity value for 
each subject and frequency band.  
After screening 84 patients, we included 46 of them in the 
study (see Figure 20). The sample comprised 17 patients in UWS, 23 
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in MCS, and 6 in EMCS with both traumatic (n=22) and non-traumatic 
(n=24) etiologies. The median [IQR] age was 46 [35 – 59] years; 
median [IQR] time post-injury was 12 [5 – 47] months. Individual 
demographic data and CRS-R total scores of the stimulation 
conditions can be found in Table 7. 
 
 
Figure 20 – Flow diagram of the study participants 
 
 Patients adequately tolerated all the tDCS sessions (i.e., no 
burns, skin damage or clinical signs of pain or discomfort) and no 
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patients dropped-out. We checked a potential significant difference 
between allocation groups (active-sham vs. sham-active) and there 
was none regarding age (p=0.308), gender (p=0.766), etiology 
(p=0.497), time since onset (p=0.317), baseline CRS-R score (p=0.680) 
and baseline diagnosis (p=0.172), as evaluated by Wilcoxon Rank Sum 
test for continuous variables, Fisher test for dichotomous variables 











































































































































































































































































































































































































































































































































































CRS-R scores are depicted as follows: Total Score (Auditory subscore – Visual subscore – Motor subscore – Oromotor/Verbal subscore 
– Communication subscore – Arousal subscore). Diag.= diagnosis based on 3 consecutive CRS-R assessments; F= Female; M= Male; 
diag.= diagnosis; UWS= Unresponsive Wakefulness Syndrome; MCS= Minimally Conscious State; EMCS= Emergence from the MCS; 
TSO= Time Since Onset; TBI= Traumatic Brain Injury: nTBI= non-Traumatic Brain Injury; CRS-R= Coma Recovery Scale-Revised; ∆ = post 
– pre. In the last column, “tDCS+” = patients showing a new sign of consciousness after a-tDCS; “tDCS-” = patients losing a sign of 
consciousness after a-tDCS and “tDCS=” = patients not gaining nor losing a sign of consciousness a-tDCS, taking into account the 4 
CRS-R assessments (pre and post a-tDCS and s-tDCS) conducted during the study period





The median [IQR] total CRS-R scores are reported in Table 7. 
Regarding the changes in the CRS-R total score, no carryover effect 
was observed between a-tDCS and s-tDCS (p=0.449). When 
comparing the ΔCRS-R (i.e., CRS-R total score post minus pre tDCS) of 
a-tDCS vs. s-tDCS at the group level (i.e., treatment effect; primary 
outcome), we did not find a significant difference (p=0.915). When 
stratified by diagnosis (i.e., secondary outcome), no significant 
treatment effect was observed for either UWS, MCS, or EMCS 
subgroups (Table 7). When subcategorizing by etiology (i.e., 
secondary outcome), we did not find a significant treatment effect 
for TBI or for non-TBI patients, even though patients with TBI did 
show an overall increase in CRS-R total score (median [IQR] 
improvement of 2 [0 – 2] points). The test statistics of these group 
comparisons can be found in Table 8. 
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Table 8 – Median CRS-R total scores for active and sham tDCS conditions  
Sample Median CRS-R total score Wilcoxon 
match-paired 
Active tDCS Sham tDCS Z value p 
value 
Pre Post median 
Δ 
Pre Post median 
Δ 
  
All (n=46) 7.5 7.5 0 7.5 7 0 0.107 0.915 
UWS (n=17) 5 5 0 5 5 0 1.219 0.223 
MCS (n=23) 9 9 0 9 9 0 -0.427 0.669 
EMCS (n=6) 17 17 0 17.5 18.5 0 0.108 0.914 
TBI (n=22) 9 11 0 10 10 0 -0.638 0.524 
non-TBI (n=24) 5 6 0 5 5 0 0.810 0.418 
UWS= Unresponsive Wakefulness Syndrome; MCS= Minimally Conscious State; EMCS= 
Emergence from the MCS; TBI= Traumatic Brain Injury; Pre= score before stimulation; 
Post= score after stimulation; Δ = Post minus Pre 
 
At the individual level, we identified seven patients who 
behaviorally improved (i.e., tDCS+). Their clinical characteristics and 
individual behaviors gains can be found in Table 9. We also found out 
that seven patients behaviorally worsened by losing a sign of 
consciousness after a-tDCS that was present before, (i.e., tDCS- – 
Table 9). There were no significant differences between the three 
behavioral response groups (i.e., tDCS+, tDCS= and tDCS-) regarding 
age (p=0.44), gender (p=0.99), time since injury (p=0.99), etiology 
(p=0.27) or diagnosis (p=0.56), as assessed by Chi-square tests for 
categorical variables and Wilcoxon matched-pairs signed-rank test 





Table 9 – Individual clinically relevant behavioral changes 








Behavioral changes (appearing for the 























Gained functional communication 
P15 
(active/sham) 












Gained visual pursuit  
P17 
(active/sham) 












Gained systematic response to command, 
















Gained visual pursuit  
P24 
(active/sham) 




























Gained systematic response to command, 


















Gained object recognition 







Active Sham Behavioral changes (appearing for the first 
















































































































Lost systematic response to command & 
intentional communication 
Four CRS-R assessments and the allocation order are considered for the identification of individual behavioral changes: CRS-R before 
active, CRS-R after active, CRS-R before sham and CRS-R after sham. Subscores in bold depict gained or lost conscious behaviors. CRS-R 
scores are depicted as follows: Total Score (Auditory subscore – Visual subscore – Motor subscore – Oromotor/Verbal subscore – 
Communication subscore – Arousal subscore). Diag.= diagnosis; TSO= time since onset; Etiol.= etiology; MCS= Minimally Conscious State; 
EMCS= Emergence from the MCS; CRS-R= Coma Recovery Scale-Revised. TBI= traumatic brain injury; nTBI= non TBI (e.g., anoxia, stroke or 
mixed etiologies).  
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The group-level behavioral effects of frontoparietal tDCS in 
patients with DOC were not consistent with previous studies that 
stimulated the left DLPFC in single (Thibaut et al., 2014) or repeated 
sessions (Angelakis et al., 2014; Estraneo et al., 2017; Thibaut et al., 
2017b). Given the fact that this was a new type of montage, we 
included both UWS, MCS and EMCS patients, in order to check if the 
level of consciousness affects the tDCS response the way it does for 
prefrontal tDCS. Therefore, we also analyzed treatment effects in 
subsamples of subjects, because this finding could have been 
attributed to the diagnostic or etiological heterogeneity of our 
sample. Regarding diagnosis, several studies have revealed that 
patients in MCS are more responsive to tDCS than those in UWS 
(Angelakis et al., 2014; Thibaut et al., 2014; Cavinato et al., 2019). 
However, when analyzing the treatment effect in MCS patients only, 
we did not find any behavioral changes. When looking at the 
etiology, there were no significant differences in CRS-R total scores 
changes for TBI and non-TBI patients separately. These findings 
suggest that the mechanism of injury may not determine clinical 
improvements following frontoparietal tDCS and tDCS-related 
improvements most likely depend on the localization of the lesions 
rather than on the mechanisms of injury, as tDCS responders in prior 
studies showed greater structural and metabolic preservation in the 
stimulated areas compared to non-responders (Thibaut et al., 2015c).  
In addition to changes in CRS-R total scores, we also looked 
for clinically relevant behavioral changes at the single-subject level. 
Seven tDCS-responders were identified, all recovering visual abilities 
(e.g., visual pursuit, object localization), which suggests a selective 
effect of frontoparietal tDCS on visual-related behaviors. The fact 
that we also identified seven patients who lost a conscious behavior 
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after a-tDCS that was present before the stimulation (i.e., tDCS- 
group) raises concerns regarding the therapeutic efficacy of the 
chosen multichannel bihemispheric tDCS montage. The present study 
is indeed the first one to report this type of response and it would be 
interesting to better characterize these patients using neuroimaging, 
and to compare the structural and metabolic cerebral profile of 
patients who improved versus patients who worsened. This could 
help identify potential exclusion criteria for future studies that will 
need to pre-identify appropriate candidates for tDCS. Regarding 
individual behavioral responses observed after sham stimulation, 
some notable changes were observed too. Two patients showed 
indeed new signs of consciousness observed for the first time after 
sham tDCS (object localization and functional object use, 
respectively), considering the four CRS-R sessions conducted over the 
study period. Even though there were less “sham-responders” than 
“tDCS-responders”, this raises the question of whether patients with 
DOC could present a kind of placebo response due to the sole 
intervention of placing a cap and electrodes over their scalp. This 
possible placebo response in DOC has not been discussed in the 
literature yet while some isolated cases of behavioral changes 
following sham interventions have been reported (Estraneo et al., 
2017; Martens et al., 2019d). A placebo response would indeed need 
some conscious processing, which is – by definition – challenged in 
these patients. As a matter of fact, a more likely hypothesis is that 
these changes are due to spontaneous behavioral fluctuation. It is 
difficult to isolate tDCS-related effects from these spontaneous 
behavioral changes and further studies could mitigate this bias and 
select patients with particularly stable behaviors over time, as 
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assessed by repeated consecutive CRS-R assessments before 
assessing the effects of an external intervention. 
The absence of a tDCS treatment effect may be related to the 
multifocal montage used in this study. Indeed, stimulating the 
frontoparietal network in a bilateral fashion may have paradoxically 
reduced the benefits of tDCS as a result of inter-hemispheric 
competition. The principle of inter-hemispheric competition is widely 
leveraged in rehabilitation (especially for stroke patients (Murase et 
al., 2004; Bütefisch et al., 2008) and many montages target the 
affected hemisphere with the anode while decreasing the excitability 
of the unaffected side with the cathode, leading to significant 
improvements in therapy (Schlaug et al., 2008) and reduced inter-
hemispheric imbalance (Di Lazzaro et al., 2014). In our population, 
we stimulated both hemispheres with anodes, meaning that, even 
though our population typically sustains damage to both 
hemispheres (Guldenmund et al., 2016), the montage may have 
played a role in inhibiting rather than potentiating the inter-
hemispheric balance. This unanticipated mechanistic effect may have 
led to decreased treatment effects and the emergence of 
‘paradoxical responders’ who are unable to show some conscious 
behaviors such as response to command or intentional 
communication after bilateral tDCS. Future studies should investigate 
the effects of network-based unihemispheric tDCS montages to 
confirm this hypothesis. Additionally, the location of the cathodes 
over frontal and occipital areas might also have interfered with 
network activation by potentially decreasing the excitability of these 
areas. Another hypothesis for this lower clinical efficacy is related to 
our aim and not to the montage itself. It might be that increasing the 
level of consciousness using only a single session of tDCS is 
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insufficient to actively recruit the whole frontoparietal network and 
that it requires longer or more complex external interventions. The 
fact that prefrontal stimulation seems more efficient (as shown by 
the previously introduced studies) also suggests that tDCS is useful to 
improve the behavioral responsiveness of patients with DOC, that is 
more closely related to the prefrontal cortex functions (i.e., motor 
control, working memory, attention, decision-making (Heekeren et 
al., 2006; Collette et al., 2007; Barbey et al., 2012)). tDCS might 
therefore be a better option to stimulate patients’ responsiveness 
(through the prefrontal cortex) than to increase patients’ 
consciousness itself (through the frontoparietal network), for which 





Four EEGs could not be recorded due to too bad signal 
quality (impedances were too high and could not be reduced). 
Therefore, the EEG analyses were performed on 42 patients (14 
UWS, 22 MCS, 6 EMCS, 22 TBI, 20 non-TBI, median [IQR] age: 46 [35 – 
59] years; median [IQR] time-post injury: 13 [5 – 54] months). This 
sample did not significantly differ from the initial one (n=46) in terms 
of age (p=0.95), gender (p=0.76), time since injury (p=0.97), etiology 
(p=0.52) or diagnosis (p=0.80), as evaluated by Wilcoxon Rank Sum 
test for continuous variables, Fisher test for dichotomous variables 
and Chi-square test for categorical variables. 
For the relative power, the POC was significantly different 
between a-tDCS and s-tDCS in the beta2 band only (W=177; 
p=0.008). Indeed, the median [IQR] POCbeta2 was significantly greater 
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for s-tDCS (12.08 [-26.55 – 71.23] %) than for a-tDCS (-5.08 [-36.03 – 
47.23] %), as shown in Figure 21. When separating by level of 
consciousness, there was still a significant difference in POCbeta2 
power, but only in the conscious patients (W=51; p=0.002). Median 
[IQR] POCbeta2 power for the conscious patients was -7.10 [-34.19 – 
35.77] % after a-tDCS and 12.08 [-21.30 – 88.04] % after s-tDCS. No 
other significant differences were found in the other bands. The 
median POC values by level of consciousness are presented in Figure 
21. The data for pre, post and POC for relative power and LZW 
complexity can be found in Appendix 3. 
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Figure 21 – Median percentage of change (POC) between baseline and 
active/sham tDCS in relative power for each band for the whole sample 
(n=42; upper part) and for the subsamples of unconscious (i.e., UWS; n=14; 
lower left part) and conscious (i.e., (E)MCS=MCS and EMCS; n=28; lower 
right part) patients. The horizontal black lines represent the medians of the 
baseline (before active stimulation) complexity values and boxes represent 
the interquartile range.  p<0.05= significant difference between active and 
sham with Wilcoxon rank sum test. UWS=Unresponsive Wakefulness 
Syndrome; MCS=Minimally Conscious State; EMCS= Emergence from the 
MCS. 
 
For LZW complexity, the POC was significantly different 
between the active and sham conditions in the beta1 band only 
(W=69; p=0.006), for the whole sample (n=42). The median POCbeta1 
complexity decreased significantly more after a-tDCS (-0.23 [-0.69 – 
0.002] %) than after s-tDCS (0.05 [-0.32 – 0.31] %) – see Figure 22. 
When separating by level of consciousness, there was still a 
significant difference between a-tDCS and s-tDCS (W=21; p=0.002; -
0.18 [-0.72 – 0.001] % after a-tDCS and 0.08 [-0.18 – 0.34] % after s-
tDCS) in POCbeta1 in the conscious patients (MCS and EMCS) but not in 
the UWS group (median POCbeta1 active: -0.25 [-0.63 – 0.07] %; 
median POCbeta1 sham: -0.11 [-0.65 – 0.30]; W=10; p:0.578), as 
presented in Figure 22. No other significant differences were found in 
the other bands. 
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Figure 22 – Median percentage of change (POC) between baseline and 
active/sham tDCS in LZW complexity for each band for the whole sample 
(n=42; upper part) and for the subsamples of unconscious (i.e., UWS; n=14; 
lower left part) and conscious (i.e., (E)MCS=MCS and EMCS; n=28; lower 
right part) patients. The horizontal black lines represent the medians of the 
baseline (before active stimulation) complexity values and boxes represent 
the interquartile range.  p<0.05= significant difference between active and 
sham with Wilcoxon rank sum test. UWS=Unresponsive Wakefulness 
Syndrome; MCS=Minimally Conscious State; EMCS= Emergence from the 
MCS. 
 
The only significantly measurable electrophysiological direct 
effect of tDCS were thus the decrease in beta1 complexity and the 
decrease in beta2 relative power. Up to now, only a few studies have 
used complexity metrics to evaluate the effects of tDCS and none 
used it for patients with DOC. A previous study compared left/right 
tDCS and sham while measuring CRS-R and EEG changes. The authors 
mentioned increased EEG functional connectivity in the beta band 
activity in the right frontal lobe following right DLPFC tDCS, while in 
the lower frequency bands (delta and theta), the increased 
connectivity was widely distributed across the cortex, with no 
notable behavioral changes for this montage (Wu et al., 2019). Even 
though this study was limited by a low sample size (i.e., 5 patients in 
each stimulation group), it contradicts our present findings. The 
decrease in beta2 could be due to a spectral shift to the delta band, 
that is the only one showing a power increase in conscious patients. 
The greater change in power in the beta2 band for the sham 
stimulation also implies the variability in this band is extremely high. 
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Relationship between behavioral and electrophysiological metrics 
 
 Both band power POC values and LZW complexity POC values 
following a-tDCS were not significantly correlated with the difference 
in the CRS-R total score following a-tDCS (ΔCRS-R active), as shown in 
Table 10. 
 
Table 10 – Statistics of the Spearman’s correlation tests  
 POC Band Power POC LZW Complexity 
 Delta Theta Alpha Beta1 Beta2 Delta Theta Alpha Beta1 Beta2 
 All (n=42) 
rho 0.18 -0.05 -0.11 -0.14 -0.13 -0.07 -0.15 -0.13 -0.02 0.28 
p  0.29 0.76 0.51 0.42 0.46 0.71 0.43 0.50 0.92 0.12 
 UWS only (n=14) 
rho 0.32 -0.23 -0.15 -0.23 -0.44 -0.66 -0.61 -0.61 0.20 0.58 
p  0.28 0.45 0.64 0.46 0.13 0.16 0.14 0.14 0.66 0.13 
 MCS & EMCS (n=28) 
rho 0.17 -0.05 -0.18 -0.12 -0.07 -0.01 -0.08 -0.07 -0.03 0.34 
p  0.39 0.83 0.39 0.56 0.74 0.97 0.72 0.76 0.89 0.11 
Tests performed between the POC values following active stimulation and the difference 
in CRS-R total score (∆CRS-R) following active stimulation, for both power and 
complexity in the sample who had complete behavioral and electrophysiological 
outcomes. POC= Percentage of Change; LZW= Lempel-Ziv-Welch; UWS= Unresponsive 
Wakefulness Syndrome; MCS= Minimally Conscious State; EMCS= Emergence from the 
MCS 
 
There was no significant difference either between the three 
responders’ groups in POC for band power and complexity, as shown 
in Table 11. However, when further investigating the relationships 
between baseline EEG metrics and behavioral changes, we found a 
significant difference between responders’ groups (“tDCS+”, “tDCS=” 
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and “tDCS-”) in baseline complexity values for the theta (H=6.62; 
p=0.04) and the beta2 (H=6.29; p=0.04) bands – see Table 11. The 
median baseline complexity in the theta band was indeed higher for 
tDCS- (0.270 [0.256 – 0.280]) than for tDCS= (0.251 [0.247 – 0.258]) 
and tDCS+ (0.246 [0.243 – 0.264]). Post-hoc Bonferroni corrected 
(p<0.016) pairwise comparisons showed a significant difference 
between the tDCS= and the tDCS- groups (W=34; p=0.008; tDCS- 
being higher). This is presented in Figure 23.  
 
Table 11 – Statistics of the Kruskal-Wallis tests performed to compare the three 
different responders groups (“tDCS+”, “tDCS=” and “tDCS-”)  
 POC Band Power POC LZW Complexity 
 Delta Theta Alpha Beta1 Beta2 Delta Theta Alpha Beta1 Beta2 
H 1.35 0.76 0.59 0.25 1.19 0.88 0.63 2.37 0.27 1.21 
p  0.51 0.68 0.75 0.88 0.55 0.64 0.73 0.31 0.87 0.55 
 Baseline Band Power Baseline LZW Complexity 
H 3.40 3.57 2.92 2.88 4.80 4.05 6.62 1.40 2.33 6.29 
p  0.18 0.17 0.23 0.24 0.09 0.13 0.04 0.50 0.31 0.04 
Comparison of percentage of change (POC) and baseline values for the active stimulation, 
for both power and complexity in the sample who had complete behavioral and 
electrophysiological outcomes (n=42). Values in bold depict a significant difference 
(p<0.05). 
 
For the baseline complexity in the beta2 band, it was higher 
in tDCS= (0.606 [0.603 – 0.609]) than in tDCS- (0.605 [0.603 – 0.606]) 
and tDCS+ (0.602 [0.601 – 0.605]). Post-hoc Bonferroni corrected 
(p<0.016) pairwise comparisons showed a significant difference 
between the tDCS+ and the tDCS= groups (W=37; p=0.013; higher in 
tDCS=). 
 




Figure 23 – Baseline LZW complexity values in the theta band for the three 
responders’ groups: tDCS- (i.e., loss of a sign of consciousness following active 
stimulation); tDCS= (i.e., no loss nor gain of conscious behavior following active 
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stimulation) and; tDCS+ (i.e., gain of a sign of consciousness following active 
stimulation). The black lines represent the medians of the baseline (before active 
stimulation) complexity values and the boxes represent the interquartile range. 
p<0.05= Kruskal Wallis test comparing the 3 responders’ groups; **= significant 
difference for Bonferroni corrected (p<0.016) Wilcoxon rank sum test pairwise 
comparison; NS=non-significant. 
 
 When looking at the ΔCRS-R active (i.e., for a-tDCS), we did 
not find a significant correlation with the baseline values for power 
or for complexity in the whole sample. When subgrouping by level of 
consciousness, we found a significant negative correlation between 
the baseline complexity in theta and the ΔCRS-R for the conscious 
patients (r= -0.429; p=0.02), as presented in Figure 24. 
 




Figure 24 – Correlation between the baseline theta complexity values and the 
ΔCRS-R (i.e., CRS-R total score post active stimulation minus before active 
stimulation) in the MCS (n=23; dots) and the EMCS (n=6; triangles) patients. 
Spearman’s rho= -0.429; p=0.02. 
 
The electrophysiological changes were accordingly not 
correlated to behavioral changes, indicating that some subtle 
changes in EEG were not translated into behavioral changes. This 
inconsistency had been reported in the past by studies combining 
tDCS with electrophysiological measurements that showed 
interesting effects on functional connectivity. A modulation of 
cortical global excitability, that was different within UWS and MCS, 
was measured by TMS-EEG following left DLPFC stimulation (Bai et 
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al., 2017a). The same authors showed increased frontoparietal 
coherence in the EEG theta band after the same type of stimulation 
in MCS only (Bai et al., 2018). These effects were however not 
paralleled by any relevant clinical improvement but suggest that tDCS 
can alter connectivity in functional networks. In our study, a unique 
session of tDCS may have been not sufficient to promote the 
recovery of new conscious behaviors while still influencing neural 
activity measured with EEG (e.g., decrease for power and complexity 
in the beta bands). This absence of significant relationship between 
behavioral and electrophysiological outcomes does however not 
apply to our baseline EEG metrics. 
Baseline neurophysiological values accurately discriminated 
between different behavioral response groups. This applies especially 
for the theta band, for which baseline low complexity appeared as a 
biomarker for responsiveness. A previous high density EEG-tDCS 
study with DOC patients also showed increased theta band spatial 
connectivity (using graph-theory analyses) and higher network 
centrality in the theta band (indicating a large density of richly 
connected hub regions) in DLPFC tDCS-responders as compared to 
non-responders (Thibaut et al., 2018b). In the present findings, 
patients with higher theta complexity would be more likely to show a 
paradoxical response to tDCS (i.e., losing conscious behaviors) 
whereas patients with lower baseline complexity are more likely to 
show a positive response (i.e., gaining conscious behaviors). This 
would mean there is a limit to the benefits of having rich theta 
activity to respond to tDCS; a high complexity (around 0.24) would 
indicate a high probability to positively respond to tDCS but a too 
high complexity (around 0.27) would be deleterious, in an inverted 
complexity-response U-shape. Another hypothesis would be that low 
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theta complexity at baseline can potentiate a spectral shift from 
theta to alpha, which would induce a clinical improvement, as 
suggested by previous works (Williams et al., 2013; Thibaut et al., 
2018b). The shift to alpha was not observed here, which can be 
attributed to the low dose of tDCS and the small number of 
responders.  
Some limitations in this study should be considered before 
generalizing the results. First, we applied a single session of tDCS 
while it is now known that behavioral effects of tDCS are enhanced 
with repeated stimulations (Boggio et al., 2007; Marangolo et al., 
2013; Thibaut et al., 2017b). The heavy setup inherent to EEG 
recording and multifocal stimulation required to be performed at the 
University Hospital, as opposed to home-based tDCS studies using 
user-friendly stimulators (Charvet et al., 2015; Martens et al., 2018b; 
Garcia-Larrea et al., 2019). Second, the fluctuations in vigilance that 
are characteristic of this population (Candelieri et al., 2011; Piarulli et 
al., 2016) might have impacted the results, as suggested by changes 
happening after s-tDCS too. Indeed, it is impossible to exclude the 
impact of behavioral fluctuation over the results as some patients 
seem to lose and gain conscious behaviors repeatedly. This concern is 
nevertheless partly mitigated by the fact that no significant 
differences were identified between the baseline conditions (i.e., 
before a-tDCS and before s-tDCS) regarding CRS-R total score, 
baseline EEG power and baseline EEG complexity. 
In conclusion, at the group level, a single session of multifocal 
frontoparietal tDCS does not induce clinically relevant effects in 
patients with DOC. The fact that some of the patients improved and 
other worsened following frontoparietal tDCS underlines the inter-
individual variability in response to tDCS that was already observed in 
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previous studies. These results highlight the need to promote the use 
of individualized montages that are chosen based on prior structural 
and neuroimaging findings. To this end, we showed that baseline EEG 
activity in the theta band could be used to characterize tDCS 
responders and non-responders’ profiles. Optimizing therapeutic 
approaches for patients with DOC is still a challenge and further 
efforts should be made toward individualized care and treatments 
combination (e.g., tDCS during rehabilitation intervention).  
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3.4. Closing the loop, a brain-state 
dependent approach  
 
 Another common feature concerning all of the above-
presented tDCS studies, in DOC patients but in other populations as 
well, is that the application of the stimulation was performed at an 
arbitrary moment, in a so-called open-loop fashion, treating the brain 
as a “black box”. As a matter of fact, the brain acts as a complex 
generator of behavior in an environment composed of inputs and 
outputs (Zrenner et al., 2016). The important variability in individual 
response to tDCS might partly be explained by this limiting approach 
(Wiethoff et al., 2014; López-Alonso et al., 2015). Using the brain’s 
own output to trigger a future input (i.e., closed-loop model) 
represents a way to overcome this limitation. It is particularly 
relevant for tDCS since the brain state can condition its efficacy. For 
instance, during a choice reaction task, tDCS applied over the frontal 
gyrus produces increased salience network activation whereas during 
resting state, only activity in the default mode network is observed 
with deactivation of the salience network, as measured with fMRI in 
healthy subjects. Task-dependent effects of tDCS have been 
confirmed in others trials with cognitive testing on working memory 
in healthy subjects (Wu et al., 2014; Gill et al., 2015). The challenge of 
brain-state dependent tDCS efficacy is of particular importance for 
patients with DOC, who typically present fluctuations in vigilance 
impacting their responsiveness to external stimuli (Schiff, 2005; 
Schnakers et al., 2009, 2014; Cruse et al., 2013; Giacino et al., 2014; 
Piarulli et al., 2016). One of the surrogate markers of this level of 
vigilance is the spectral entropy of the EEG, which measures the 
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disorder characteristic of the irregularity, the complexity and the 
unpredictability of the signals (Palanca et al., 2009). It is known to be 
greater when individuals are in completely alert states, as compared 
to sleep (Mateos et al., 2018) or anesthesia (Bein, 2006). In DOC 
patients, this index correlates with the CRS-R total score, as 
measured in 56 patients with DOC for both chronic and acute states 
and both traumatic and non-traumatic etiologies (Gosseries et al., 
2011). Piarulli and colleagues used the spectral entropy measured 
with resting EEG in six UWS and six MCS patients to highlight the 
periodicity in its fluctuation. They suggested that the EEG spectral 
entropy variability in MCS could mirror the fluctuation of vigilance 
previously described in this population. In this study, the authors 
showed that patients in MCS present a periodicity of 70 minutes in 
these fluctuations (range 57-80 minutes), comparable to the 
fluctuations in attention observed in healthy controls, while patient 
in UWS do not present this type of periodicity (Piarulli et al., 2016). A 
key component to tDCS responsiveness might therefore be the 
timing of the stimulations, that could also explain the inconsistent 
rate of responders reported in previous trials. Administering tDCS 
during specific time windows (i.e., periods of low or high arousal) 
could therefore influence its clinical efficacy in patients in MCS since 
it is known that the positive effects of tDCS are dependent on the 
brain state (Zrenner et al. 2016). To this end, recent advances in tDCS 
software and hardware enable the implementation of a closed-loop 
set-up by complex computations being performed in real-time. Proof-
of-concept studies showed the efficiency of such approaches using 
EEG patterns to trigger tDCS in both animal models of epilepsy 
(Berényi et al., 2012) and healthy subjects (Leite et al., 2017). This 
brain state-dependent use of tDCS has never been investigated in 
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DOC patients, yet. Using this technology to target specific levels of 
vigilance when applying tDCS could give insight into patterns of 
responsiveness and optimize future applications. Based on these 
hypotheses, we wanted to test a closed-loop system using EEG-
arousal measures (spectral entropy) to define the best moment of 
the day for the application of tDCS in patients in MCS. We therefore 
designed a protocol for a new randomized controlled trial aiming at 
investigating whether tDCS applied during high vigilance states is 
more effective in increasing the level of conscious awareness than 
during low vigilance states and/or sham stimulation in patients in 
MCS, as measured by behavioral and electrophysiological metrics. 
Our primary outcome will be the changes in power spectra in 
all relevant frequency bands (1 – 35 Hz). We hypothesize to observe 
a greater shift from lower to higher frequencies 
following active tDCS applied at high vigilance, as compared to tDCS 
applied at low vigilance and sham tDCS. Our secondary outcome will 
be the behavioral improvement measured with the CRS-R after 
stimulation. We hypothesize a greater increase in the CRS-R total 
score as well a larger number of responders in patients receiving 
tDCS during high vigilance states, than for the two other conditions. 
Inclusion criteria will be as follows: centrally-active 
medication stable for at least a week; stable diagnosis of MCS (no 
diagnosis change based on two CRS-Rs performed within one week); 
adult (16 years old - 65 years old); at least three months post-injury. 
Exclusion criteria will be: open craniotomies; ventriculo-peritoneal 
shunt under the stimulated area (prefrontal cortex); pacemaker; 
metallic cerebral implant; severe medical condition(s) that might 
influence clinical diagnosis and EEG activity (e.g., severe hepatic 
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insufficiency or renal failure, or sub-continuous or abundant 
epileptiform discharges on standard EEG recordings). 
We conducted an a priori sample size estimation based on 
the individual CRS-R data relative to the chronic (i.e., >3 months post-
injury) MCS patients included in our previously published randomized 
clinical trial testing the effect of a single prefrontal tDCS session 
(Thibaut et al., 2014). The effect size in favor of the active tDCS 
treatment for this subsample of 21 patients was 1.03 (mean ± SD of 
the CRS-R total score difference for the active group: 1.048 ± 1.244; 
for the sham group: -0.095 ± 0.889). Based on this effect size and a 
power of 0.90 with an alpha error probability of 0.05, the sample size 
was estimated at 13 patients. To compensate for the potential 
amount of dropouts (20% based on our previous experience), we will 
include 16 patients. 
The tDCS closed-loop system that will be used is a 
customized version of the Starstim 20 (Neuroelectrics, Barcelona) 
that enables generation of complex tDCS patterns driven by real-time 
analysis of EEG dynamics. As presented in Figure 25, the Closed-Loop 
Manager (CLM) receives the EEG streaming, analyzes vigilance levels 
in real-time, and remotely commands tDCS stimulation. CLM 
connects to Starstim’s software suite (NIC) and receives via Lab 
Streaming Layer (LSL) the EEG measured in real time. LSL provides 
accurate synchronization and time-stamping of received EEG 
samples. Samples are filtered, buffered, cleaned and split into short-
time epochs. Replicating the study conducted by Piarulli and co-
workers (Piarulli et al., 2016), the spectral entropy time-courses are 
analyzed at midline electrodes Fz, Cz and Pz.   
 




Figure 25 – Closed-loop system hardware and software setup, provided by 
Starlab Barcelona. 
  
CLM monitors vigilance levels at a 1-minute rate remotely 
commanding NIC to launch two different stimulations protocols 
when low or high pre-set vigilance thresholds are reached. In order 
to ensure patient’s safety, CLM limits the total stimulation dose and 
continuously monitors optimal impedance levels at stimulation 
channels.  
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This study will be a double-blind sham-controlled study, using 
a crossover design with three sessions performed on three different 
days spaced by at least 48 hours: 1. tDCS applied at high vigilance 
levels; 2. tDCS applied at low vigilance levels and; 3. Sham tDCS 
applied at random vigilance levels. Each session will consist of an 
initial behavioral assessment using the CRS-R, a continuous EEG 
recording to detect changes in spectral entropy, a stimulation 
session, and a behavioral assessment with the CRS-R and an EEG 
recording post intervention. The protocol is presented in Figure 26. 
 Regarding the intervention, 20-channels EEG will be 
recorded using the Starstim 20 and the stimulation will be applied 
using a customized version of the device, designed in collaboration 
with the company. For the stimulation, anodes are placed over F3, Fz 
and F4 while the cathodes will be placed over P7, Cz, P8, to target the 
prefrontal cortex bilaterally and thereby executive functions. We 
decided to target the whole executive functional network to further 
increase patients’ behavioral responsiveness. The seeds for highest 
Figure 26 – Study Protocol consisting in a screening phase with two CRS-Rs to confirm the MCS 
diagnosis and a study phase with three different sessions applied in a randomized order: tDCS-hv 
= tDCS applied at high vigilance state using the closed-loop system computing the EEG spectral 
entropy in real time; tDCS-lv= tDCS applied at low vigilance state with the same system and; 
tDCS-s = sham tDCS applied at a random moment. 
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current density were therefore located in the DLPFC bilaterally. The 
optimized current modelling using Stimweaver (Ruffini et al., 2014) is 
presented in Figure 27. 
 
Figure 27 – Optimized stimulation montage based on current modelling 
(left) and montage that will be used for both EEG recordings and stimulation 
(right). 
Stimulation will be applied for 20 minutes using six 3.14 cm2 
Ag/AgCl gelled electrodes, each one delivering an intensity of 1 mA 
with 15 seconds ramp up/down period. Sham tDCS will consist of 
applying the same parameters as for active conditions, but the 
corresponding device will be turned off after 30 seconds, as to mimic 
the initial sensation of the active current.  
Neurobehavioral assessments will be conducted using the 
Coma Recovery Scale Revised (CRS-R). Demographic and clinical data 
relating to the past and current medical history will be collected via 
review of the medical record or discussion with family members and 
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clinicians familiar with the case to supplement the data acquired 
from the medical chart.   
Statistical analyses on the behavioral data will be performed 
using Kruskal Wallis rank sum tests to calculate the differences in 
delta CRS-R between the three conditions (high vigilance, low 
vigilance and sham). As secondary analyses, we will identify potential 
responders at the individual level and compute the rates of 
responders in the three subgroups (i.e., high vigilance, low vigilance 
and sham). Responders will be defined as patients showing a new 
sign of consciousness (based on the CRS-R) after active tDCS that was 
not observed before stimulation or during the baseline screening. We 
will also investigate the impact of etiology (i.e., traumatic or non-
traumatic) and of time since injury using Fisher’s test and Spearman 
correlation, respectively. 
Before starting the trial above-presented, we conducted a 
pilot phase consisting in recording 6-hour spontaneous EEG in 
patients meeting inclusion and exclusion criteria. The aim was to 
improve the algorithms and the usability of the software. We 
conducted successful recordings in seven patients. As a sanity check, 
we first wanted to see if we could find the same fluctuations in 
vigilance described by Piarulli and colleagues (Piarulli et al., 2016) 
using our Starstim closed-loop EEG setup. As shown in Figure 28 as an 
example, there is a periodicity in the spectral entropy fluctuation, 
that is similar to the ones previously described. The results further 
showed that the changes in the spectral entropy of the arousal level 
in these patients were predictable from the software. 
 




Figure 28 – Evolution of spectral entropy over time, measured in one pilot patient 
 
After these encouraging results regarding usability of the 
software, the study could move on to the next phase of including 
patients in the randomized controlled trial. This represents the first 
step toward a new way to administer tDCS in patients with DOC. 
Patients in DOC need targeted individual interventions in 
order to optimize their responsiveness to external interventions. This 
study will be the first of its kind to use a closed-loop EEG-tDCS 
approach to determine the optimal time window to apply 
stimulation, based on the patient’s own vigilance level. Fluctuations 
in vigilance represent a well-known challenge for clinicians and 
researchers working with this population. They may prevent optimal 
diagnostic assessments and therapeutic interventions. Online EEG 
provides a relatively affordable tool to tackle this issue and to 
sharpen the use of non-invasive brain stimulation techniques. Several 
teams already used EEG as an outcome measure to evaluate the 
effects of tDCS. Combined with transcranial magnetic stimulation to 
assess cortical excitability, it could underlie differences in tDCS-
response between UWS and MCS patients, with a premature 
decrease in global cerebral excitability in UWS (Bai et al., 2017a). 
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Differences between these two diagnostic groups have been 
confirmed by Cavinato et al., who showed that tDCS increases power 
and coherence on alpha and beta bands in MCS patients, that are 
correlated with behavioral improvements, while only slower 
frequencies are affected in UWS (Cavinato et al., 2019). 
Neuroimaging approaches have therefore a relevant role in 
identifying different response patterns. Thibaut and colleagues 
further retrospectively compared structural, metabolic and 
electrophysiological profiles of known tDCS-responders and non-
responders. They showed a greater atrophy in non-responders in 
regions including the left dorsolateral prefrontal cortex, the medial 
prefrontal cortex and the left thalamus as compared to responders. 
The same areas as well as the thalamus were hypometabolic in non-
responders as compared to responders (Thibaut et al., 2015c). 
Regarding EEG brain connectivity, they showed higher theta 
centrality in responders (as compared to non-responders) meaning 
this new biomarker can be used as well in order to predict tDCS 
response in patients with DOC (Thibaut et al. 2018). Metabolic, 
structural and electrophysiological patterns of responsiveness have 
therefore been investigated in DOC patients, but the literature is 
scarce regarding the brain-state dependent application of tDCS, 
although the effects of tDCS are reliant on the ongoing cortical 
activity (Ohn et al., 2008). Selectively administering tDCS during 
specific EEG state patterns reflecting brain states, in a closed-loop 
fashion, is therefore a promising approach. For patients in DOC, these 
patterns should reflect the level of vigilance, as these patients are 
prone to fluctuations, conditioning responsiveness at the bedside 
(Schnakers et al., 2009; Giacino et al., 2014). The spectral entropy of 
the frontal EEG signals has been shown to indicate reliably the level 
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of vigilance (Gosseries et al., 2011), while periodic fluctuations have 
only been observed in MCS patients (Piarulli et al., 2016). Applying 
tDCS when the spectral entropy is high (i.e., assuming when the level 
of vigilance is high) could improve the behavioral responsiveness as 
measured by the CRS-R, as compared to states of low vigilance.  
From a feasibility perspective, recent works and the data 
presented here showed that scalp-recorded low-density EEG is able 
to detect patterns of interest based on a pre-defined algorithm and 
to trigger tDCS within milliseconds time frame (Leite et al., 2017). The 
implication of feasibility of brain state-triggered interventions hereby 
goes beyond application of tDCS. A couple of studies on transcranial 
alternating current stimulation (tACS) used a closed-loop system to 
modulate specific brain oscillations. During sleep for instance, tACS 
could be triggered during fast spindles to enhance motor memory 
consolidation (Lustenberger et al., 2016). The effects of closed-loop 
tACS in memory consolidation have been confirmed in other studies 
(Jones et al., 2018; Ketz et al., 2018) and this setup has shown 
therapeutic benefits in sleep quality (Robinson et al., 2018) and 
tremor suppression as well (Brittain et al., 2013).  
The field of closed-loop application of non-invasive brain 
stimulation is still subject to important challenges such as 
development of accurate and optimized triggering algorithms, 
translation into clinical use and correct identification of inputs to 
feed the system with. Nevertheless, the clinical applications are 
multiple, and could be part of the therapeutic options for patients 
with DOC, which are still limited. The present study will be the first 
proof of concept toward this application. As patients with DOC 
cannot be actively engaged in a specific task to prompt their brain to 
be in an “active state”, using such closed-loop EEG-tDCS approach to 
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monitor patients’ vigilance and determine the most appropriate 
moment to trigger the stimulation represents an important step 







4. Discussion and Perspectives 
 
“Your assumptions are your windows on the world. Scrub them off 
every once in a while, or the light won't come in.” 
Isaac Asimov 
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Patients with DOC following a severe acquired brain injury 
represent a challenging population to take care of, both from a 
clinical and a research perspective. The clinician working with them 
may feel ill-equipped facing the complexity of the clinical picture: 
typically lying in a bed, with no communicative behavior, requiring a 
lot of nursing, with a varying number of comorbidities or 
complications such as spasticity, aphasia or pain (Majerus et al., 
2009; Schnakers et al., 2012; Nakase-Richardson et al., 2013) and a 
very limited amount of treatment options (Thibaut et al., 2019b). 
From a research perspective, the scientist apprehending this 
population will also be confronted with the heterogeneity of this 
group in terms of injury mechanisms, location of the lesions, 
potential for recovery, responsiveness to the treatments, etc. which 
makes conducting studies with a high level of evidence, such as 
randomized controlled trials, difficult. The present thesis had the 
ambitious aim to tackle both of these issues using a two-step 
approach: focusing on the diagnosis, and then focusing on the 
treatment. 
While the first step in the care of such dramatic cases is 
indeed to pin down the diagnosis reflecting the level of 
consciousness of the patient, even that initial approach is intricate. 
The high misdiagnosis rates, consistently reported around 40% 
(Andrews et al., 1996; Childs and Mercer, 1996; Schnakers et al., 
2009), can make the clinician reasonably insecure, which in turn 
impacts the patient’s family, the therapy staff and their counseling 
capacities. Bearing in mind these difficulties encountered on the 
field, we investigated in Part One how to provide relevant and helpful 
information to the clinician, using existing data from a specialized 
rehabilitation setting.  
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We first focused on a not-so-rare scenario of a patient being 
admitted to a rehabilitation facility several weeks after a serious 
injury to the head, with no observable signs of consciousness. The 
main rehabilitation objectives for this comatose or UWS patient will 
be to increase his level of consciousness and thereafter improve his 
functional status. The transition from his state of unconsciousness to 
a state of consciousness (MCS or EMCS) will therefore be a pivotal 
point in his management. The earlier this transition will be identified, 
the better, especially in specific contexts where insurance policies 
limit the length of stay in specialized facilities. More importantly, the 
therapeutic management for conscious or unconscious patients will 
differ, in terms of pain management for instance, responsiveness to 
treatments and rehabilitation interventions. Our first retrospective 
study therefore better characterized which behaviors mark this 
transition and when (Martens et al., 2019b). Thanks to bi-weekly 
CRS-R assessments collected on a sample of 79 patients, we showed 
that we can expect to observe the first sign(s) of consciousness 
within six weeks after injury and after two weeks of rehabilitation. 
We further showed that visual pursuit was the most prevalent by far, 
and that in 72% of the cases, only a single subscale of the CRS-R 
marked this transition. This confirms the key role of visual pursuit as 
early indicator of consciousness (Dolce et al., 2011). Visual pathways 
seem therefore to be part of the areas with the most potential for 
early recovery, through neuroplastic processes and long-range 
connectivity between the cortex and the brainstem, which is often 
impacted in the UWS (Laureys et al., 1999; Silva et al., 2010). While 
interestingly, the traumatic or non-traumatic nature of the injury did 
not significantly impact these results, there was a notable exception 
for behaviors with an important motor contribution such as 
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localization to pain or functional object use, which were significantly 
more observed in TBI patients. Automatic movements (e.g., 
scratching nose, grabbing sheets) largely contributed to this 
difference, possibly due to the fact that they can be triggered either 
by internal or external stimuli, whereas the other motor behaviors 
have a stronger reliance on external stimuli only. The 
pathophysiological differences between TBI and non-TBI in terms of 
preferential damage of highly oxygen-demanding areas could also 
drive the greater motor impairment in non-traumatic cases. With 
these results, we narrowed down the previously reported time 
window of about three months for consciousness recovery during 
rehabilitation (Bagnato et al., 2016) to six weeks. We also 
emphasized the importance of conducting thorough and repeated 
bedside assessments, as the risk of missing a sign of consciousness 
can be high since only one of them tends to appear first. This has 
been underlined by recently updated DOC care guidelines as well 
(Giacino et al., 2018b).  
We then attempted to embrace the perspective of the 
relatives and the caregivers by investigating, with a similar study 
design, one of the most anticipated milestones in recovery that is 
undoubtedly the recovery of communication (Krishnan et al., 2017; 
Lugo et al., 2017). We showed in a larger sample of 175 patients that 
it takes between two to four months post-injury to recover functional 
communication, and that nearly two thirds of the DOC patients 
analyzed in this study recover it, either during the two first months of 
rehabilitation or later on. Patients with shorter acute stays and with 
older age have greater chance to regain this ability. This important 
step also marks the next transition to EMCS, a clinical state often 
associated with a confusional state and that is still in need for better 
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characterization and appropriate care (Nakase-Richardson et al., 
2009; Bodien et al., 2019). 
Based on these behavioral findings combined with modern 
neuroimaging tools, clinicians and researchers can now rely on 
objective data to complement the path to recovery in the subacute 
phase of a DOC. These two studies are of course limited by their 
retrospective design and the inherent absence of intervention-based 
outcomes. It would have been interesting, for instance, to investigate 
the effects of specific rehabilitation interventions, such as 
environmental management or the addition of communicative 
devices and strategies, on communication recovery. Regarding the 
identification of the most prevalent behaviors denoting 
consciousness, the next step would be to investigate if any patterns 
in recovery can be properly identified and clustered (e.g., concurrent 
recovery of visual pursuit and command-following, recovery of 
automatic movement only) and whether any of these clusters are 
significantly associated with a better outcome. Long-term outcome 
data are difficult to collect, partly because it is easy to lose track of 
the patients once they are discharged home or to nursing facilities 
and the repositories are rare. On top of that, collecting data such as 
the CRS-R requires expertise and time commitment and the burden 
in terms of travels and human resources is therefore too high. A 
potential solution is the “tele-diagnosis” using phone-based 
questionnaires extracted from the CRS-R that are currently being 
validated in large multi-center trials. Another option is the use of 
abbreviated scales providing the same diagnostic accuracy than the 
CRS-R but requiring shorter completion time. Again, validation 
studies built on the most frequently observed behaviors depicting 
consciousness are ongoing (Wannez et al., 2017a). This type of tools 
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could then also be used in constraining settings such as intensive care 
units. However, these options still require some training and 
experienced clinicians. An approach addressing these issues has been 
investigated by Hermann and colleagues (Hermann et al., 2019). 
Taking advantage of the time spent by the caregivers at the patient’s 
bedside, they used the principle of wisdom of the crowds to pool a 
large amount of subjective reports regarding the level of 
consciousness (about 700 ratings from 80 nurses). Based on a visual 
analog scale quantifying the own feeling about the patient’s level of 
consciousness and compared to the CRS-R, they used receiver 
operating characteristics curve to assess the diagnostic accuracy of 
the “DoC-feeling” and report an area under the curve of 0.92. This 
excellent diagnostic performance encourages further use of this tool 
to complement the clinician’s diagnosis and to multiply the 
assessments as it is easily implementable in any setting and is way 
less time-demanding than behavioral assessment at the bedside. 
Finally, another limitation pertaining to both of these studies is the 
fact that they were conducted in US healthcare facilities, with the 
specific healthcare context described above. The population of 
patients with DOC can therefore not plainly be compared with 
European ones and the results presented in these two studies may 
not completely translate to public healthcare settings. 
Bearing these limitations in mind, Part One thus contributed 
to characterizing clinical signs of consciousness, thereby improving 
the behavioral diagnosis at the bedside in a rehabilitation setting, 
while also anticipating relatives’ expectations and providing objective 
answers. Moving forward to offering curative treatment solutions, 
Part Two widely investigated the use of tDCS within the therapeutic 
options available for these patients.  
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We first explored different types of environments to perform 
tDCS. In a randomized controlled trial investigating long-term 
prefrontal tDCS in chronic MCS patients, we showed that when 
delivered at home or in a rehabilitation or nursing facility by trained 
caregivers or relatives, long-term prefrontal tDCS can safely and 
significantly improve CRS-R scores  (Martens et al., 2018b). This has 
tremendous implications regarding affordability and clinical efficacy 
of the technique, as we are expanding the environment of tDCS 
application beyond research and medical facilities. As long as the 
compliance was satisfying (i.e., patients received at least 80% of the 
planned sessions), the treatment effect of active 4-week tDCS was 
significant, suggesting the dose of applied tDCS is another important 
parameter of responsiveness. This has been confirmed by a previous 
randomized controlled trial performed with the same type of 
population (16 chronic MCS patients), where some patients started 
to show new signs of consciousness after one, two or three days of 
consecutive stimulations (Thibaut et al., 2017b). Repeating the 
sessions therefore unsurprisingly appears as a valuable option to 
increase the amount of responders. Home-based application of tDCS 
opens the door for larger application reaching more patients and for 
expanded results that will guide the effective and appropriate clinical 
use of tDCS (Charvet et al., 2015). 
Given the imbalance between trials investigating prefrontal 
stimulation and the ones targeting other areas, in favor of the DLPFC, 
we decided to explore the potential benefits of stimulating zones 
that have not been investigated yet. Our pilot trial in 10 DOC patients 
(MCS and UWS) focusing on the motor cortex showed no behavioral 
treatment effect at the group level (Martens et al., 2019d), which 
contradicts a more recent open label study reporting 80% of 
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responders in a MCS TBI population (Straudi et al., 2019). This 
inconsistency encourages further investigation in properly designed 
randomized controlled trials with a priori sample size estimation 
based on this available data. Repeated sessions should also be 
investigated given the known cumulative effects of tDCS that could 
increase the patient’s behavioral responsiveness if directed to the 
motor cortex (Boggio et al., 2007). 
We also investigated, in a large randomized controlled trial 
on 46 patients, the use of multifocal tDCS targeting a whole network: 
the external awareness network located in the frontoparietal areas. 
Again, no behavioral treatment was identified at the group level 
while seven tDCS-responders were identified at the individual level. 
Noteworthy, we also identified for the first time patients who 
behaviorally worsened following stimulation by losing a sign of 
consciousness after the active tDCS session. These “paradoxical” 
responders shared a common baseline EEG pattern that significantly 
differed from the other patients: they had a higher initial complexity 
in the theta band. This is the first known report of a biomarker for 
negative treatment response in the DOC population. It is unsurprising 
that this finding concerned the theta band, as it appears as a key 
frequency band for patients with DOC. Indeed, as a diagnostic 
marker, patients in UWS have significantly lower connectivity as 
compared to MCS in this band (Lehembre et al., 2012). In active EEG 
paradigms (e.g., counting own name versus other names), it is also in 
that band that changes in power and synchronization are observed 
following the stimulus condition in both MCS and UWS (Fellinger et 
al., 2011). Following application of prefrontal tDCS, changes in 
coherence have also been reported in the theta band exclusively (Bai 
et al., 2018). Furthermore, higher initial spatial connectivity and 
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network centrality in the theta band are known features of positive 
response to tDCS, as revealed when comparing known tDCS-
responders and non-responders using high-density EEG  (Thibaut et 
al., 2018b). It would be interesting to conduct complexity analyses on 
the same dataset and check if the level of complexity is higher in 
these non-responders as compared to responders. 
 Overall, when investigating alternative targets such as the 
motor cortex or the frontoparietal network and comparing them with 
the existing literature, it appeared that the behavioral effects were 
way less remarkable than for the DLPFC. Therefore, as highlighted by 
Figure 29, the left DLPFC still appears for now as the optimal target 
for tDCS, especially in MCS patients.  
Figure 29 – Pooled effect sizes for different targets extracted from all available data in 
randomized controlled trials investigating tDCS in patients with DOC.  
 
This might be explained by the mesocircuit hypothesis stating 
that the strong connectivity between the prefrontal cortex and the 
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striatum might be potentiated by stimulating the prefrontal area and 
thereby could down regulate the inhibition on the thalamus from the 
striatum, enhancing thalamo-cortical connectivity, critical for 
consciousness recovery (Schiff, 2010; Fridman et al., 2014). It could 
also be explained by another hypothesis introduced above: that non-
invasive neuromodulation methods can act on the patient’s 
behavioral responsiveness, through the prefrontal cortex, but not on 
his/her consciousness per se. This would explain why stimulating the 
external awareness network (i.e., frontoparietal areas) with tDCS did 
not lead to drastic clinical improvements. Eliciting increased levels of 
consciousness may indeed need stronger activation of subcortical 
areas located in the thalamus or the precuneus for instance, as 
opposed to elective intervention on the cortical areas, as enabled by 
tDCS. Given its inherent physiological functioning, tDCS cannot reach 
deep subcortical structures, as about half of the current is already 
lost when crossing the scalp and the skull (Miranda et al., 2006; Stagg 
and Nitsche, 2011). Reaching subcortical structures underlying 
consciousness could be achieved using other techniques. Invasive 
approaches, with DBS for instance, could be an option to directly 
activate the thalamic nuclei, with the known associated challenges 
regarding surgical risks and eligibility criteria however. Invasive VNS 
could also be a way to activate the thalamus and hypothalamus 
through the nucleus of the solitary tract located in the brainstem. 
Feasibility of the surgical implantation has been proven in an 
uncontrolled case-report performed with a patient who was UWS for 
15 years and transitioned to MCS following one month of 
stimulation, accompanied by metabolic (higher activity in cortical and 
basal ganglia regions) and electrophysiological (increase in theta 
power) changes (Corazzol et al., 2017). This encouraging first step 
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needs to be followed-up by randomized controlled trials. The non-
invasive alternative, transauricular VNS has also been investigated in 
an uncontrolled cohort study of 14 patients in UWS or MCS and 
induced significant improvement in total CRS-R scores at the group 
level after one month on bi-daily 30-minute stimulation (Noé et al., 
2019). Another completely innovative approach that can target 
deeper subcortical structures is the use of ultrasonic stimulation. 
Using sound waves focused on the thalamus, a case-report showed 
recovery of spatio-temporal orientation and language 
comprehension in an acute young TBI patient (Monti et al., 2016). 
Again, further investigation is warranted. Other theories also suggest 
that critical hubs in consciousness processes are posterior and not 
depending on the frontal areas. A temporo-parietal-occipital hot 
zone located in the posterior cerebral cortex would support 
conscious experiences in general, or in a particular context (e.g., 
recognizing faces), based on fMRI and EEG findings (Koch et al., 
2016). The only trial targeting the posterior parietal cortex with tDCS 
in MCS showed significant effects yet to a lesser extent than for the 
DLPFC but again, tDCS might not be the most suitable tool to increase 
the excitability of these hubs. Invasive options could be investigated 
to corroborate these hypotheses. 
Taken together, our findings show that the best target to 
increase the behavioral responsiveness of patients with DOC, as 
measured by the CRS-R, is the left DLPFC (see Figure 29). However, 
we did not conduct a priori sample size estimation before conducting 
our studies and there might therefore have been under-powered, 
from a statistical perspective. As a post-hoc analysis, we calculated 
the achieved power of the three tDCS trials above-presented and 
based on the effect sizes we found, we recalculated the sample size 
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needed to obtain a statistical power of 90%. These results are 
presented in Table 12. 
 
Table 12 – Power and sample size estimation for the three tDCS studies presented 








sample size  
Left DLPFC (home-
based, 20 sessions), 
(Martens et al., 2018b) 
27 0.053 0.47 0.63 52 
Motor cortex (single 
session), (Martens et 
al., 2019d) 




46 0.92 0.05 0.06 4404 
Power calculated using effect size, N and α =0.05; sample size estimated using 
effect size, power (1-β) =0.90 and α =0.05. 
a
 Wilcoxon Rank-Sum Test 
 
An overarching observation is that all of the studies are 
underpowered with too small sample sizes but it is most striking for 
the two studies using single sessions of tDCS on other targets than 
the DLPFC, corroborating our previous hypotheses. For the motor 
and frontoparietal targets, the effect is indeed way too small which 
makes recruiting enough patients an impossible task. The optimal 
sample size for the left DLPFC target is more achievable but still 
underlines the important difficulty of achieving enough statistical 
power with patients with DOC. This condition is indeed very rare and 
study recruitment is a major challenge. From a clinical perspective, it 
is also relevant to not focus on the group level treatment effect only 
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but on the individual changes observed as well and how to improve 
single-level responsiveness. 
Moving a step beyond in that direction, shifting from an 
arbitrary timing of stimulation toward a brain-state dependent 
application represents a promising option to further increase the 
response rate. This closed-loop model could fit in research, clinical 
and home-based settings. As stated above, EEG can be used to 
identify patterns of individual responsiveness, notably in the theta 
band. It could further be used to monitor ongoing cerebral activity 
and trigger interventions, in a brain state-dependent fashion. We 
hypothesize, based on previous works (Gosseries et al., 2011; Piarulli 
et al., 2016), that spectral entropy can be an appropriate marker for 
vigilance, and that vigilance-dependent application of tDCS could 
represent an additional therapeutic benefit for patients in MCS. We 
here chose to stimulate the DLPFC bilaterally, focusing this time on 
improving executive functions, directly involved in the patient’s 
behavioral responsiveness. Shifting our aims from improving the level 
of consciousness toward improving the behavioral responsiveness, as 
discussed above, may represent a more optimal and realistic way to 
use tDCS, as it can only reach cortical structures, whereas 
consciousness lies in both cortical and subcortical areas. If the 
upcoming results confirm our hypotheses, this would imply that 
accounting for the timing of the stimulations has to be featured in 
future stimulation parameters. 
In the future, thanks to fast evolving technological 
advancements, we could imagine a combination of home-based and 
closed-loop approaches, with long-term monitoring of brain EEG 
signals and optimal delivering of tDCS. This requires of course 
portable user-friendly closed-loop devices, along with an extensive 
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training of all the participants. It could offer new ways to treat 
patients with DOC using non-invasive brain stimulation in a way 
never observed before. Remotely-supervised tDCS is already 
efficiently used in other conditions (Palm et al., 2018) such as 
multiple sclerosis (Charvet et al., 2017), chronic tinnitus (Hyvärinen et 
al., 2016) or vascular dementia (André et al., 2016). 
While the present work aimed at improving both diagnostic 
and therapeutic aspects of the management of patients with DOC, a 
series of challenges still need to be addressed. The first one being to 
change the overly-pessimistic misconception that failure to recover 
consciousness within the first weeks post-injury portends an 
unfavorable outcome. This widespread belief probably originates 
from the first consensus statement of the Multi-Society Task Force on 
the “persistent vegetative state” (stating that recovery from a non-
TBI UWS is exceedingly rare after three months) (The Multi-Society 
Task Force on PVS, 1994a), but it also largely relies on individual 
clinical judgment. Premature end-of-life decisions have been 
reflected by a large retrospective Canadian study including 720 
patients admitted to intensive care following a TBI (Turgeon et al., 
2011). They highlighted that 70% of deaths in the intensive care units 
were due to life-sustaining therapy withdrawal and that in 65% of 
these cases, it happened within the first three days following 
admission. Our investigations however show that patients admitted 
to rehabilitation later on, with still major deficits, are able to recover 
complex cortically mediated behaviors such as response to command 
or communication (Martens et al., 2019b). These findings have been 
confirmed by an observational cohort study conducted on 95 TBI 
patients in MCS or UWS in the subacute phase of injury (four to 16 
weeks) and focusing on the recovery of the most complex behavior 
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of each CRS-R subscale (Giacino et al., 2019). The authors showed 
that 20% of the sample recovered all six of the target behaviors 
within the 6-week observation period and further suggest to consider 
aggressive rehabilitation and medical interventions for the patients in 
the subacute phase. Clinicians working in intensive care settings 
should therefore keep this data in view when discussing prognosis 
with families or caregivers, especially since even long-term outcome 
studies demonstrate that about 20% of patients with DOC are able to 
live independently within two to five years post-injury (Katz et al., 
2009). 
The second challenge pertains to the widely discussed 
important variations in individual response to interventions such as 
tDCS. The fluctuations in vigilance, characteristics of patients with 
DOC, are a well-known yet under investigated phenomenon, as no 
study has focused on properly characterizing them. The approach 
currently used to reduce the related diagnostic errors (with 
potentially dramatic consequences) is to repeat the behavioral 
assessments in order to decrease the chances of misdiagnosis 
(Wannez et al., 2017b). Accurate monitoring of vigilance could 
however help the clinician identify the best moment to perform a 
bedside assessment. To this end, EEG and pupillometry appear as 
valuable potential markers (Schleicher et al., 2008; Landsness et al., 
2011; Piarulli et al., 2016). If such markers are validated, they could 
also be integrated into closed-loop systems to complement the 
inputs feeding the algorithm. Another part of the variations in 
responsiveness is the heterogeneity of the lesions in DOC patients, 
that also affects the clinical presentation and leads to various 
phenotypes of treatment response. Neuroimaging is undoubtedly a 
valuable tool to explore why some patients respond to tDCS and 
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others do not. Grey matter integrity and relative metabolic 
preservation of the stimulated brain area clearly appear to play a role 
in the observed behavioral improvements in DOC patients. Indeed, 
when retrospectively investigating the T1 MRI and FDG PET data of 
known tDCS responders and non-responders, significant differences 
in structural integrity and metabolic activity were observed between 
the two subgroups in the stimulated cortical area (i.e., the DLPFC) but 
also in distant connected areas (i.e., precuneus and thalamus) with a 
greater preservation for the responders group, suggesting clinical 
responsiveness appears to rely on, at least partial, structural and 
functional preservation of the stimulated area (Thibaut et al., 2015c). 
Another characteristic of tDCS responders is that they present higher 
connectivity in the executive control network as measured by fMRI 
(Cavaliere et al., 2016). However, MRI and PET scanner machines are 
expensive and not available in every facility. It also requires skilled 
nursing teams and expertise for signal analysis and cannot be used at 
the bedside. To tackle these issues, EEG can be used at the bedside, 
is more affordable and requires less training. It has been shown for 
instance that in MCS patients, responders show higher cortical 
connectivity in the theta band as compared to non-responders 
(Thibaut et al., 2018b). As a matter of fact, additional work needs to 
be done in identifying patterns of responsiveness in patients with 
DOC. To this end, developing biomarkers of responsiveness using 
machine learning approaches to categorize EEG signals according to 
clinical responsiveness to the treatment could represent a valuable 
support. Treatment for patients with DOC using non-invasive 
neuromodulation methods such as tDCS needs to further evolve 
toward individualized approaches. Clearly, the varying nature and 
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extend of brain lesions in DOC patients make “one size fits all” 
stimulation montages challenging if not inappropriate.  
On the other hand, there is emerging evidence that tDCS is 
more efficient when applied in combination with other rehabilitation 
interventions such as physical and occupational therapies (Nair et al., 
2011; Allman et al., 2016; Lefebvre et al., 2017; Dehem et al., 2018). 
Simultaneous stimulation of the central and the peripheral nervous 
systems (i.e., neuromuscular facilitation or sensorimotor techniques) 
could better enhance synaptic plasticity and skill relearning (Schlaug 
et al., 2008). It would therefore also be of interest to apply tDCS in 
patients with DOC during rehabilitation interventions, to induce 
stronger effects on neural plasticity. In the same vein, even passively 
engaging the patient through external sensorial stimuli such as music, 
flavors and fragrances, could also potentiate the effects of tDCS. As a 
matter of fact, tDCS responsiveness is multifactorial, as it also 
includes the repetition of tDCS sessions, as previously stated (Boggio 
et al., 2007; Ulam et al., 2014).  
Finally, the aim of moving toward home-based application to 
enable better clinical translation, larger samples and more powerful 
results is ambitious but comes of course with its own challenges, 
including safety and efficacy monitoring. To this end, some new tools 
could have the overarching goal to assist in both diagnostic 
assessments and treatment efficacy outcome measurements and 
deserve some attention. The DOC-feeling for instance (Hermann et 
al., 2019), offers this opportunity in addition to giving an important 
role to families and caregivers, who sometimes feel helpless when 







 “The important thing is not to stop questioning. Curiosity has its own 






DOC represent a rare and dramatic condition, with the 
unfortunate consequence of few available treatment options, partly 
because they are under investigated. Patients affected by this 
alteration in consciousness demonstrate various clinical 
presentations, in terms of level of awareness, behavioral output, 
motor complications, etc. which adds on the challenge for optimized 
care. Beyond better characterizing the potential for recovery of these 
patients, we explored further a specific treatment option; tDCS, and 
its modes of application: where to stimulate? In which environment? 
When?  
In view of our findings, the left DLPFC is the target with the 
most potential behavioral benefits, as compared to the motor or the 
frontoparietal cortices. We should bear in mind however that 
individual response has a key and often neglected role to play and 
that assumptions on the group level effects should be taken 
cautiously. Regarding clinical translation, tDCS can be safely and 
efficiently applied by non-experts in the patient’s daily environment. 
This open several doors for home-based and long-term use, as well as 
better involvement of the caregivers and relatives, who are often 
eager to take an active part in the therapeutic management. The 
optimal moment of application could be identified using EEG entropic 
patterns, that could in turn trigger tDCS and thereby potentiate its 
neuroplastic effects. This approach is still in the early stages but 
represents a promising therapeutic option. 
Considering the fact that one of the aims of the present work 
was to help clinicians facing the challenges surrounding the 
management of DOC, we would like to conclude with some clinical 




- Clinicians working in rehabilitation facilities should put a 
specific emphasis on tracking visual pursuit, reproducible 
response to command and automatic motor movements 
when diagnosing comatose or UWS patients at the 
bedside 
- Clinicians working in rehabilitation facilities with a 
specialized DOC program may expect patients admitted as 
comatose or UWS to change their bedside diagnosis to 
MCS or EMCS within six weeks of injury  
- Clinicians working in intensive care settings should be 
aware that non-communicative patients discharged to 
rehabilitation may recover functional communication in 
61% of cases  
- Clinicians working in rehabilitation facilities may expect 
non-communicative admitted patients to recover IC 
within 40 days of injury and FC within 49 days of injury in 
70% of cases. Cases of late communication recovery (i.e., 
past 8 weeks of rehabilitation) can occur in 33% of cases 
- Clinicians treating patients with DOC should consider tDCS 
in their therapeutic options to improve behavioral 
responsiveness without having safety concerns 
- One session of tDCS should be applied as follows: 20 
minutes of anodal stimulation (2 mA) over the left DLPFC 
(F3) using sponge 35 cm² electrodes 
- Clinicians can anticipate a greater rate of behavioral 
improvement for MCS patients than for UWS patients, 
regardless of etiology and chronicity of the injury 
- The behavioral effects of one tDCS session are transient 




sessions on a daily basis. Repeated tDCS sessions can be 
safely applied for five consecutive days, up to 20 days of 
stimulation 
- tDCS sessions can be applied by trained relatives and 
caregivers, upon regular professional supervision and use 
of tDCS devices designed to this application 
- Clinicians treating patients with DOC should not prioritize 
right prefrontal, motor, posterior parietal nor bilateral 
frontoparietal tDCS 
These recommendations finely complement the most recent 
ones based on systematic reviews of the literature (Giacino et al., 
2018b; Kondziella et al., 2020) and build on the foundations of 
comprehensive evidence-based guidelines for the management of 
patients with DOC following severe brain injury. 
As stated above, other treatment options are available and 
deserve more investigations too: VNS, ultrasound or repeated TMS to 
name a few. The findings presented here, notably in terms of remote 
supervision, can be easily translated to these techniques and 
contribute to enrich the still too scattered panel of treatment options 
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Buzsáki, G. (2006). Rhythms of the brain. Oxford University Press  
Candelieri, A., Cortese, M. D., Dolce, G., Riganello, F., and Sannita, W. G. (2011). 
Visual Pursuit: Within-Day Variability in the Severe Disorder of Consciousness. 
J. Neurotrauma 28, 2013–2017. doi:10.1089/neu.2011.1885. 
Carboncini, M. C., Piarulli, A., Virgillito, A., Arrighi, P., Andre, P., Tomaiuolo, F., et al. 
(2014). A case of post-traumatic minimally conscious state reversed by 
midazolam: Clinical aspects and neurophysiological correlates. Restor. Neurol. 
Neurosci. 32, 767–787. doi:10.3233/RNN-140426. 
Casali, A. G., Gosseries, O., Rosanova, M., Boly, M., Sarasso, S., Casali, K. R., et al. 
(2013). A theoretically based index of consciousness independent of sensory 
processing and behavior. Sci. Transl. Med. 5, 198ra105. 
doi:10.1126/scitranslmed.3006294. 
Casarotto, S., Comanducci, A., Rosanova, M., Sarasso, S., Fecchio, M., Napolitani, M., 
et al. (2016). Stratification of unresponsive patients by an independently 
validated index of brain complexity. Ann. Neurol. 80, 718–729. 
doi:10.1002/ana.24779. 
Cavaliere, C., Aiello, M., Di Perri, C., Amico, E., Martial, C., Thibaut, A., et al. (2016). 
Functional Connectivity Substrates for tDCS Response in Minimally Conscious 
State Patients. Front. Cell. Neurosci. 10, 257. doi:10.3389/fncel.2016.00257. 
Cavinato, M., Genna, C., Formaggio, E., Gregorio, C., Storti, S. F., Manganotti, P., et 
al. (2019). Behavioural and electrophysiological effects of tDCS to prefrontal 
cortex in patients with disorders of consciousness. Clin. Neurophysiol. 130, 
231–238. doi:10.1016/j.clinph.2018.10.018. 
Cervós-Navarro, J., and Diemer, N. H. (1991). Selective vulnerability in brain hypoxia. 
Crit. Rev. Neurobiol. 6, 149–82.  
Charvet, L. E., Kasschau, M., Datta, A., Knotkova, H., Michael, C., Alonzo, A., et al. 
(2015). Remotely-supervised transcranial direct current stimulation ( tDCS ) 
for clinical trials : guidelines for technology and protocols. 9, 1–13. 
doi:10.3389/fnsys.2015.00026. 
Charvet, L., Shaw, M., Dobbs, B., Frontario, A., Sherman, K., Bikson, M., et al. (2017). 
Remotely Supervised Transcranial Direct Current Stimulation Increases the 
Benefit of At-Home Cognitive Training in Multiple Sclerosis. Neuromodulation 
Technol. Neural Interface 2017. doi:10.1111/ner.12583. 
Chatelle, C., and Laureys, S. (2011). “Understanding disorders of consciousness,” in 
The Oxford Handbook of Neuroethics, eds. J. Illes and B. Sahakian (New York: 
Oxford University Press), 119–133. 
Chatelle, C., Majerus, S., Whyte, J., Laureys, S., and Schnakers, C. (2012). A sensitive 




Neurol Neurosurg Psychiatry 83, 1233–1237. doi:10.1136/jnnp-2012-302987. 
Cheng, L., Gosseries, O., Ying, L., Hu, X., Yu, D., Gao, H., et al. (2013). Assessment of 
localisation to auditory stimulation in post-comatose states: use the patient’s 
own name. BMC Neurol 13, 27. doi:10.1186/1471-2377-13-27. 
Chennu, S., Annen, J., Wannez, S., Thibaut, A., Chatelle, C., Cassol, H., et al. (2017). 
Brain networks predict metabolism, diagnosis and prognosis at the bedside in 
disorders of consciousness. Brain 140, 2120–2132. doi:10.1093/brain/awx163. 
Childs, N. L., and Mercer, W. N. (1996). Misdiagnosing the persistent vegetative 
state. Misdiagnosis certainly occurs. BMJ 313, 944.  
Childs, N. L., Mercer, W. N., and Childs, H. W. (1993). Accuracy of diagnosis of 
persistent vegetative state. Neurology 43, 1465–7. 
doi:10.1212/WNL.43.8.1465. 
Chudy, D., Deletis, V., Almahariq, F., Marčinković, P., Škrlin, J., and Paradžik, V. 
(2018). Deep brain stimulation for the early treatment of the minimally 
conscious state and vegetative state: experience in 14 patients. J. Neurosurg. 
128, 1189–1198. doi:10.3171/2016.10.JNS161071. 
Cincotta, M., Giovannelli, F., Chiaramonti, R., Bianco, G., Godone, M., Battista, D., et 
al. (2015). No effects of 20 Hz-rTMS of the primary motor cortex in vegetative 
state: A randomised, sham-controlled study. Cortex. 71, 368–376. 
doi:10.1016/j.cortex.2015.07.027. 
Coben, R., and Evans, J. R. (2011). Neurofeedback and Neuromodulation Techniques 
and Applications. Elsevier Inc. doi:10.1016/C2009-0-64101-5. 
Collette, F., Van der Linden, M., Laureys, S., Arigoni, F., Delfiore, G., Degueldre, C., et 
al. (2007). Mapping the updating process: common and specific brain 
activations across different versions of the running span task. Cortex 43, 146–
158.  
Corazzol, M., Lio, G., Lefevre, A., Deiana, G., Tell, L., André-Obadia, N., et al. (2017). 
Restoring consciousness with vagus nerve stimulation. Curr. Biol. 27, R994–
R996. doi:10.1016/j.cub.2017.07.060. 
Cruse, D., Thibaut, A., Demertzi, A., Nantes, J. C., Bruno, M.-A., Gosseries, O., et al. 
(2013). Actigraphy assessments of circadian sleep-wake cycles in the 
Vegetative and Minimally Conscious States. BMC Med. 11, 11.  
D’Esposito, M., Aguirre, G. K., Zarahn, E., Ballard, D., Shin, R. K., and Lease, J. (1998). 
Functional MRI studies of spatial and nonspatial working memory. Brain Res 
Cogn Brain Res 7, 1–13.  
D’Esposito, M., Detre, J. A., Alsop, D. C., Shin, R. K., Atlas, S., and Grossman, M. 
(1995). The neural basis of the central executive system of working memory. 
Nature 378, 279–281. doi:10.1038/378279a0. 
Dehaene, S., and Naccache, L. (2001). Towards a cognitive neuroscience of 





Dehem, S., Gilliaux, M., Lejeune, T., Delaunois, E., Mbonda, P., Vandermeeren, Y., et 
al. (2018). Effectiveness of a single session of dual-transcranial direct current 
stimulation in combination with upper limb robotic-assisted rehabilitation in 
chronic stroke patients: A randomized, double-blind, cross-over study. Int. J. 
Rehabil. Res. 41, 138–145. doi:10.1097/MRR.0000000000000274. 
Demertzi, A., Antonopoulos, G., Heine, L., Voss, H. U., Crone, J. S., De Los Angeles, C., 
et al. (2015). Intrinsic functional connectivity differentiates minimally 
conscious from unresponsive patients. Brain 138, 2619–2631. 
doi:10.1093/brain/awv169. 
Demertzi, A., Ledoux, D., Bruno, M. A., Vanhaudenhuyse, A., Gosseries, O., Soddu, A., 
et al. (2011). Attitudes towards end-of-life issues in disorders of 
consciousness: a European survey. J Neurol 258, 1058–1065. 
doi:10.1007/s00415-010-5882-z. 
Devinsky, O., and D’Esposito, M. (2004). Neurology of cognitive and behavioural 
disorders. Oxford, New York: Oxord University Press. 
Di, H. B., Yu, S. M., Weng, X. C., Laureys, S., Yu, D., Li, J. Q., et al. (2007). Cerebral 
response to patient’s own name in the vegetative and minimally conscious 
states. Neurology 68, 895–899. doi:10.1212/01.wnl.0000258544.79024.d0. 
Di, H., Boly, M., Weng, X., Ledoux, D., and Laureys, S. (2008). Neuroimaging 
activation studies in the vegetative state: predictors of recovery? Clin Med 8, 
502–507.  
Di, H., Nie, Y., Hu, X., Tong, Y., Heine, L., Wannez, S., et al. (2014). Assessment of 
visual fixation in vegetative and minimally conscious states. BMC Neurol. 14, 
147.  
Di Lazzaro, V., Dileone, M., Capone, F., Pellegrino, G., Ranieri, F., Musumeci, G., et al. 
(2014). Immediate and late modulation of interhemipheric imbalance with 
bilateral transcranial direct current stimulation in acute stroke. Brain Stimul. 7, 
841–848. doi:10.1016/j.brs.2014.10.001. 
Di Perri, C., Bahri, M. A., Amico, E., Thibaut, A., Heine, L., Antonopoulos, G., et al. 
(2016). Neural correlates of consciousness in patients who have emerged 
from a minimally conscious state: a cross-sectional multimodal imaging study. 
Lancet Neurol. 15, 830–842. doi:10.1016/S1474-4422(16)00111-3. 
Dolce, G., Lucca, L. F., Candelieri, A., Rogano, S., Pignolo, L., and Sannita, W. G. 
(2011). Visual pursuit in the severe disorder of consciousness. J. Neurotrauma 
28, 1149–1154. doi:10.1089/neu.2010.1405. 
Dolce, G., Quintieri, M., Serra, S., Lagani, V., and Pignolo, L. (2008). Clinical signs and 
early prognosis in vegetative state: A decisional tree, data-mining study. Brain 
Inj. 22, 617–623. doi:10.1080/02699050802132503. 
Estraneo, A., Loreto, V., Guarino, I., Boemia, V., Paone, G., Moretta, P., et al. (2016). 
Standard EEG in diagnostic process of prolonged disorders of consciousness. 




Estraneo, A., Moretta, P., Cardinale, V., De Tanti, A., Gatta, G., Giacino, J. T., et al. 
(2015). A multicentre study of intentional behavioural responses measured 
using the Coma Recovery Scale–Revised in patients with minimally conscious 
state. Clin. Rehabil. 29, 803–808. doi:10.1177/0269215514556002. 
Estraneo, A., Moretta, P., Loreto, V., Lanzillo, B., Santoro, L., and Trojano, L. (2010). 
Late recovery after traumatic, anoxic, or hemorrhagic long-lasting vegetative 
state. Neurology 75, 239–245. doi:10.1212/WNL.0b013e3181e8e8cc. 
Estraneo, A., Pascarella, A., Moretta, P., Masotta, O., Fiorenza, S., Chirico, G., et al. 
(2017). Repeated transcranial direct current stimulation in prolonged 
disorders of consciousness: A double-blind cross-over study. J. Neurol. Sci. 
375, 464–470. doi:10.1016/j.jns.2017.02.036. 
Fellinger, R., Klimesch, W., Schnakers, C., Perrin, F., Freunberger, R., Gruber, W., et 
al. (2011). Cognitive processes in disorders of consciousness as revealed by 
EEG time-frequency analyses. Clin Neurophysiol 122, 2177–2184. 
doi:10.1016/j.clinph.2011.03.004. 
Fernández-Espejo, D., Rossit, S., and Owen, A. M. (2015). A Thalamocortical 
Mechanism for the Absence of Overt Motor Behavior in Covertly Aware 
Patients. JAMA Neurol. 72, 1442. doi:10.1001/jamaneurol.2015.2614. 
Fernández, A., López-Ibor, M.-I., Turrero, A., Santos, J.-M., Morón, M.-D., Hornero, 
R., et al. (2011). Lempel–Ziv complexity in schizophrenia: a MEG study. Clin. 
Neurophysiol. 122, 2227–2235. 
Fernández, A., Zuluaga, P., Abásolo, D., Gómez, C., Serra, A., Méndez, M. A., et al. 
(2012). Brain oscillatory complexity across the life span. Clin. Neurophysiol. 
123, 2154–2162. 
Ferrucci, R., Bortolomasi, M., Vergari, M., Tadini, L., Salvoro, B., Giacopuzzi, M., et al. 
(2009). Transcranial direct current stimulation in severe, drug-resistant major 
depression. J. Affect. Disord. 118. 
Fox, M. D., Snyder, A. Z., Vincent, J. L., Corbetta, M., Van Essen, D. C., and Raichle, M. 
E. (2005). The human brain is intrinsically organized into dynamic, 
anticorrelated functional networks. Proc. Natl. Acad. Sci. U. S. A. 102, 9673–
9678. doi:10.1073/pnas.0504136102. 
Francois, B., Vacher, P., Roustan, J., Salle, J. Y., Vidal, J., Moreau, J. J., et al. (2001). 
Intrathecal baclofen after traumatic brain injury: Early treatment using a new 
technique to prevent spasticity. J. Trauma - Inj. Infect. Crit. Care 50, 158–161. 
Fregni, F., Boggio, P. S., Lima, M. C., Ferreira, M. J., Wagner, T., Rigonatti, S. P., et al. 
(2006). A sham-controlled, phase II trial of transcranial direct current 
stimulation for the treatment of central pain in traumatic spinal cord injury. 
Pain 122, 197–209. doi:10.1016/j.pain.2006.02.023. 
Fregni, F., and Pascual-Leone, A. (2006). Hand motor recovery after stroke: tuning 
the orchestra to improve hand motor function. Cogn Behav Neurol 19, 21–33.  




cerebral metabolic patterns demonstrate the role of anterior forebrain 
mesocircuit dysfunction in the severely injured brain. Proc Natl Acad Sci U S A 
111, 6473–6478. doi:10.1073/pnas.1320969111. 
Fridman, E. A., Calvar, J., Bonetto, M., Gamzu, E., Krimchansky, B. Z., Meli, F., et al. 
(2009). Fast awakening from minimally conscious state with apomorphine. 
Brain Inj 23, 172–177. doi:10.1080/02699050802649662. 
Fridman, E. A., Krimchansky, B. Z., Bonetto, M., Galperin, T., Gamzu, E. R., Leiguarda, 
R. C., et al. (2010). Continuous subcutaneous apomorphine for severe 
disorders of consciousness after traumatic brain injury. Brain Inj. 24, 636–641. 
doi:10.3109/02699051003610433. 
Gallucci, A., Lucena, P. H., Martens, G., Thibaut, A., and Fregni, F. (2019). Transcranial 
direct current stimulation to prevent and treat surgery-induced opioid 
dependence: a systematic review. Pain Manag. 9, 93–106. doi:10.2217/pmt-
2018-0053. 
Ganesh, S., Guernon, A., Chalcraft, L., Harton, B., Smith, B., and Louise-Bender Pape, 
T. (2013). Medical comorbidities in disorders of consciousness patients and 
their association with functional outcomes. Arch Phys Med Rehabil 94, 1899–
1907. doi:10.1016/j.apmr.2012.12.026. 
Garcia-Larrea, L., Perchet, C., Hagiwara, K., and André-Obadia, N. (2019). At-Home 
Cortical Stimulation for Neuropathic Pain: a Feasibility Study with Initial 
Clinical Results. Neurotherapeutics. doi:10.1007/s13311-019-00734-3. 
Giacino, J. T., Ashwal, S., Childs, N., Cranford, R., Jennett, B., Katz, D. I., et al. (2002). 
The minimally conscious state: definition and diagnostic criteria. Neurology 
58, 349–353.  
Giacino, J. T., Fins, J. J., Laureys, S., and Schiff, N. D. (2014). Disorders of 
consciousness after acquired brain injury: the state of the science. Nat Rev 
Neurol 10, 99–114. doi:10.1038/nrneurol.2013.279. 
Giacino, J. T., Kalmar, K., and Whyte, J. (2004). The JFK Coma Recovery Scale-Revised: 
measurement characteristics and diagnostic utility. Arch Phys Med Rehabil 85, 
2020–2029.  
Giacino, J. T., Katz, D. I., Schiff, N. D., Whyte, J., Ashman, E. J., Ashwal, S., et al. 
(2018a). Comprehensive systematic review update summary: Disorders of 
consciousness: Report of the Guideline Development, Dissemination, and 
Implementation Subcommittee of the American Academy of Neurology; The 
American Congress of Rehabilitation Medicine; And the National Institute on 
Disability, Independent Living, and Rehabilitati. Neurology 91, 461–470. 
doi:10.1212/WNL.0000000000005928. 
Giacino, J. T., Katz, D. I., Schiff, N. D., Whyte, J., Ashman, E. J., Ashwal, S., et al. 
(2018b). Practice guideline update recommendations summary: Disorders of 
consciousness: Report of the Guideline Development, Dissemination, and 




American Congress of Rehabilitation Medicine; and the National Institute on 
Disability, Independent Living, and Rehabilitation Research. Neurology 91, 
450–460. doi:10.1212/WNL.0000000000005926. 
Giacino, J. T., Schnakers, C., Rodriguez-Moreno, D., Kalmar, K., Schiff, N., and Hirsch, 
J. (2009). Behavioral assessment in patients with disorders of consciousness: 
gold standard or fool’s gold? Prog. Brain Res. 177, 33–48. doi:10.1016/S0079-
6123(09)17704-X. 
Giacino, J. T., Sherer, M., Christoforou, A., Maurer-Karattup, P., Hammond, F. M., 
Long, D., et al. (2019). Behavioral Recovery and Early Decision Making in 
Patients with Prolonged Disturbance in Consciousness after Traumatic Brain 
Injury. J. Neurotrauma, neu.2019.6429. doi:10.1089/neu.2019.6429. 
Giacino, J. T., Whyte, J., Bagiella, E., Kalmar, K., Childs, N., Khademi, A., et al. (2012). 
Placebo-controlled trial of amantadine for severe traumatic brain injury. N. 
Engl. J. Med. 366, 819–826. doi:10.1056/NEJMoa1102609. 
Giacino, J. T., Zasler, N. D., Katz, D. I., Kelly, J. P., Rosenberg, J. H., and Filley, C. M. 
(1997). Development of practice guidelines for assessment and management 
of the vegetative and minimally conscious states. J. Head Trauma Rehabil. 12, 
79–89. 
Gill-Thwaites, H., and Munday, R. (1999). The Sensory Modality Assessment and 
Rehabilitation Technique (SMART): a comprehensive and integrated 
assessment and treatment protocol for the vegetative state and minimally 
responsive patient. Neuropsychol. Rehabil. 9, 305–320. 
doi:10.1080/096020199389392. 
Gill, J., Shah-Basak, P. P., and Hamilton, R. (2015). It’s the thought that counts: 
Examining the task-dependent effects of transcranial direct current 
stimulation on executive function. Brain Stimul. 8, 253–259. 
doi:10.1016/j.brs.2014.10.018. 
Giovannella, M., Ibañez, D., Gregori-Pla, C., Kacprzak, M., Mitjà, G., Ruffini, G., et al. 
(2018). Concurrent measurement of cerebral hemodynamics and 
electroencephalography during transcranial direct current stimulation. 
Neurophotonics 5, 1. doi:10.1117/1.NPh.5.1.015001. 
Gladson, B. (2010). Pharmacology for Rehabilitation Professionals. Elsevier Health 
Sciences. 
Golland, Y., Bentin, S., Gelbard, H., Benjamini, Y., Heller, R., Nir, Y., et al. (2007). 
Extrinsic and intrinsic systems in the posterior cortex of the human brain 
revealed during natural sensory stimulation. Cereb. Cortex 17, 766–77. 
doi:10.1093/cercor/bhk030. 
Gomez-Tames, J., Asai, A., and Hirata, A. (2020). Significant group-level hotspots 
found in deep brain regions during transcranial direct current stimulation 





Gosseries, O., Demertzi, A., Ledoux, D., Bruno, M.-A. M.-A., Vanhaudenhuyse, A., 
Thibaut, A., et al. (2012). Burnout in healthcare workers managing chronic 
patients with disorders of consciousness. Brain Inj. 26, 1493–1499. 
doi:10.3109/02699052.2012.695426. 
Gosseries, O., Di, H., Laureys, S., and Boly, M. (2014). Measuring Consciousness in 
Severely Damaged Brains. Annu. Rev. Neurosci. 37, 457–478. 
doi:10.1146/annurev-neuro-062012-170339. 
Gosseries, O., Schnakers, C., Ledoux, D., Vanhaudenhuyse, A., Bruno, M. A., 
Demertzi, A., et al. (2011). Automated EEG entropy measurements in coma, 
vegetative state/unresponsive wakefulness syndrome and minimally 
conscious state. Funct Neurol 26, 25–30.  
Gracies, J. M. (2005). Pathophysiology of spastic paresis. II: Emergence of muscle 
overactivity. Muscle Nerve 31, 552–571. doi:10.1002/mus.20285. 
Grillner, S., Hellgren, J., Ménard, A., Saitoh, K., and Wikström, M. A. (2005). 
Mechanisms for selection of basic motor programs – roles for the striatum 
and pallidum. Trends Neurosci. 28, 364–370. doi:10.1016/J.TINS.2005.05.004. 
Guldenmund, P., Soddu, A., Baquero, K., Vanhaudenhuyse, A., Bruno, M.-A., 
Gosseries, O., et al. (2016). Structural brain injury in patients with disorders of 
consciousness: A voxel-based morphometry study. Brain Inj. 30, 343–352. 
doi:10.3109/02699052.2015.1118765. 
Guo, Y., Bai, Y., Xia, X., Li, J., Wang, X., Dai, Y., et al. (2019). Effects of Long-Lasting 
High-Definition Transcranial Direct Current Stimulation in Chronic Disorders of 
Consciousness: A Pilot Study. Front. Neurosci. 13, 412. 
doi:10.3389/fnins.2019.00412. 
Harris, P. A., Taylor, R., Thielke, R., Payne, J., Gonzalez, N., and Conde, J. G. (2009). 
Research electronic data capture (REDCap)—A metadata-driven methodology 
and workflow process for providing translational research informatics support. 
J. Biomed. Inform. 42, 377–381. doi:10.1016/J.JBI.2008.08.010. 
Heekeren, H. R., Marrett, S., Ruff, D. A., Bandettini, P. A., and Ungerleider, L. G. 
(2006). Involvement of human left dorsolateral prefrontal cortex in perceptual 
decision making is independent of response modality. Proc Natl Acad Sci U S A 
103, 10023–10028. doi:10.1073/pnas.0603949103. 
Hermann, B., Goudard, G., Courcoux, K., Valente, M., Labat, S., Despois, L., et al. 
(2019). Wisdom of the caregivers: Pooling individual subjective reports to 
diagnose states of consciousness in brain-injured patients, a monocentric 
prospective study. BMJ Open 9. doi:10.1136/bmjopen-2018-026211. 
Herrold, A. A., Pape, T. L. B., Guernon, A., Mallinson, T., Collins, E., and Jordan, N. 
(2014). Prescribing multiple neurostimulants during rehabilitation for severe 
brain injury. Sci. World J. 2014. doi:10.1155/2014/964578. 
Herwig, U., Satrapi, P., and Schonfeldt-Lecuona, C. (2003). Using the international 10-




Topogr 16, 95–99.  
Huang, W., Wannez, S., Fregni, F., Hu, X., Jing, S., Martens, G., et al. (2017). Repeated 
stimulation of the posterior parietal cortex in patients in minimally conscious 
state: A sham-controlled randomized clinical trial. Brain Stimul. 10, 718–720. 
doi:10.1016/j.brs.2017.02.001. 
Huang, Y., and Parra, L. C. (2019). Can transcranial electric stimulation with multiple 
electrodes reach deep targets? Brain Stimul. 12, 30–40. 
doi:10.1016/j.brs.2018.09.010. 
Hyvärinen, P., Mäkitie, A., and Aarnisalo, A. A. (2016). Self-Administered Domiciliary 
tDCS Treatment for Tinnitus: A Double-Blind Sham-Controlled Study. PLoS One 
11, e0154286. doi:10.1371/journal.pone.0154286. 
Jennett, B., and Plum, F. (1972). Persistent vegetative state after brain damage. A 
syndrome in search of a name. Lancet 1, 734–737.  
Jones, A. P., Choe, J., Bryant, N. B., Robinson, C. S. H., Ketz, N. A., Skorheim, S. W., et 
al. (2018). Dose-dependent effects of closed-loop tACS delivered during slow-
wave oscillations on memory consolidation. Front. Neurosci. 12. 
doi:10.3389/fnins.2018.00867. 
Kampfl, A., Schmutzhard, E., Franz, G., Pfausler, B., Haring, H.-P., Ulmer, H., et al. 
(1998). Prediction of recovery from post-traumatic vegetative state with 
cerebral magnetic-resonance imaging. Lancet 351, 1763–1767. 
doi:10.1016/S0140-6736(97)10301-4. 
Katz, D. I., Polyak, M., Coughlan, D., Nichols, M., and Roche, A. (2009). Natural 
history of recovery from brain injury after prolonged disorders of 
consciousness: outcome of patients admitted to inpatient rehabilitation with 
1–4 year follow-up. Prog. Brain Res. 177, 73–88. 
Katz, R. T., Rovai, G. P., Brait, C., and Rymer, W. Z. (1992). Objective quantification of 
spastic hypertonia: correlation with clinical findings. Arch Phys Med Rehabil 
73, 339–347. 
Katzenschlager, R., Hughes, A., Evans, A., Manson, A. J., Hoffman, M., Swinn, L., et al. 
(2005). Continuous subcutaneous apomorphine therapy improves dyskinesias 
in Parkinson’s disease: A prospective study using single‐dose challenges. Mov. 
Disord. 20, 151–157. doi:10.1002/mds.20276. 
Ketz, N., Jones, A. P., Bryant, N. B., Clark, V. P., and Pilly, P. K. (2018). Closed-loop 
slow-wave tACS improves sleep-dependent long-term memory generalization 
by modulating endogenous oscillations. J. Neurosci. 38, 7314–7326. 
doi:10.1523/JNEUROSCI.0273-18.2018. 
Khedr, E. M., Gamal, N. F., El-Fetoh, N. A., Khalifa, H., Ahmed, E. M., Ali, A. M., et al. 
(2014). A double-blind randomized clinical trial on the efficacy of cortical 
direct current stimulation for the treatment of Alzheimer’s disease. Front 
Aging Neurosci 6, 275. doi:10.3389/fnagi.2014.00275. 




consciousness: progress and problems. Nat. Rev. Neurosci. 17. 
doi:10.1038/nrn.2016.22. 
Kolls, B. J., and Stacy, M. (2006). Apomorphine: A Rapid Rescue Agent for the 
Management of Motor Fluctuations in Advanced Parkinson Disease. Clin. 
Neuropharmacol. 29, 292–301. doi:10.1097/01.WNF.0000220824.57769.E5. 
Kondziella, D., Bender, A., Diserens, K., van Erp, W., Estraneo, A., Formisano, R., et al. 
(2020). European Academy of Neurology guideline on the diagnosis of coma 
and other disorders of consciousness. Eur. J. Neurol., ene.14151. 
doi:10.1111/ene.14151. 
Krewer, C., Luther, M., Koenig, E., and Müller, F. (2015). Tilt Table Therapies for 
Patients with Severe Disorders of Consciousness: A Randomized, Controlled 
Trial. PLoS One 10, e0143180. doi:10.1371/journal.pone.0143180. 
Krishnan, S., Pappadis, M. R., Weller, S. C., Stearnes, M., Kumar, A., Ottenbacher, K. 
J., et al. (2017). Needs of Stroke Survivors as Perceived by Their Caregivers: A 
Scoping Review. Am. J. Phys. Med. Rehabil. 96, 487–505. 
doi:10.1097/PHM.0000000000000717. 
Landsness, E., Bruno, M. A., Noirhomme, Q., Riedner, B., Gosseries, O., Schnakers, C., 
et al. (2011). Electrophysiological correlates of behavioural changes in 
vigilance in vegetative state and minimally conscious state. Brain 134, 2222–
2232. doi:10.1093/brain/awr152. 
Laureys, S. (2005). The neural correlate of (un)awareness: lessons from the 
vegetative state. Trends Cogn Sci 9, 556–559. doi:10.1016/j.tics.2005.10.010. 
Laureys, S., Celesia, G. G., Cohadon, F., Lavrijsen, J., Leon-Carrion, J., Sannita, W. G., 
et al. (2010). Unresponsive wakefulness syndrome: a new name for the 
vegetative state or apallic syndrome. BMC Med 8, 68. doi:10.1186/1741-7015-
8-68. 
Laureys, S., Faymonville, M. E., Luxen, A., Lamy, M., Franck, G., and Maquet, P. 
(2000). Restoration of thalamocortical connectivity after recovery from 
persistent vegetative state. Lancet 355, 1790–1791. 
Laureys, S., Faymonville, M. E., Peigneux, P., Damas, P., Lambermont, B., Del Fiore, 
G., et al. (2002). Cortical processing of noxious somatosensory stimuli in the 
persistent vegetative state. Neuroimage 17, 732–741.  
Laureys, S., Goldman, S., Phillips, C., Van Bogaert, P., Aerts, J., Luxen, A., et al. (1999). 
Impaired effective cortical connectivity in vegetative state: preliminary 
investigation using PET. Neuroimage 9, 377–382. 
doi:10.1006/nimg.1998.0414. 
Laureys, S., Owen, A. M., and Schiff, N. D. (2004). Brain function in coma, vegetative 
state, and related disorders. Lancet Neurol 3, 537–546. doi:10.1016/S1474-
4422(04)00852-X. 
Laureys, S., and Schiff, N. D. (2012). Coma and consciousness: Paradigms (re)framed 





Lefaucheur, J. P. (2016). A comprehensive database of published tDCS clinical trials 
(2005–2016). Neurophysiol. Clin. 46, 319–398. 
doi:10.1016/j.neucli.2016.10.002. 
Lefebvre, S., Dricot, L., Laloux, P., Desfontaines, P., Evrard, F., Peeters, A., et al. 
(2017). Increased functional connectivity one week after motor learning and 
tDCS in stroke patients. Neuroscience 340, 424–435. 
doi:10.1016/j.neuroscience.2016.10.066. 
Lehembre, R., Bruno, M. A., Vanhaudenhuyse, A., Chatelle, C., Cologan, V., Leclercq, 
Y., et al. (2012). Resting-state EEG study of comatose patients: a connectivity 
and frequency analysis to find differences between vegetative and minimally 
conscious states. Funct Neurol 27, 41–47.  
Leite, J., Morales-Quezada, L., Carvalho, S., Thibaut, A., Doruk, D., Chen, C.-F., et al. 
(2017). Surface EEG-Transcranial Direct Current Stimulation (tDCS) Closed-
Loop System. Int. J. Neural Syst., 1750026. doi:10.1142/S0129065717500265. 
Lempel, A., and Ziv, J. (1976). On the complexity of finite sequences. IEEE Trans. Inf. 
theory 22, 75–81. 
Leuchter, A. F., Cook, I. A., Feifel, D., Goethe, J. W., Husain, M., Carpenter, L. L., et al. 
(2015). Efficacy and safety of low-field synchronized transcranial magnetic 
stimulation (sTMS) for treatment of major depression. Brain Stimul. 8, 787–
794. doi:10.1016/j.brs.2015.05.005. 
Li, D., and Mashour, G. A. (2019). Cortical dynamics during psychedelic and 
anesthetized states induced by ketamine. Neuroimage 196, 32–40. 
doi:10.1016/j.neuroimage.2019.03.076. 
Li, Y., Tong, S., Liu, D., Gai, Y., Wang, X., Wang, J., et al. (2008). Abnormal EEG 
complexity in patients with schizophrenia and depression. Clin. Neurophysiol. 
119, 1232–1241. 
Liebetanz, D., Nitsche, M. A., Tergau, F., and Paulus, W. (2002). Pharmacological 
approach to the mechanisms of transcranial DC-stimulation-induced after-
effects of human motor cortex excitability. Brain 125, 2238–2247.  
Lisman, J. E. (2001). Three Ca 
2+
 levels affect plasticity differently: the LTP zone, the 
LTD zone and no man’s land. J. Physiol. 532, 285–285. doi:10.1111/j.1469-
7793.2001.0285f.x. 
Liu, P., Gao, J., Pan, S., Meng, F., Pan, G., Li, J., et al. (2016a). Effects of High-
Frequency Repetitive Transcranial Magnetic Stimulation on Cerebral 
Hemodynamics in Patients with Disorders of Consciousness: A Sham-
Controlled Study. Eur. Neurol. 76, 1–7. doi:10.1159/000447325. 
Liu, P., Gao, J., Pan, S., Meng, F., Pan, G., Li, J., et al. (2016b). Effects of High-
Frequency Repetitive Transcranial Magnetic Stimulation on Cerebral 
Hemodynamics in Patients with Disorders of Consciousness: A Sham-




Locke, J. (1841). An essay concerning human understanding. 
López-Alonso, V., Fernández-Del-Olmo, M., Costantini, A., Gonzalez-Henriquez, J. J., 
and Cheeran, B. (2015). Intra-individual variability in the response to anodal 
transcranial direct current stimulation. Clin. Neurophysiol. 126, 2342–7. 
doi:10.1016/j.clinph.2015.03.022. 
Løvstad, M., Andelic, N., Knoph, R., Jerstad, T., Anke, A., Skandsen, T., et al. (2014). 
Rate of Disorders of Consciousness in a Prospective Population-Based Study of 
Adults With Traumatic Brain Injury. J. Head Trauma Rehabil. 29, E31–E43. 
doi:10.1097/HTR.0000000000000017. 
Luaute, J., Maucort-Boulch, D., Tell, L., Quelard, F., Sarraf, T., Iwaz, J., et al. (2010). 
Long-term outcomes of chronic minimally conscious and vegetative states. 
Neurology 75, 246–252. doi:10.1212/WNL.0b013e3181e8e8df. 
Lugo, Z., Pellas, F., Blandin, V., Laureys, S., and Gosseries, O. (2017). Assessment of 
needs, psychological impact and quality of life in families of patients with 
locked-in syndrome. Brain Inj. 31, 1590–1596. 
doi:10.1080/02699052.2017.1347277. 
Lustenberger, C., Boyle, M. R., Alagapan, S., Mellin, J. M., Vaughn, B. V., and Fröhlich, 
F. (2016). Feedback-Controlled Transcranial Alternating Current Stimulation 
Reveals a Functional Role of Sleep Spindles in Motor Memory Consolidation. 
Curr. Biol. 26, 2127–2136. doi:10.1016/j.cub.2016.06.044. 
Magrassi, L., Maggioni, G., Pistarini, C., Di Perri, C., Bastianello, S., Zippo, A. G., et al. 
(2016). Results of a prospective study (CATS) on the effects of thalamic 
stimulation in minimally conscious and vegetative state patients. J. Neurosurg. 
125, 972–981. doi:10.3171/2015.7.JNS15700. 
Majerus, S., Bruno, M. A., Schnakers, C., Giacino, J. T., and Laureys, S. (2009). The 
problem of aphasia in the assessment of consciousness in brain-damaged 
patients. Prog Brain Res 177, 49–61. doi:10.1016/S0079-6123(09)17705-1. 
Marangolo, P., Fiori, V., Calpagnano, M. A., Campana, S., Razzano, C., Caltagirone, C., 
et al. (2013). tDCS over the left inferior frontal cortex improves speech 
production in aphasia. Front Hum Neurosci 7, 539. 
doi:10.3389/fnhum.2013.00539. 
Margetis, K., Korfias, S. I., Gatzonis, S., Boutos, N., Stranjalis, G., Boviatsis, E., et al. 
(2014). Intrathecal baclofen associated with improvement of consciousness 
disorders in spasticity patients. Neuromodulation 17, 699–704. 
doi:10.1111/ner.12147. 
Martens, G., Barra, A., and Thibaut, A. (2019a). Neuromodulation for patients with 
disorders of consciousness following severe brain injury: a systematic review. 
PROSPERO CRD42019122420.  
Martens, G., Bodien, Y., Sheau, K., Christoforou, A., and Giacino, J. T. (2019b). Which 
behaviours are first to emerge during recovery of consciousness after severe 




Martens, G., Deltombe, T., Foidart-Dessalle, M., Laureys, S., and Thibaut, A. (2019c). 
Clinical and electrophysiological investigation of spastic muscle overactivity in 
patients with disorders of consciousness following severe brain injury. Clin. 
Neurophysiol. 130, 207–213. doi:10.1016/J.CLINPH.2018.10.021. 
Martens, G., Foidart-Dessalle, M., Laureys, S., and Thibaut, A. (2018a). “How Does 
Spasticity Affect Patients with Disorders of Consciousness?,” in Coma and 
Disorders of Consciousness, eds. C. Schnakers and S. Laureys (Cham: Springer 
International Publishing), 119–135. doi:10.1007/978-3-319-55964-3_7. 
Martens, G., Fregni, F., Carrière, M., Barra, A., Laureys, S., and Thibaut, A. (2019d). 
Single tDCS session of motor cortex in patients with disorders of 
consciousness: a pilot study. Brain Inj., 1–5. 
doi:10.1080/02699052.2019.1667537. 
Martens, G., Laureys, S., and Thibaut, A. (2017). Spasticity management in disorders 
of consciousness. Brain Sci. 7, 162. doi:10.3390/brainsci7120162. 
Martens, G., Lejeune, N., O’Brien, A. T., Fregni, F., Martial, C., Wannez, S., et al. 
(2018b). Randomized controlled trial of home-based 4-week tDCS in chronic 
minimally conscious state. Brain Stimul. 11, 982–990. 
doi:10.1016/J.BRS.2018.04.021. 
Mateos, D. M., Guevara Erra, R., Wennberg, R., and Perez Velazquez, J. L. (2018). 
Measures of entropy and complexity in altered states of consciousness. Cogn. 
Neurodyn. 12, 73–84. doi:10.1007/s11571-017-9459-8. 
Matsumoto-Miyazaki, J., Asano, Y., Ikegame, Y., Kawasaki, T., Nomura, Y., and 
Shinoda, J. (2016). Acupuncture Reduces Excitability of Spinal Motor Neurons 
in Patients with Spastic Muscle Overactivity and Chronic Disorder of 
Consciousness Following Traumatic Brain Injury. J. Altern. Complement. Med. 
22, 895–902. doi:10.1089/acm.2016.0180. 
Méndez, M. A., Zuluaga, P., Hornero, R., Gómez, C., Escudero, J., Rodríguez-Palancas, 
A., et al. (2012). Complexity analysis of spontaneous brain activity: effects of 
depression and antidepressant treatment. J. Psychopharmacol. 26, 636–643. 
Miranda, P. C., Lomarev, M., and Hallett, M. (2006). Modeling the current 
distribution during transcranial direct current stimulation. Clin Neurophysiol 
117, 1623–1629. doi:10.1016/j.clinph.2006.04.009. 
Monai, H., and Hirase, H. (2018). Astrocytes as a target of transcranial direct current 
stimulation (tDCS) to treat depression. Neurosci. Res. 126, 15–21. 
doi:10.1016/j.neures.2017.08.012. 
Monai, H., Ohkura, M., Tanaka, M., Oe, Y., Konno, A., Hirai, H., et al. (2016). Calcium 
imaging reveals glial involvement in transcranial direct current stimulation-
induced plasticity in mouse brain. Nat. Commun. 7, 11100. 
doi:10.1038/ncomms11100. 
Monti, M. M., Schnakers, C., Korb, A. S., Bystritsky, A., and Vespa, P. M. (2016). Non-




Severe Brain Injury: A First-in-Man Report. Brain Stimul. 9, 940–941. 
doi:10.1016/j.brs.2016.07.008. 
Monti, M. M., Vanhaudenhuyse, A., Coleman, M. R., Boly, M., Pickard, J. D., 
Tshibanda, L., et al. (2010). Willful modulation of brain activity in disorders of 
consciousness. N Engl J Med 362, 579–589. doi:10.1056/NEJMoa0905370. 
Murase, N., Duque, J., Mazzocchio, R., and Cohen, L. G. (2004). Influence of 
interhemispheric interactions on motor function in chronic stroke. Ann. 
Neurol. 55, 400–409. doi:10.1002/ana.10848. 
Naccache, L. (2018). Minimally conscious state or cortically mediated state? Brain 
141, 949–960. doi:10.1093/brain/awx324. 
Nair, D. G., Renga, V., Lindenberg, R., Zhu, L., and Schlaug, G. (2011). Optimizing 
recovery potential through simultaneous occupational therapy and non-
invasive brain-stimulation using tDCS. Restor Neurol Neurosci 29, 411–420. 
doi:10.3233/RNN-2011-0612. 
Najenson, T., Sazbon, L., Fiselzon, J., Becker, E., and Schechter, I. (1978). Recovery of 
communicative functions after prolonged traumatic coma. Scand. J. Rehabil. 
Med. 10, 15–21. 
Nakase-Richardson, R., McNamee, S., Howe, L. L., Massengale, J., Peterson, M., 
Barnett, S. D., et al. (2013). Descriptive characteristics and rehabilitation 
outcomes in active duty military personnel and veterans with disorders of 
consciousness with combat- and noncombat-related brain injury. Arch. Phys. 
Med. Rehabil. 94, 1861–1869. doi:10.1016/j.apmr.2013.05.027. 
Nakase-Richardson, R., Yablon, S. A., Sherer, M., Nick, T. G., and Evans, C. C. (2009). 
Emergence from minimally conscious state: Insights from evaluation of 
posttraumatic confusion. Neurology 73, 1120–1126. 
doi:10.1212/WNL.0b013e3181bacf34. 
Nakayama, N., Okumura, A., Shinoda, J., Nakashima, T., and Iwama, T. (2006). 
Relationship between regional cerebral metabolism and consciousness 
disturbance in traumatic diffuse brain injury without large focal lesions: an 
FDG-PET study with statistical parametric mapping analysis. J Neurol 
Neurosurg Psychiatry 77, 856–862. doi:10.1136/jnnp.2005.080523. 
Naro, A., Calabro, R. S., Russo, M., Leo, A., Pollicino, P., Quartarone, A., et al. (2015). 
Can transcranial direct current stimulation be useful in differentiating 
unresponsive wakefulness syndrome from minimally conscious state patients? 
- PubMed - NCBI. Restor Neurol Neurosci 33, 159–176.  
Newcombe, V., Chatfield, D., Outtrim, J., Vowler, S., Manktelow, A., Cross, J., et al. 
(2011). Mapping traumatic axonal injury using diffusion tensor imaging: 
Correlations with functional outcome. PLoS One 6. 
doi:10.1371/journal.pone.0019214. 
Nitsche, M. A., Fricke, K., Henschke, U., Schlitterlau, A., Liebetanz, D., Lang, N., et al. 




transcranial direct current stimulation in humans. J Physiol 553, 293–301. 
doi:10.1113/jphysiol.2003.049916. 
Nitsche, M. A., Jaussi, W., Liebetanz, D., Lang, N., Tergau, F., and Paulus, W. (2004). 
Consolidation of human motor cortical neuroplasticity by D-cycloserine. 
Neuropsychopharmacology 29, 1573–1578. doi:10.1038/sj.npp.1300517. 
Nitsche, M. A., Liebetanz, D., Lang, N., Antal, A., Tergau, F., and Paulus, W. (2003b). 
Safety criteria for transcranial direct current stimulation (tDCS) in humans. Clin 
Neurophysiol 114, 2220–2223.  
Nitsche, M. A., and Paulus, W. (2001). Sustained excitability elevations induced by 
transcranial DC motor cortex stimulation in humans. Neurology 57, 1899–901. 
doi:10.1212/WNL.57.10.1899. 
Noé, E., Ferri, J., Colomer, C., Moliner, B., O’Valle, M., Ugart, P., et al. (2019). 
Feasibility, safety and efficacy of transauricular vagus nerve stimulation in a 
cohort of patients with disorders of consciousness. Brain Stimul. 
doi:10.1016/j.brs.2019.12.005. 
Noé, E., Olaya, J., Navarro, M. D., Noguera, P., Colomer, C., García-Panach, J., et al. 
(2012). Behavioral recovery in disorders of consciousness: A prospective study 
with the Spanish version of the coma recovery scale-revised. Arch. Phys. Med. 
Rehabil. 93, 428-433.e12. doi:10.1016/j.apmr.2011.08.048. 
Ohn, S. H., Park, C. I., Yoo, W. K., Ko, M. H., Choi, K. P., Kim, G. M., et al. (2008). Time-
dependent effect of transcranial direct current stimulation on the 
enhancement of working memory. Neuroreport 19, 43–47. 
doi:10.1097/WNR.0b013e3282f2adfd. 
Palanca, B. J. A., Mashour, G. A., and Avidan, M. S. (2009). Processed 
electroencephalogram in depth of anesthesia monitoring. Curr. Opin. 
Anaesthesiol. 22, 553–559. doi:10.1097/ACO.0b013e3283304032. 
Palm, U., Kumpf, U., Behler, N., Wulf, L., Kirsch, B., Wörsching, J., et al. (2018). Home 
Use, Remotely Supervised, and Remotely Controlled Transcranial Direct 
Current Stimulation: A Systematic Review of the Available Evidence. 
Neuromodulation Technol. Neural Interface 21, 323–333. 
doi:10.1111/ner.12686. 
Palm, U., Reisinger, E., Keeser, D., Kuo, M.-F., Pogarell, O., Leicht, G., et al. (2013). 
Evaluation of Sham Transcranial Direct Current Stimulation for Randomized, 
Placebo-Controlled Clinical Trials. Brain Stimul. 6, 690–695. 
doi:10.1016/J.BRS.2013.01.005. 
Pandyan, A. D., Gregoric, M., and Barnes, M. P. (2005). Spasticity: clinical 
perceptions, neurological realities and meaningful measurement. Disabil 
Rehabil 27, 2–6. 
Pape, T. L.-B., Heinemann, A. W., Kelly, J. P., Hurder, A. G., and Lundgren, S. (2005). A 
measure of neurobehavioral functioning after coma. Part I: Theory, reliability, 





Peeters, M., Page, G., Maloteaux, J.-M., and Hermans, E. (2002). Hypersensitivity of 
dopamine transmission in the rat striatum after treatment with the NMDA 
receptor antagonist amantadine. Brain Res. 949, 32–41. doi:10.1016/S0006-
8993(02)02961-X. 
Piarulli, A., Bergamasco, M., Thibaut, A., Cologan, V., Gosseries, O., and Laureys, S. 
(2016). EEG ultradian rhythmicity differences in disorders of consciousness 
during wakefulness. J. Neurol. 263, 1746–1760. doi:10.1007/s00415-016-
8196-y. 
Pisani, L. R., Naro, A., Leo, A., Aricò, I., Pisani, F., Silvestri, R., et al. (2015a). Repetitive 
transcranial magnetic stimulation induced slow wave activity modification: A 
possible role in disorder of consciousness differential diagnosis? Conscious. 
Cogn. 38, 1–8. doi:10.1016/J.CONCOG.2015.09.012. 
Pisani, L. R., Naro, A., Leo, A., Aricò, I., Pisani, F., Silvestri, R., et al. (2015b). Repetitive 
transcranial magnetic stimulation induced slow wave activity modification: A 
possible role in disorder of consciousness differential diagnosis? Conscious. 
Cogn. 38, 1–8. doi:10.1016/J.CONCOG.2015.09.012. 
Pistoia, F., Sacco, S., Sarà, M., Franceschini, M., and Carolei, A. (2015). Intrathecal 
Baclofen: Effects on Spasticity, Pain, and Consciousness in Disorders of 
Consciousness and Locked-in Syndrome. Curr. Pain Headache Rep. 19. 
doi:10.1007/s11916-014-0466-8. 
Plum, F., and Posner, J. B. (1972). The diagnosis of stupor and coma. Contemp Neurol 
Ser 10, 1–286.  
Polanía, R., Paulus, W., Antal, A., and Nitsche, M. A. (2011). Introducing graph theory 
to track for neuroplastic alterations in the resting human brain: A transcranial 
direct current stimulation study. Neuroimage 54, 2287–2296. 
doi:10.1016/j.neuroimage.2010.09.085. 
Purpura, D. P., and McMurtry, J. G. (1965). Intracellular activities and evoked 
potential changes during polarization of motor cortex. J. Neurophysiol. 28, 
166–185. doi:10.1152/jn.1965.28.1.166. 
R Core Team (2008). R: A language and environment for statistical computing. R 
Foundation for Statistical Computing, Vienna, Austria. 
Raine, T. R., Harper, C. C., Rocca, C. H., Fischer, R., Padian, N., Klausner, J. D., et al. 
(2005). Direct access to emergency contraception through pharmacies and 
effect on unintended pregnancy and STIs: A randomized controlled trial. J. Am. 
Med. Assoc. 293, 54–62. doi:10.1001/jama.293.1.54. 
Rémi, J., Pfefferkorn, T., Owens, R. L., Schankin, C., Dehning, S., Birnbaum, T., et al. 
(2011). The crossed leg sign indicates a favorable outcome after severe stroke. 
Neurology 77, 1453–6. doi:10.1212/WNL.0b013e318232abe4. 
Richard, I., and Menei, P. (2007). Intrathecal baclofen in the treatment of adult 




Robinson, C. S. H., Bryant, N. B., Maxwell, J. W., Jones, A. P., Robert, B., Lamphere, 
M., et al. (2018). The benefits of closed-loop transcranial alternating current 
stimulation on subjective sleep quality. Brain Sci. 8. 
doi:10.3390/brainsci8120204. 
Rosanova, M., Gosseries, O., Casarotto, S., Boly, M., Casali, A. G., Bruno, M. A., et al. 
(2012). Recovery of cortical effective connectivity and recovery of 
consciousness in vegetative patients. Brain 135, 1308–1320. 
doi:10.1093/brain/awr340. 
Ruffini, G. (2017). An algorithmic information theory of consciousness. Neurosci. 
Conscious. 3. 
Ruffini, G., Fox, M. D., Ripolles, O., Miranda, P. C., and Pascual-Leone, A. (2014). 
Optimization of multifocal transcranial current stimulation for weighted 
cortical pattern targeting from realistic modeling of electric fields. 
Neuroimage 89, 216–225. doi:10.1016/j.neuroimage.2013.12.002. 
Russo, C., Souza Carneiro, M., Bolognini, N., and Fregni, F. (2017). Safety Review of 
Transcranial Direct Current Stimulation in Stroke. Neuromodulation 20, 21–
222. 
Sacco, K., Galetto, V., Dimitri, D., Geda, E., Perotti, F., Zettin, M., et al. (2016). 
Concomitant Use of Transcranial Direct Current Stimulation and Computer-
Assisted Training for the Rehabilitation of Attention in Traumatic Brain Injured 
Patients: Behavioral and Neuroimaging Results. Front. Behav. Neurosci. 10, 57. 
doi:10.3389/fnbeh.2016.00057. 
Sanz, L., Lejeune, N., Thibaut, A., Blandiaux, S., Stender, J., Farber, N., et al. (2018). 
Treating severely brain-injured patients with apomorphine: study protocol for 
a double blind randomized placebo-controlled trial using behavioral and 
neuroimaging assessments. Front. Neurosci. 12. 
doi:10.3389/conf.fnins.2018.95.00065. 
Sara, M., Sacco, S., Cipolla, F., Onorati, P., Scoppetta, C., Albertini, G., et al. (2007). 
An unexpected recovery from permanent vegetative state. Brain Inj 21, 101–
103. doi:10.1080/02699050601151761. 
Schartner, M. M., Pigorini, A., Gibbs, S. A., Arnulfo, G., Sarasso, S., Barnett, L., et al. 
(2017). Global and local complexity of intracranial EEG decreases during NREM 
sleep. Neurosci. Conscious., niw022. doi:10.1093/nc/niw022. 
Schartner, M., Seth, A., Noirhomme, Q., Boly, M., Bruno, M.-A., Laureys, S., et al. 
(2015). Complexity of multi-dimensional spontaneous EEG decreases during 
propofol induced general anaesthesia. PLoS One 10, e0133532. 
Schiff, N. D. (2005). Modeling the minimally conscious state: measurements of brain 
function and therapeutic possibilities. Prog Brain Res 150, 473–493. 
doi:10.1016/S0079-6123(05)50033-5. 
Schiff, N. D. (2010). Recovery of consciousness after brain injury: a mesocircuit 




Schiff, N. D., Giacino, J. T., Kalmar, K., Victor, J. D., Baker, K., Gerber, M., et al. (2007). 
Behavioural improvements with thalamic stimulation after severe traumatic 
brain injury. Nature 448, 600–603. doi:10.1038/nature06041. 
Schlaug, G., Renga, V., and Nair, D. (2008). Transcranial Direct Current Stimulation in 
Stroke Recovery. Arch. Neurol. 65, 1571–1576. 
doi:10.1001/archneur.65.12.1571. 
Schleicher, R., Galley, N., Briest, S., and Galley, L. (2008). Blinks and saccades as 
indicators of fatigue in sleepiness warnings: looking tired? Ergonomics 51, 
982–1010. doi:10.1080/00140130701817062. 
Schnakers, C., Chatelle, C., Demertzi, A., Majerus, S., and Laureys, S. (2012). What 
about Pain in Disorders of Consciousness? AAPS J 14, 437–444. 
doi:10.1208/s12248-012-9346-5. 
Schnakers, C., Edlow, B. L., Chatelle, C., and Giacino, J. T. (2015). “Minimally 
Conscious State,” in The Neurology of Consciousness, eds. S. Laureys, O. 
Gosseries, and G. Tononi (Academic Press), 488. 
Schnakers, C., Giacino, J. T., Lovstad, M., Habbal, D., Boly, M., Di, H., et al. (2014). 
Preserved Covert Cognition in Noncommunicative Patients With Severe Brain 
Injury? Neurorehabil Neural Repair. doi:10.1177/1545968314547767. 
Schnakers, C., Hustinx, R., Vandewalle, G., Majerus, S., Moonen, G., Boly, M., et al. 
(2008). Measuring the effect of amantadine in chronic anoxic minimally 
conscious state. J Neurol Neurosurg Psychiatry 79, 225–227. 
doi:10.1136/jnnp.2007.124099. 
Schnakers, C., Vanhaudenhuyse, A., Giacino, J., Ventura, M., Boly, M., Majerus, S., et 
al. (2009). Diagnostic accuracy of the vegetative and minimally conscious 
state: clinical consensus versus standardized neurobehavioral assessment. 
BMC Neurol 9, 35. doi:10.1186/1471-2377-9-35. 
Seel, R. T., Sherer, M., Whyte, J., Katz, D. I., Giacino, J. T., Rosenbaum, A. M., et al. 
(2010). Assessment Scales for Disorders of Consciousness: Evidence-Based 
Recommendations for Clinical Practice and Research. Arch. Phys. Med. 
Rehabil. 91, 1795–1813. doi:10.1016/j.apmr.2010.07.218. 
Sheean, G. (2002). The pathophysiology of spasticity. Eur J Neurol 9 Suppl 1, 3–61.  
Sherer, M., Nakase-Thompson, R., Yablon, S. A., and Gontkovsky, S. T. (2005). 
Multidimensional Assessment of Acute Confusion After Traumatic Brain Injury. 
Arch. Phys. Med. Rehabil. 86, 896–904. doi:10.1016/j.apmr.2004.09.029. 
Shiel, A., Horn, S. A., Wilson, B. A., Watson, M. J., Campbell, M. J., and McLellan, D. L. 
(2000). The Wessex Head Injury Matrix (WHIM) main scale: a preliminary 
report on a scale to assess and monitor patient recovery after severe head 
injury. Clin Rehabil 14, 408–416.  
Shrestha, P., Malla, H., Pant, B., and Taira, T. (2011). Intrathecal baclofen therapy in 
severe head injury, first time in Nepal, a technique suitable for 





Silva, S., Alacoque, X., Fourcade, O., Samii, K., Marque, P., Woods, R., et al. (2010). 
Wakefulness and loss of awareness: brain and brainstem interaction in the 
vegetative state. Neurology 74, 313–320. 
doi:10.1212/WNL.0b013e3181cbcd96. 
Simis, M., Bravo, G. L., Boggio, P. S., Devido, M., Gagliardi, R. J., and Fregni, F. (2014). 
Transcranial Direct Current Stimulation in de novo Artistic Ability After Stroke. 
Neuromodulation Technol. Neural Interface 17, 497–501. 
doi:10.1111/ner.12140. 
Stagg, C. J., Antal, A., and Nitsche, M. A. (2018). Physiology of Transcranial Direct 
Current Stimulation. J. ECT 34, 144–152. doi:10.1097/YCT.0000000000000510. 
Stagg, C. J., and Nitsche, M. A. (2011). Physiological basis of transcranial direct 
current stimulation. Neuroscientist 17, 37–53. 
doi:10.1177/1073858410386614. 
Stender, J., Gosseries, O., Bruno, M.-A., Charland-Verville, V., Vanhaudenhuyse, A., 
Demertzi, A., et al. (2014). Diagnostic precision of PET imaging and functional 
MRI in disorders of consciousness: a clinical validation study. Lancet 6736, 8–
16. doi:10.1016/S0140-6736(14)60042-8. 
Straudi, S., Bonsangue, V., Mele, S., Craighero, L., Montis, A., Fregni, F., et al. (2019). 
Bilateral M1 anodal transcranial direct current stimulation in post traumatic 
chronic minimally conscious state: a pilot EEG-tDCS study. Brain Inj., 1–6. 
doi:10.1080/02699052.2019.1565894. 
Sturm, W., and Willmes, K. (2001). On the functional neuroanatomy of intrinsic and 
phasic alertness. in NeuroImage (Academic Press Inc.), S76–S84. 
doi:10.1006/nimg.2001.0839. 
Sun, Y., Wang, J., Heine, L., Huang, W., Wang, J., Hu, N., et al. (2018). Personalized 
objects can optimize the diagnosis of EMCS in the assessment of functional 
object use in the CRS-R: a double blind, randomized clinical trial. BMC Neurol. 
18, 38. doi:10.1186/s12883-018-1040-5. 
Teasdale, G., and Jennett, B. (1974). Assessment of Coma and Impaired 
Consciousness. Lancet 304, 81–84. doi:10.1016/S0140-6736(74)91639-0. 
The Multi-Society Task Force on PVS (1994a). Medical aspects of the persistent 
vegetative state (1). N Engl J Med 330, 1499–1508. 
doi:10.1056/NEJM199405263302107. 
The Multi-Society Task Force on PVS (1994b). Medical aspects of the persistent 
vegetative state (2). N Engl J Med 330, 1572–1579. 
doi:10.1056/NEJM199406023302206. 
Thibaut, A., Bruno, M.-A., Ledoux, D., Demertzi, A., and Laureys, S. (2014). tDCS in 
patients with disorders of consciousness Sham-controlled randomized double-
blind study. Neurology 82, 1112–1118. doi:10.1212/WNL.0000000000000260. 




al. (2018a). Transcranial direct current stimulation unveils covert 
consciousness. Brain Stimul. 11, 642–644. doi:10.1016/j.brs.2018.02.002. 
Thibaut, A., Chatelle, C., Wannez, S., Deltombe, T., Stender, J., Schnakers, C., et al. 
(2015a). Spasticity in disorders of consciousness: A behavioral study. Eur J 
Phys Rehabil Med 51, 289–397. 
Thibaut, A., Chatelle, C., Ziegler, E., Bruno, M.-A., Laureys, S., and Gosseries, O. 
(2013). Spasticity after stroke: physiology, assessment and treatment. Brain 
Inj. 27, 1093–1105. doi:10.3109/02699052.2013.804202. 
Thibaut, A., Chennu, S., Chatelle, C., Martens, G., Annen, J., Cassol, H., et al. (2018b). 
Theta network centrality correlates with tDCS response in disorders of 
consciousness. Brain Stimul. 11, 1407–1409. doi:10.1016/j.brs.2018.09.002. 
Thibaut, A., Deltombe, T., Wannez, S., Gosseries, O., Ziegler, E., Dieni, C., et al. 
(2015b). Impact of soft splints on upper limb spasticity in chronic patients with 
disorders of consciousness: A randomized, single-blind, controlled trial. Brain 
Inj. 29, 830–836. doi:10.3109/02699052.2015.1005132. 
Thibaut, A., Di Perri, C., Chatelle, C., Bruno, M.-A., Bahri, M. A., Wannez, S., et al. 
(2015c). Clinical response to tDCS depends on residual brain metabolism and 
grey matter integrity in patients with minimally conscious state. Brain Stimul. 
8, 1116–1123. doi:10.1016/j.brs.2015.07.024. 
Thibaut, A., O’Brien, A. T., and Fregni, F. (2017a). Strategies for replacing non-
invasive brain stimulation sessions: recommendations for designing 
neurostimulation clinical trials. Expert Rev. Med. Devices 14, 633–649. 
doi:10.1080/17434440.2017.1352470. 
Thibaut, A., Piarulli, A., Martens, G., Chatelle, C., and Laureys, S. (2019a). Effect of 
multichannel transcranial direct current stimulation to reduce hypertonia in 
individuals with prolonged disorders of consciousness: A randomized 
controlled pilot study. Ann. Phys. Rehabil. Med. 
doi:10.1016/J.REHAB.2019.05.009. 
Thibaut, A., Schiff, N., Giacino, J., Laureys, S., and Gosseries, O. (2019b). Therapeutic 
interventions in patients with prolonged disorders of consciousness. Lancet 
Neurol. 18, 600–614. doi:10.1016/S1474-4422(19)30031-6. 
Thibaut, A., Wannez, S., Donneau, A.-F., Chatelle, C., Gosseries, O., Bruno, M.-A., et 
al. (2017b). Controlled clinical trial of repeated prefrontal tDCS in patients 
with chronic minimally conscious state. Brain Inj. 31, 1–9. 
doi:10.1080/02699052.2016.1274776. 
Thonnard, M., Gosseries, O., Demertzi, A., Lugo, Z., Vanhaudenhuyse, A., Bruno, M.-
A. A., et al. (2014). Effect of zolpidem in chronic disorders of consciousness: A 
prospective open-label study. Funct Neurol 28, 259–264.  
Threlkeld, Z. D., Bodien, Y. G., Rosenthal, E. S., Giacino, J. T., Nieto-Castanon, A., Wu, 
O., et al. (2018). Functional networks reemerge during recovery 





Tononi, G., and Edelman, G. M. (1998). Consciousness and complexity. Science (80-. 
). 282, 1846–1851.  
Turgeon, A. F., Lauzier, F., Simard, J.-F., Scales, D. C., Burns, K. E. A., Moore, L., et al. 
(2011). Mortality associated with withdrawal of life-sustaining therapy for 
patients with severe traumatic brain injury: a Canadian multicentre cohort 
study. CMAJ 183, 1581–8. doi:10.1503/cmaj.101786. 
Ulam, F., Shelton, C., Richards, L., Davis, L., Hunter, B., Fregni, F., et al. (2014). 
Cumulative effects of transcranial direct current stimulation on EEG 
oscillations and attention/working memory during subacute 
neurorehabilitation of traumatic brain injury. Clin Neurophysiol 126, 486–496. 
doi:10.1016/j.clinph.2014.05.015. 
Valle, A., Roizenblatt, S., Botte, S., Zaghi, S., Riberto, M., Tufik, M., et al. (2009). 
Efficacy of anodal transcranial direct current stimulation (tDCS) for the 
treatment of fibromyalgia: results of a randomized, sham controlled 
longitudinal clinical trial. J Pain Manag 2, 353–361. 
van Erp, W. S., Lavrijsen, J. C. M., van de Laar, F. A., Vos, P. E., Laureys, S., and 
Koopmans, R. T. C. M. (2014). The vegetative state/unresponsive wakefulness 
syndrome: a systematic review of prevalence studies. Eur. J. Neurol. 21, 1361–
1368. doi:10.1111/ene.12483. 
Vanhaudenhuyse, A., Demertzi, A., Schabus, M., Noirhomme, Q., Bredart, S., Boly, 
M., et al. (2011). Two distinct neuronal networks mediate the awareness of 
environment and of self. J Cogn Neurosci 23, 570–578. 
doi:10.1162/jocn.2010.21488. 
Vanhaudenhuyse, A., Noirhomme, Q., Tshibanda, L. J., Bruno, M. A., Boveroux, P., 
Schnakers, C., et al. (2010). Default network connectivity reflects the level of 
consciousness in non-communicative brain-damaged patients. Brain 133, 161–
171. doi:10.1093/brain/awp313. 
Vanhaudenhuyse, A., Schnakers, C., Bredart, S., and Laureys, S. (2008). Assessment 
of visual pursuit in post-comatose states: use a mirror. J Neurol Neurosurg 
Psychiatry 79, 223. doi:10.1136/jnnp.2007.121624. 
Voss, H. U., Uluc, A. M., Dyke, J. P., Watts, R., Kobylarz, E. J., McCandliss, B. D., et al. 
(2006). Possible axonal regrowth in late recovery from the minimally 
conscious state. J Clin Invest 116, 2005–2011. doi:10.1172/JCI27021. 
Wallace, T., and Bradshaw, A. (2011). Technologies and strategies for people with 
communication problems following brain injury or stroke. NeuroRehabilitation 
28, 199–209. doi:10.3233/NRE-2011-0649. 
Wannez, S., Gosseries, O., Azzolini, D., Martial, C., Cassol, H., Aubinet, C., et al. 
(2017a). Prevalence of coma-recovery scale-revised signs of consciousness in 





Wannez, S., Heine, L., Thonnard, M., Gosseries, O., and Laureys, S. (2017b). The 
repetition of behavioral assessments in disorders of consciousness. Ann. 
Neurol. 81, 883–889. 
Wannez, S., Vanhaudenhuyse, A., Laureys, S., and Brédart, S. (2017c). Mirror 
efficiency in the assessment of visual pursuit in patients in minimally 
conscious state. Brain Inj. 31, 1429–1435. 
doi:10.1080/02699052.2017.1376755. 
Whyte, J., DiPasquale, M. C., and Vaccaro, M. (1999). Assessment of command-
following in minimally conscious brain injured patients. Arch. Phys. Med. 
Rehabil. 80, 653–660. doi:10.1016/S0003-9993(99)90168-5. 
Whyte, J., Rajan, R., Rosenbaum, A., Katz, D., Kalmar, K., Seel, R., et al. (2014). 
Zolpidem and restoration of consciousness. Am J Phys Med Rehabil 93, 101–
113. doi:10.1097/PHM.0000000000000069. 
Wiethoff, S., Hamada, M., and Rothwell, J. C. (2014). Variability in response to 
transcranial direct current stimulation of the motor cortex. Brain Stimul 7, 
468–475. doi:10.1016/j.brs.2014.02.003. 
Wijdicks, E. F., Bamlet, W. R., Maramattom, B. V, Manno, E. M., and McClelland, R. L. 
(2005). Validation of a new coma scale: The FOUR score. Ann Neurol 58, 585–
593. doi:10.1002/ana.20611. 
Williams, S. T., Conte, M. M., Goldfine, A. M., Noirhomme, Q., Gosseries, O., 
Thonnard, M., et al. (2013). Common resting brain dynamics indicate a 
possible mechanism underlying zolpidem response in severe brain injury. Elife 
2, e01157. 
Wu, M., Yu, Y., Luo, L., Wu, Y., Gao, J., Ye, X., et al. (2019). Efficiency of Repetitive 
Transcranial Direct Current Stimulation of the Dorsolateral Prefrontal Cortex 
in Disorders of Consciousness: A Randomized Sham-Controlled Study. Neural 
Plast. 2019, 1–11. doi:10.1155/2019/7089543. 
Wu, Y. J., Tseng, P., Chang, C. F., Pai, M. C., Hsu, K. Sen, Lin, C. C., et al. (2014). 
Modulating the interference effect on spatial working memory by applying 
transcranial direct current stimulation over the right dorsolateral prefrontal 
cortex. Brain Cogn. 91, 87–94. doi:10.1016/j.bandc.2014.09.002. 
Yampolsky, C., Hem, S., and Bendersky, D. (2012). Dorsal column stimulator 
applications. Surg. Neurol. Int. 3, 275. doi:10.4103/2152-7806.103019. 
Yu, Y., Yang, Y., Wang, L., Fang, J., Chen, Y., He, J., et al. (2017). Transcutaneous 
auricular vagus nerve stimulation in disorders of consciousness monitored by 
fMRI: The first case report. Brain Stimul. 10, 328–330. 
doi:10.1016/j.brs.2016.12.004. 
Zhang, Y., Song, W., Du, J., Huo, S., Shan, G., and Li, R. (2017). Transcranial Direct 
Current Stimulation in Patients with Prolonged Disorders of Consciousness: 





Zheng, Z. S., Reggente, N., Lutkenhoff, E., Owen, A. M., and Monti, M. M. (2017). 
Disentangling disorders of consciousness: Insights from diffusion tensor 
imaging and machine learning. Hum. Brain Mapp. 38, 431–443. 
doi:10.1002/hbm.23370. 
Ziv, J., and Lempel, A. (1978). Compression of individual sequences via variable-rate 
coding. IEEE Trans. Inf. Theory 24, 530–536. doi:10.1109/TIT.1978.1055934. 
Zrenner, C., Belardinelli, P., Müller-Dahlhaus, F., and Ziemann, U. (2016). Closed-
Loop Neuroscience and Non-Invasive Brain Stimulation: A Tale of Two Loops. 








































































7.2. Appendix 2 – Operational definitions of 
CRS-R behaviors indicating conscious 
awareness. 
Behavior Operational Definition† 
Auditory Subscale 
Consistent movement to 
command† 
A clearly-discernible, accurate response is 
observed following administration of a one-
step command (eye, limb, oral). Responses 
must be accurate on 4 consecutive trials of 
2 different commands. 
Reproducible movement to 
command† 
A clearly-discernible, accurate response is 
observed following administration of a one-
step command. Responses must be 
accurate on 3 of 4 trials of at least one 
command. 
Visual Subscale 
Object recognition† Two different familiar objects presented 
together are correctly identified by pointing 
or touch. Responses must be accurate on at 
least 3 of 4 trials administered. 
Object localization† Following presentation of an object to the 
right and left of an extremity, the extremity 
moves in the direction of the object. The 
limb does not need to make contact with 
the object, only to move toward it. 
Movement must occur in the correct 
direction on 3 of 4 trials administered. 
Visual pursuit† One or both eyes follow movement of a 
mirror without loss of fixation for at least 45 
degrees from midline. Response must occur 
at least twice in any direction over 4 trials.   
Visual fixation† Following movement of a visual stimulus 




visual field, one or both eyes move from the 
initial position to the new stimulus location 
and re-fixate for at least 3 seconds. 
Response must occur at least twice in any 
direction over 4 trials.   
Motor Subscale 
Functional object use * Following instruction to demonstrate use of 
a common object placed in the hand, a 
movement sequence is executed that is 
generally compatible with the object’s 
specific function. Responses must be 
accurate on 2 of 2 trials with two different 
objects. 
Automatic movement† At least 2 episodes of non-reflexive motor 
behavior (e.g., scratching, wave) are 
observed during the examination. 
Object manipulation† Following placement of a ball on the dorsal 
surface of the hand, there is rotation of the 
wrist and sustained (≥5s) grasp of the 
object. Cannot be accomplished through 
grasp reflex. 
Localization to noxious 
stimulation† 
Following pressure applied for a minimum 
of 5 seconds on the finger or toe, the non-
stimulated limb locates and makes contact 
with the stimulated body part on at least 2 
of the 4 trials administered on each side. 
Oromotor/Verbal Subscale 
Intelligible verbalization† At least two different fully-intelligible 
words, consisting of a consonant-vowel-
consonant blend, are verbalized during the 
course of the examination. 
Communication Subscale 
Functional communication * A clearly discernible, accurate verbal or 
gestural yes-no responses occurs following 
administration of 6 consecutive questions 




I touching my ear/nose?”).  
Intentional communication† A clearly discernible verbal or gestural yes-
no response occurs following 
administration of at least 2 of 6 questions 
concerning situational orientation (e.g. “Am 
I touching my ear/nose?”).  
† Denotes the minimally conscious state; * denotes emergence from the 
minimally conscious state. Operational definitions are extracted from the 






7.3. Appendix 3 – Median EEG values 
 Band Power 
 
Active tDCS Sham tDCS 
Pre Post POC (%) Pre Post POC (%) 
 All (n=42) 
Delta (1-4 Hz) 0.6832 0.7119 1.8385 0.6373 0.6086 -0.5191 
Theta (4-8 Hz) 0.1114 0.1001 -6.9476 0.1078 0.1035 -3.5746 
Alpha (8-13 Hz) 0.0614 0.0702 -6.9252 0.0772 0.0720 2.3533 
Beta1 (13-23 Hz) 0.0580 0.0752 2.1878 0.0773 0.0925 4.3483 
Beta2 (23-35 Hz) 0.0258 0.0209 -5.0804 0.0342 0.0392 12.0768 
 UWS (n=14) 
Delta (1-4 Hz) 0.7478 0.7378 -1.4414 0.7077 0.6485 -0.1335 
Theta (4-8 Hz) 0.0816 0.0682 -14.5778 0.0924 0.0775 -5.0588 
Alpha (8-13 Hz) 0.0355 0.0412 -14.7607 0.0299 0.0589 3.4494 
Beta1 (13-23 Hz) 0.0379 0.0528 15.6503 0.0309 0.0701 3.6072 
Beta2 (23-35 Hz) 0.0203 0.0209 34.2773 0.0187 0.0329 4.6304 
 MCS & EMCS (n=28) 
Delta (1-4 Hz) 0.6822 0.6682 4.1525 0.6279 0.5978 -1.3138 
Theta (4-8 Hz) 0.1169 0.1055 -6.224 0.1166 0.1087 -3.4368 
Alpha (8-13 Hz) 0.0616 0.0769 -6.6933 0.0803 0.0888 2.3533 
Beta1 (13-23 Hz) 0.0732 0.0862 -2.1058 0.0852 0.0925 4.3483 
Beta2 (23-35 Hz) 0.0288 0.0226 -7.1006 0.0353 0.0392 12.0791 
 LZW Complexity 
 All (n=42) 
Delta (1-4 Hz) 0.1477 0.1476 -1.5524 0.1512 0.1469 -0.2489 
Theta (4-8 Hz) 0.2552 0.2575 -0.2245 0.2576 0.2589 -0.7161 
Alpha (8-13 Hz) 0.4068 0.4113 0.3103 0.4145 0.4132 -0.0133 
Beta1 (13-23 Hz) 0.5149 0.5137 -0.2398 0.5160 0.5165 0.0545 
Beta2 (23-35 Hz) 0.6053 0.6050 -0.0149 0.6037 0.6048 0.0504 
 UWS (n=14) 
Delta (1-4 Hz) 0.1456 0.1459 -2.1267 0.1436 0.1448 -0.2489 
Theta (4-8 Hz) 0.2472 0.2509 3.8052 0.2472 0.2462 -1.1196 
Alpha (8-13 Hz) 0.4047 0.4120 2.8911 0.4133 0.4106 -0.1517 




Beta2 (23-35 Hz) 0.6054 0.6056 0.5424 0.6034 0.6049 0.0504 
 MCS & EMCS (n=28) 
Delta (1-4 Hz) 0.1478 0.1477 -1.5524 0.1519 0.1475 -0.3877 
Theta (4-8 Hz) 0.2569 0.2591 -0.5019 0.2623 0.2600 -0.0113 
Alpha (8-13 Hz) 0.4068 0.4105 -0.0537 0.4148 0.4132 -0.0133 
Beta1 (13-23 Hz) 0.5151 0.5140 -0.1750 0.5155 0.5165 0.0769 
Beta2 (23-35 Hz) 0.6051 0.6037 -0.0332 0.6039 0.6039 0.0692 
Median values of the relative EEG band power and LZW complexity averaged across all 
electrodes per patient and per band. POC= median percentage of change; UWS= 
Unresponsive Wakefulness Syndrome; MCS= Minimally Conscious State; EMCS= 


















7.5. Appendix 5 – Case Report Form Adverse 
Event Reporting 
 
 
 
 
 
  
 
 
 
 
